{"text": "The observed event rates ( approximately 6 % ) were less than expected .Considering a new trial with a 6 % expected primary end point event rate , with all other assumptions unchanged , then with the same sample size , the power would become 90 % .", "label": "", "metadata": {}, "score": "33.39963"}
{"text": "Follow - up period was shortened from 6 months to 4 months to ensure that patients recruited to the trial could be followed up by the end of the study .", "label": "", "metadata": {}, "score": "41.135883"}
{"text": "It was agreed that the most efficient method to improve patient recruitment was to increase the number of general practices in the trial and to reduce the follow - up period .", "label": "", "metadata": {}, "score": "47.03679"}
{"text": "This combined clinical end point is being used , to the best of our knowledge , for the first time in this trial .Thus , the power of the study was calculated under various scenarios concerning different values of the 12 months percentage of improvement in either group .", "label": "", "metadata": {}, "score": "47.311546"}
{"text": "This combined clinical end point is being used , to the best of our knowledge , for the first time in this trial .Thus , the power of the study was calculated under various scenarios concerning different values of the 12 months percentage of improvement in either group .", "label": "", "metadata": {}, "score": "47.311546"}
{"text": "For the reasons listed above , this study was designed as a Prospective Randomized Open Blinded End - point trial with two parallel groups and with dynamic allocation at the individual level .", "label": "", "metadata": {}, "score": "49.65226"}
{"text": "The study was designed by taking into account ( 1 ) the need to include all patients who are potential candidates for the therapeutic benefit of angioplasty and ( 2 ) the need for a short enrollment period and a follow - up of 12 months .", "label": "", "metadata": {}, "score": "50.314342"}
{"text": "The study was designed by taking into account ( 1 ) the need to include all patients who are potential candidates for the therapeutic benefit of angioplasty and ( 2 ) the need for a short enrollment period and a follow - up of 12 months .", "label": "", "metadata": {}, "score": "50.314342"}
{"text": "The target training regimen for home exercise was 5 times per week for 40 minutes at a heart rate of 60 % to 70 % of heart rate reserve .", "label": "", "metadata": {}, "score": "51.14998"}
{"text": "The ability to achieve a 13 % risk reduction for the end point of cardiovascular mortality or heart failure hospitalization is important , given the exceptional use of evidence - based therapies among the patients in this study at baseline and throughout the trial .", "label": "", "metadata": {}, "score": "51.205296"}
{"text": "Trial Steering Committee .Declarations .Acknowledgements .This project was funded from the NIHR Collaboration for Leadership in Applied Health Research and Care for Greater Manchester .", "label": "", "metadata": {}, "score": "51.403908"}
{"text": "It would thus add little to what we know from observational studies and leave the question of efficacy still in need of a rigorous phase III trial .", "label": "", "metadata": {}, "score": "51.491093"}
{"text": "It would thus add little to what we know from observational studies and leave the question of efficacy still in need of a rigorous phase III trial .", "label": "", "metadata": {}, "score": "51.491093"}
{"text": "A group of larger trials were designed to detect an effect of impregnated bed nets or curtains on all - cause mortality as the primary end - point .", "label": "", "metadata": {}, "score": "51.509323"}
{"text": "Follow - up .To take into account the additional time needed to recruit patients from six additional clusters , baseline patient recruitment was extended until 30 April 2013 .", "label": "", "metadata": {}, "score": "51.771553"}
{"text": "This trial is a multicenter , parallel group , blinded , phase III randomized controlled trial .The study flow chart is shown in Figure 2 .", "label": "", "metadata": {}, "score": "52.46411"}
{"text": "This trial is a multicenter , parallel group , blinded , phase III randomized controlled trial .The study flow chart is shown in Figure 2 .", "label": "", "metadata": {}, "score": "52.46411"}
{"text": "Over 20,000 clinic attendances were included in the primary analysis and a statistically significant efficacy of 27 % against all - cause clinic attendance was reported .", "label": "", "metadata": {}, "score": "52.742035"}
{"text": "When the potential participant contacts the study trial office , he or she will be informed of the objectives of the study and asked if they are willing to participate .", "label": "", "metadata": {}, "score": "52.968758"}
{"text": "Discussion .Modifications to cluster and patient recruitment targets following feedback to the TSC have offered opportunities for this trial to retain adequate statistical power and deliver on all aims and objectives .", "label": "", "metadata": {}, "score": "54.248375"}
{"text": "Two issues have been identified that are of some concern .Firstly , the choice of primary endpoint is not stated in the reports of a number of the trials and , secondly , the relationship between pre - specified analysis plans and trial reports is rarely made clear .", "label": "", "metadata": {}, "score": "54.680008"}
{"text": "We based the study design on the traditional 36-session cardiac rehabilitation model , followed by regular home exercise .Unlike the study by Belardinelli et al , 6 evaluating a strategy of only supervised training was not feasible , and it is unlikely that such a strategy would be adopted in practice .", "label": "", "metadata": {}, "score": "55.12905"}
{"text": "Exercise was initiated at 15 to 30 minutes per session at a heart rate corresponding to 60 % of heart rate reserve ( maximal heart rate on cardiopulmonary exercise test minus resting heart rate ) .", "label": "", "metadata": {}, "score": "55.32495"}
{"text": "Methods such as these that allow variable follow - up time between individuals to be taken into account are generally accepted to be preferable for field efficacy trials .", "label": "", "metadata": {}, "score": "55.337757"}
{"text": "Had this been a typical situation , without strong media pressure [ 57 ] , a phase III comparative randomized trial at this stage probably would not have been justified and we would have proceeded with a phase II study .", "label": "", "metadata": {}, "score": "55.957924"}
{"text": "Had this been a typical situation , without strong media pressure [ 57 ] , a phase III comparative randomized trial at this stage probably would not have been justified and we would have proceeded with a phase II study .", "label": "", "metadata": {}, "score": "55.957924"}
{"text": "Details of the exercise training protocol have been reported .16 Patients were to begin home - based exercise after completing 18 supervised sessions and were to fully transition to home exercise after 36 supervised sessions .", "label": "", "metadata": {}, "score": "56.04333"}
{"text": "Recruitment will last 12 months , and patients will be followed up for 12 months ( 15 months in the event that the last follow - up has to be delayed ) .", "label": "", "metadata": {}, "score": "56.105736"}
{"text": "Recruitment will last 12 months , and patients will be followed up for 12 months ( 15 months in the event that the last follow - up has to be delayed ) .", "label": "", "metadata": {}, "score": "56.105736"}
{"text": "Power calculation for different scenarios of baseline values and deltas of the probability of improvement at 1 year in the combined clinical end point ( intention - to - treat analysis ) .", "label": "", "metadata": {}, "score": "56.109863"}
{"text": "Power calculation for different scenarios of baseline values and deltas of the probability of improvement at 1 year in the combined clinical end point ( intention - to - treat analysis ) .", "label": "", "metadata": {}, "score": "56.109863"}
{"text": "The end - points and measurement methods must allow comparability of the performance of the same intervention in different locations and age groups and over time at the same location .", "label": "", "metadata": {}, "score": "57.02578"}
{"text": "Within 1.5 years after the start of recruitment , the DCC member in charge of monitoring study quality will provide a description of preliminary results on the subset of patients with 1 year of follow - up , allowing assessment of the validity of the sample size calculations .", "label": "", "metadata": {}, "score": "57.132004"}
{"text": "Within 1.5 years after the start of recruitment , the DCC member in charge of monitoring study quality will provide a description of preliminary results on the subset of patients with 1 year of follow - up , allowing assessment of the validity of the sample size calculations .", "label": "", "metadata": {}, "score": "57.132004"}
{"text": "This rate was higher than projected in the study design .After approximately 2000 patients were enrolled , unconditional power calculations based on the higher overall event rate revealed that the number of events required for 90 % statistical power could be achieved with 2300 patients rather than the original goal of 3000 .", "label": "", "metadata": {}, "score": "57.330864"}
{"text": "Data on trial methods and reporting for each study were extracted into tables and are summarized [ see additional file 1 ] .Eligibility criteria .", "label": "", "metadata": {}, "score": "57.385044"}
{"text": "All end points were independently adjudicated by a Clinical Events Committee blinded to randomization groups .In addition , interim analyses at enrollment of each 500 patients were evaluated by an independent data and safety monitoring board blinded to study allocation .", "label": "", "metadata": {}, "score": "57.606564"}
{"text": "The relapse rate ( secondary end point ) in the two treatment groups will be compared by means of a LRT , assuming a Poisson model ( also adjusting for the same factors considered for the primary end point ) .", "label": "", "metadata": {}, "score": "57.92997"}
{"text": "The relapse rate ( secondary end point ) in the two treatment groups will be compared by means of a LRT , assuming a Poisson model ( also adjusting for the same factors considered for the primary end point ) .", "label": "", "metadata": {}, "score": "57.92997"}
{"text": "Methods and analysis : This Prospective Randomized Open Blinded End - point study is designed with two parallel groups , with dynamic allocation at the individual level .", "label": "", "metadata": {}, "score": "58.14461"}
{"text": "The absolute reduction in the primary event rate at 3 years was 4 % .At least 1 hospitalization was experienced in 729 patients ( 63 % ) in the exercise training group vs 760 ( 65 % ) in the usual care group .", "label": "", "metadata": {}, "score": "58.412197"}
{"text": "The randomization procedure will be defined by the Data Coordination Center ( DCC ) and will be stratified by participating center and disease course , RRMS or SPMS , with variable length blocks .", "label": "", "metadata": {}, "score": "58.69452"}
{"text": "The randomization procedure will be defined by the Data Coordination Center ( DCC ) and will be stratified by participating center and disease course , RRMS or SPMS , with variable length blocks .", "label": "", "metadata": {}, "score": "58.69452"}
{"text": "Biomedical data are collected and psychosocial scales completed at baseline , and 6 , 12 , and 18 months post programme .Qualitative research with participants and educators will explore views and experiences of the trial and preferences for methods of monitoring .", "label": "", "metadata": {}, "score": "58.97639"}
{"text": "The follow - up period ended March 15 , 2008 .The median duration of follow - up for the primary end point was 30.1 months ( goal of a minimum of 1 year and a maximum of 4 years ) .", "label": "", "metadata": {}, "score": "59.027134"}
{"text": "In the latter study , SP pre - treatment delayed the median time to first clinical episode from 38 days to 68 days .The data now available suggest that pre - treatment of vaccine trial participants may have complex effects of unpredictable duration on observed vaccine efficacy .", "label": "", "metadata": {}, "score": "59.197113"}
{"text": "Having agreed these aspects the plan is to produce standardized clinical trial methods , protocols and reporting templates .This report forms one part of the background to such harmonization and standardization efforts .", "label": "", "metadata": {}, "score": "59.310658"}
{"text": "In addition , all patients were asked to complete a physical activity questionnaire at the baseline , 6-month , 12-month , 24-month , 3-year , and final visits .", "label": "", "metadata": {}, "score": "59.319656"}
{"text": "All participants will be required to provide written informed consent .The trial will be implemented and reported in accordance with the recommendations of CONSORT .", "label": "", "metadata": {}, "score": "59.49183"}
{"text": "All participants will be required to provide written informed consent .The trial will be implemented and reported in accordance with the recommendations of CONSORT .", "label": "", "metadata": {}, "score": "59.49183"}
{"text": "Furthermore , an independent data monitoring committee will accurate assess the progress of the clinical trial , the safety data and critical efficacy variables and provide recommendations to the sponsor regarding the continuation , modification or termination of the trial .", "label": "", "metadata": {}, "score": "59.876633"}
{"text": "This is a multicenter , randomized , parallel group , blinded , sham - controlled trial to assess the efficacy and safety of PTA .Participants with relapsing remitting MS or secondary progressive MS and a sonographic diagnosis of CCSVI will be enrolled after providing their informed consent .", "label": "", "metadata": {}, "score": "60.183914"}
{"text": "This is a multicenter , randomized , parallel group , blinded , sham - controlled trial to assess the efficacy and safety of PTA .Participants with relapsing remitting MS or secondary progressive MS and a sonographic diagnosis of CCSVI will be enrolled after providing their informed consent .", "label": "", "metadata": {}, "score": "60.183914"}
{"text": "The study is a multi - center , randomized , double - blinded placebo controlled study to evaluate the efficacy and safety of two different doses of Nefecon in 90 primary IgA nephropathy patients at risk of end - stage renal disease .", "label": "", "metadata": {}, "score": "60.282066"}
{"text": "The treatment effect on each single functional parameter of the combined end point will also be assessed using the Hochberg correction for multiple testing [ 54 ] .", "label": "", "metadata": {}, "score": "60.617664"}
{"text": "The treatment effect on each single functional parameter of the combined end point will also be assessed using the Hochberg correction for multiple testing [ 54 ] .", "label": "", "metadata": {}, "score": "60.617664"}
{"text": "Based on the main analysis adjusted for heart failure etiology only , exercise training produced nonsignificant reductions in the primary end point ( all - cause mortality or all - cause hospitalization ) and in key secondary clinical end points .", "label": "", "metadata": {}, "score": "60.78713"}
{"text": "The uncertainty surrounding CCSVI and PTA treatment means that it should be dealt with only as part of a properly designed randomized clinical trial .Outcomes should include clinical and quality of life measures \" [ 38 ] .", "label": "", "metadata": {}, "score": "60.82583"}
{"text": "The uncertainty surrounding CCSVI and PTA treatment means that it should be dealt with only as part of a properly designed randomized clinical trial .Outcomes should include clinical and quality of life measures \" [ 38 ] .", "label": "", "metadata": {}, "score": "60.82583"}
{"text": "Six hundred seventy - nine patients will be recruited .The follow - up is scheduled at 12 months .Patients , treating neurologists , trained outcome assessors , and the statistician in charge of data analysis will be masked to the assigned treatment .", "label": "", "metadata": {}, "score": "61.053463"}
{"text": "Six hundred seventy - nine patients will be recruited .The follow - up is scheduled at 12 months .Patients , treating neurologists , trained outcome assessors , and the statistician in charge of data analysis will be masked to the assigned treatment .", "label": "", "metadata": {}, "score": "61.053463"}
{"text": "In trials where the choice of the end - point is designed to approximate what might happen in the usual health care system the use of ACD should be avoided .", "label": "", "metadata": {}, "score": "61.097717"}
{"text": "CBT programme Individual - administered CBT will be employed in this study .CBT intervention will be conducted over 16 weekly , individual sessions .Most sessions will last for a period of 50 min , but the protocol allows therapists to extend up to six sessions to a maximum of 90 min to facilitate behavioural experiments .", "label": "", "metadata": {}, "score": "61.234596"}
{"text": "2009;301(14):1451 - 1459 Link to Article .Whellan DJ , O'Connor CM , Lee KL , et al ; HF - ACTION Trial Investigators .Heart failure and a controlled trial investigating outcomes of exercise training ( HF - ACTION ) : design and rationale .", "label": "", "metadata": {}, "score": "61.238136"}
{"text": "2009;301(14):1451 - 1459 Link to Article .Whellan DJ , O'Connor CM , Lee KL , et al ; HF - ACTION Trial Investigators .Heart failure and a controlled trial investigating outcomes of exercise training ( HF - ACTION ) : design and rationale .", "label": "", "metadata": {}, "score": "61.238136"}
{"text": "Patients randomized to the exercise training group first participated in a structured , group - based , supervised exercise program , with a goal of 3 sessions per week for a total of 36 sessions in 3 months .", "label": "", "metadata": {}, "score": "61.243706"}
{"text": "Dropout cases ( missing data at both the 12-month assessment and the 3-month extension ) will be excluded from both the ITT and the PP analyses .", "label": "", "metadata": {}, "score": "61.307198"}
{"text": "Dropout cases ( missing data at both the 12-month assessment and the 3-month extension ) will be excluded from both the ITT and the PP analyses .", "label": "", "metadata": {}, "score": "61.307198"}
{"text": "Patients in the usual care group were not provided with a formal exercise prescription .All patients were asked to return for clinic visits every 3 months for the first 2 years of participation and yearly thereafter for up to 4 years .", "label": "", "metadata": {}, "score": "61.435524"}
{"text": "In the usual care group , 22 patients had such a hospitalization , despite not undergoing a formal exercise program .Only 1 patient had an ICD discharge that caused at least 1 supervised exercise training session to fail to reach the target duration or intensity .", "label": "", "metadata": {}, "score": "61.554794"}
{"text": "Bensimhon DR , Leifer ES , Ellis SJ , et al ; HF - ACTION Trial Investigators .Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure ( from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing ) .", "label": "", "metadata": {}, "score": "61.97953"}
{"text": "Bensimhon DR , Leifer ES , Ellis SJ , et al ; HF - ACTION Trial Investigators .Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure ( from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing ) .", "label": "", "metadata": {}, "score": "61.97953"}
{"text": "All patients were to undergo baseline cardiopulmonary exercise testing .Test results were reviewed by investigators to ( 1 ) identify significant arrhythmias or ischemia that would prevent safe exercise training , ( 2 ) determine appropriate levels of exercise training , and ( 3 ) establish training heart rate ranges .", "label": "", "metadata": {}, "score": "62.00077"}
{"text": "All analyses were performed according to the intention - to - treat principle , with inclusion of all randomized patients according to original group allocation and without imputation .", "label": "", "metadata": {}, "score": "62.13348"}
{"text": "Statistical analyses .The DCC will be responsible for the statistical analysis at the end of the study .Analysis will be performed blinded to the treatment allocation .", "label": "", "metadata": {}, "score": "62.133522"}
{"text": "Statistical analyses .The DCC will be responsible for the statistical analysis at the end of the study .Analysis will be performed blinded to the treatment allocation .", "label": "", "metadata": {}, "score": "62.133522"}
{"text": "Thus , in some trials , specifically some of the ITN trials [ 2 , 43 - 46 ] , death from any cause has been the primary end - point .", "label": "", "metadata": {}, "score": "62.212257"}
{"text": "Further , par- ticipants will be instructed to not tell the assessor about their treatment assignment prior to the assessment .Independent assessors will receive training and supervi- sion by the study investigator as well as a manual outlin- ing the procedures for each clinician - administrated measure .", "label": "", "metadata": {}, "score": "62.336014"}
{"text": "The changes from baseline in peak oxygen consumption and distance in the 6-minute walk test at 3 months and 1 year are presented in Table 4 .", "label": "", "metadata": {}, "score": "62.359528"}
{"text": "The results of HF - ACTION should be interpreted in the context of the following potential limitations .The patients enrolled in this trial were relatively young compared with the general population with heart failure and did not have heart failure with preserved left ventricular function ( or diastolic heart failure ) .", "label": "", "metadata": {}, "score": "62.417145"}
{"text": "Further , therapists will be allowed to further customise the sessions at any stage of the CBT programme ( figure 2 presents an overview ) .", "label": "", "metadata": {}, "score": "62.578945"}
{"text": "Please refer to The JAMA Network 's Privacy Policy for additional information .Feres F , Costa RA , Abizaid A , et al .Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus - Eluting Stents : The OPTIMIZE Randomized Trial .", "label": "", "metadata": {}, "score": "62.610043"}
{"text": "The secondary analysis will be run per protocol ( PP ) and will take into consideration all randomized patients who were positive ( true CCSVI ) also at the time of venography .", "label": "", "metadata": {}, "score": "62.64845"}
{"text": "The secondary analysis will be run per protocol ( PP ) and will take into consideration all randomized patients who were positive ( true CCSVI ) also at the time of venography .", "label": "", "metadata": {}, "score": "62.64845"}
{"text": "The exercise training goal during this time was 90 minutes per week .In the third year of follow - up , patients in the exercise training group were exercising a median of 50 minutes per week ( interquartile range , 0 - 140 minutes per week ) .", "label": "", "metadata": {}, "score": "62.90805"}
{"text": "These findings build on those from other randomized noninferiority trials with relatively smaller sample sizes , which suggested safety and efficacy of short - term dual antiplatelet therapy in patients treated with second - generation drug - eluting stents .", "label": "", "metadata": {}, "score": "62.93972"}
{"text": "Design , Setting , and Patients The OPTIMIZE trial was an open - label , active - controlled , 1:1 randomized noninferiority study including 3119 patients in 33 sites in Brazil between April 2010 and March 2012 .", "label": "", "metadata": {}, "score": "62.97856"}
{"text": "To ensure that we retained power to detect a difference in the main outcome measure ( SCL-90 ) we increased the number of clusters from 30 to 36 .", "label": "", "metadata": {}, "score": "63.048115"}
{"text": "Sample size Forty - two patients will be randomised into the study .This sample size was based on results from our previous pilot study that indicated that the estimated group difference in LSAS scores was approximately 30 .", "label": "", "metadata": {}, "score": "63.09127"}
{"text": "All pharmacological or rehabilitative treatments ( motor reeducation and balance , walking and cognitive training ) , carried out during the study and in the six months previous randomization will be recorded in the e - CRF .", "label": "", "metadata": {}, "score": "63.23215"}
{"text": "All pharmacological or rehabilitative treatments ( motor reeducation and balance , walking and cognitive training ) , carried out during the study and in the six months previous randomization will be recorded in the e - CRF .", "label": "", "metadata": {}, "score": "63.23215"}
{"text": "CG contributed to the design of the training programme and edited the manuscript .CJG prepared the manuscript for publication and assisted with trial design and selection of outcome measures .", "label": "", "metadata": {}, "score": "63.25162"}
{"text": "Study progress .Patient and GP practice recruitment .General practice recruitment began on 3 January 2012 .The patient recruitment phase of the trial began when the first patient was recruited into the study on 1 May 2012 .", "label": "", "metadata": {}, "score": "63.41542"}
{"text": "We identified two primary end points , one defined by a combination of clinical parameters related to specific functional deficits experienced by patients with MS and the other one based on MRI findings , both measured 12 months after randomization .", "label": "", "metadata": {}, "score": "63.4487"}
{"text": "Post hoc superiority analysis was conducted for clinical end points .Time to the primary end point and its components , including landmark analysis at 90 days , was also evaluated using the Kaplan - Meier method , and the log - rank test was used to compare differences .", "label": "", "metadata": {}, "score": "63.479996"}
{"text": "Differences in health status between those who returned for the 12-month cardiopulmonary exercise test and those who did not also may have played a role .", "label": "", "metadata": {}, "score": "63.69735"}
{"text": "Our primary hypothesis was that in patients with stable heart failure , regular structured exercise training , when added to usual , evidence - based care in accordance with published guidelines , would significantly reduce the incidence of a combined end point of all - cause mortality or all - cause hospitalization .", "label": "", "metadata": {}, "score": "63.734085"}
{"text": "In one of the study cohorts in the study of Alonso et al [ 7 ] the scheduled interaction between study staff and participants during the efficacy follow - up period was less than for any other cohort in the vaccine studies identified .", "label": "", "metadata": {}, "score": "63.75203"}
{"text": "Changes from baseline in NYHA class were compared between treatment groups using ordinal logistic regression .An independent data and safety monitoring board was appointed by the National Heart , Lung , and Blood Institute to review the interim results of the study and evaluate patient safety and trial feasibility on a semiannual basis .", "label": "", "metadata": {}, "score": "63.79715"}
{"text": "Importance The current recommendation is for at least 12 months of dual antiplatelet therapy after implantation of a drug - eluting stent .However , the optimal duration of dual antiplatelet therapy with specific types of drug - eluting stents remains unknown .", "label": "", "metadata": {}, "score": "63.799835"}
{"text": "The duration of the procedure and the doses of radiation administered to patients will be monitored during the study .This information is clearly stated in the informed consent form .", "label": "", "metadata": {}, "score": "63.81809"}
{"text": "In practice , in addition to the primary end - point ( if one is specified ! ) the sum of the evidence from all of the end - points measured is usually taken into account , together with their biological plausibility and their consistency , in the overall assessment of the potential impact of an intervention .", "label": "", "metadata": {}, "score": "64.03593"}
{"text": "It is important to recognize that the main or primary analysis for the study that adjusted only for heart failure etiology did not result in a significant reduction in the primary end point or secondary end points .", "label": "", "metadata": {}, "score": "64.114"}
{"text": "The reporting form will be defined in collaboration with the DCC and the CRO , it will be approved by SC and it will be produced by the CRO in a blinded form .", "label": "", "metadata": {}, "score": "64.17935"}
{"text": "The reporting form will be defined in collaboration with the DCC and the CRO , it will be approved by SC and it will be produced by the CRO in a blinded form .", "label": "", "metadata": {}, "score": "64.17935"}
{"text": "Given the current number of recruited patients , the values in Table 6 indicate the minimum number of SAEs that should alert the investigators to assess whether to continue the study .", "label": "", "metadata": {}, "score": "64.428055"}
{"text": "Given the current number of recruited patients , the values in Table 6 indicate the minimum number of SAEs that should alert the investigators to assess whether to continue the study .", "label": "", "metadata": {}, "score": "64.428055"}
{"text": "At 12 months , the differences in cardiopulmonary exercise test results remained but there was no significant difference in distance in the 6-minute walk test .", "label": "", "metadata": {}, "score": "64.6662"}
{"text": "Among PatientsReceiving Short- and Long - term Dual Antiplatelet Therapy at 0 - 360 Days , 0 - 90 Days , and 91 - 360 Days .", "label": "", "metadata": {}, "score": "64.72476"}
{"text": "Recruitment The planned recruitment rate is two participants per month , between June 2012 and March 2014 , or until a total of 42 participants have been recruited .", "label": "", "metadata": {}, "score": "64.8201"}
{"text": "Although a treatment scheme of 3 months of dual antiplatelet therapy was tested in RESET , multiple types of stents were included .Recent analyses comparing first- and second - generation drug - eluting stents have demonstrated lower rates of stent thrombosis over time with second - generation stents .", "label": "", "metadata": {}, "score": "65.00374"}
{"text": "The 6-minute walk test also was performed at the 3-year and final visits .Patients made their final visit at the end of the study follow - up period or at 4 years .", "label": "", "metadata": {}, "score": "65.044754"}
{"text": "The decision to utilize two primary end points emerged from various considerations .First , the hypothesized effect of angioplasty for MS patients with CCSVI does not allow exclusion of a clinical effect independent of the incidence of active MRI lesions .", "label": "", "metadata": {}, "score": "65.23236"}
{"text": "The decision to utilize two primary end points emerged from various considerations .First , the hypothesized effect of angioplasty for MS patients with CCSVI does not allow exclusion of a clinical effect independent of the incidence of active MRI lesions .", "label": "", "metadata": {}, "score": "65.23236"}
{"text": "Discussion The 6S trial will provide important safety and efficacy data on the use of HES 130/0.4 in patients with severe sepsis .The effects on mortality , dialysis - dependency , time on ventilator , bleeding and markers of resuscitation , metabolism , kidney failure , and coagulation will be assessed .", "label": "", "metadata": {}, "score": "65.24525"}
{"text": "Some limitations must be considered when interpreting our results .First , based on the relatively low event rates observed , our study might not have been powered to detect small differences in ischemic and bleeding events after 90 days .", "label": "", "metadata": {}, "score": "65.3405"}
{"text": "43 When this trial was designed , it was expected that both groups would have a 9 % composite event rate based on historical data .", "label": "", "metadata": {}, "score": "65.3765"}
{"text": "A sixth trial used amodiaquine / SP pre - treatment in a separate cohort , where only anti - infection efficacy data was generated [ 7 ] .", "label": "", "metadata": {}, "score": "65.45774"}
{"text": "Dr Gattis Stough received non - trial funding from the study coordinating center .Mr Seils did not receive compensation for his assistance apart from his employment at the study coordinating center .", "label": "", "metadata": {}, "score": "65.471115"}
{"text": "At the baseline clinic visit prior to randomization , demographics , socioeconomic status , past medical history , current medications , a physical examination , and the most recent laboratory tests were obtained .", "label": "", "metadata": {}, "score": "65.51499"}
{"text": "This paper describes the study protocol for a randomised controlled trial to evaluate the clinical effectiveness of CBT as a next - step strategy , concomitant with conventional treatment , for patients with SSRI - resistant SAD .", "label": "", "metadata": {}, "score": "65.527954"}
{"text": "Conclusion .The data from the trial will provide evidence on the effectiveness and cost - effectiveness of collaborative care for depression in people with diabetes and/or coronary heart disease .", "label": "", "metadata": {}, "score": "65.72091"}
{"text": "All included participants will provide a written informed consent form that explains the details of the trial , interventions and study protocol in accordance with the principles of the Declaration of Helsinki and the ICH E6 Guideline for Good Clinical Practice .", "label": "", "metadata": {}, "score": "65.75757"}
{"text": "All included participants will provide a written informed consent form that explains the details of the trial , interventions and study protocol in accordance with the principles of the Declaration of Helsinki and the ICH E6 Guideline for Good Clinical Practice .", "label": "", "metadata": {}, "score": "65.75757"}
{"text": "Thus , allowing for a 20 % dropout rate , 21 participants are required per group , for a total of 42 patients in the study .", "label": "", "metadata": {}, "score": "65.76645"}
{"text": "In a case series of 24 patients , 6 patients had a relapse of clinical symptoms within 1 to 2 months of the procedure , although it was reported that they felt better than before the procedure [ 31 ] .", "label": "", "metadata": {}, "score": "65.785934"}
{"text": "In a case series of 24 patients , 6 patients had a relapse of clinical symptoms within 1 to 2 months of the procedure , although it was reported that they felt better than before the procedure [ 31 ] .", "label": "", "metadata": {}, "score": "65.785934"}
{"text": "Although the numbers were small in this study , and the primary end - point was parasite density , there was a marked \" sterilizing \" effect of SP pre - treatment for several weeks into the follow - up period , such that efficacy could not be determined in the pre - treatment group .", "label": "", "metadata": {}, "score": "65.78777"}
{"text": "BMJ .Smart N , Marwick TH .Exercise training for patients with heart failure : a systematic review of factors that improve mortality and morbidity .", "label": "", "metadata": {}, "score": "65.879875"}
{"text": "BMJ .Smart N , Marwick TH .Exercise training for patients with heart failure : a systematic review of factors that improve mortality and morbidity .", "label": "", "metadata": {}, "score": "65.879875"}
{"text": "With an average of 10 patients over 36 practices ( 18 control/18 intervention ) the study will have 79.1 % power to detect a moderate standardised effect size of 0.4 at the 5 % level of significance , allowing for an intraclass correlation ( ICC ) of 0.06 .", "label": "", "metadata": {}, "score": "66.00775"}
{"text": "Time to Event for the Primary Composite End Point ( NACCE )Among PatientsReceiving Short- and Long - term Dual Antiplatelet Therapy-0 - 360 Days , 0 - 90 Days , and 91 - 360 Days .", "label": "", "metadata": {}, "score": "66.097046"}
{"text": "In order to be able to measure new infections , in most trials , anti - malarial treatment has been given prior to vaccination to clear asexual parasitaemia .", "label": "", "metadata": {}, "score": "66.13565"}
{"text": "Page 6 .The study investigator will review the randomisation online , and the participant will then be provided with an appointment to undergo one of the two treatment regimes .", "label": "", "metadata": {}, "score": "66.152176"}
{"text": "Kandzari DE , Angiolillo DJ , Price MJ , Teirstein PS .Identifying the \" optimal \" duration of dual antiplatelet therapy after drug - eluting stent revascularization .", "label": "", "metadata": {}, "score": "66.1904"}
{"text": "Kandzari DE , Angiolillo DJ , Price MJ , Teirstein PS .Identifying the \" optimal \" duration of dual antiplatelet therapy after drug - eluting stent revascularization .", "label": "", "metadata": {}, "score": "66.1904"}
{"text": "In this trial , we aim to evaluate the efficacy and safety of angioplasty of extracranial veins for patients with RRMS or SPMS as well as sonologic diagnosis of CCSVI .", "label": "", "metadata": {}, "score": "66.25273"}
{"text": "In this trial , we aim to evaluate the efficacy and safety of angioplasty of extracranial veins for patients with RRMS or SPMS as well as sonologic diagnosis of CCSVI .", "label": "", "metadata": {}, "score": "66.25273"}
{"text": "The traceability of all data ( original and corrected ) entered into the system will be guaranteed .The research data will be stored for up to 7 years , in compliance with any integrity issues that may arise from any subsequent publications ( Article 18 , paragraph 1 , of the D.l .", "label": "", "metadata": {}, "score": "66.27724"}
{"text": "HR indicates hazard ratio .Time to Event for Individual Components of the Primary Composite End Point ( Stroke , Major Bleeding )Among PatientsReceiving Short- and Long - term Dual Antiplatelet Therapy at 0 - 360 Days , 0 - 90 Days , and 91 - 360 Days .", "label": "", "metadata": {}, "score": "66.434616"}
{"text": "HR indicates hazard ratio .Time to Event for Individual Components of the Primary Composite End Point ( Stroke , Major Bleeding )Among PatientsReceiving Short- and Long - term Dual Antiplatelet Therapy at 0 - 360 Days , 0 - 90 Days , and 91 - 360 Days .", "label": "", "metadata": {}, "score": "66.434616"}
{"text": "BMJ Open 2013;3:e002242 .Page 5 . investigators will check the therapists ' protocol adher- ence and the homework adherence by patients using the original checklist .", "label": "", "metadata": {}, "score": "66.52227"}
{"text": "Feres F , Costa RA , Bhatt DL , et al .Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus - eluting stent in real - world clinical practice ( OPTIMIZE ) trial : rationale and design of a large - scale , randomized , multicenter study .", "label": "", "metadata": {}, "score": "66.524826"}
{"text": "Feres F , Costa RA , Bhatt DL , et al .Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus - eluting stent in real - world clinical practice ( OPTIMIZE ) trial : rationale and design of a large - scale , randomized , multicenter study .", "label": "", "metadata": {}, "score": "66.524826"}
{"text": "Due to poor detection rates and under - referral for treatment for depression in primary care in the UK , consenting patients will be screened for depression by the trial team using the Patient Health Questionnaire-9 ( PHQ-9 ) on two occasions , two weeks apart .", "label": "", "metadata": {}, "score": "66.545715"}
{"text": "In order to obtain a sample size of 222 , a total of 234 patients will be recruited ( 78 in the control arm and 156 in the experimental arm ) , taking into account a 5 % of drop - out due to lack of evaluation at 12 months .", "label": "", "metadata": {}, "score": "66.911255"}
{"text": "In order to obtain a sample size of 222 , a total of 234 patients will be recruited ( 78 in the control arm and 156 in the experimental arm ) , taking into account a 5 % of drop - out due to lack of evaluation at 12 months .", "label": "", "metadata": {}, "score": "66.911255"}
{"text": "The level of missing data on home exercise makes adherence in the exercise training group difficult to quantify .Some safety end points were measured only in the exercise training group and thus have no within - trial comparator group .", "label": "", "metadata": {}, "score": "66.93201"}
{"text": "Similar rates were seen in the pooled analysis with zotarolimus - eluting stents , including an ARC definite or probable stent thrombosis rate of 0.8 % up to 5 years follow - up , because most stent thromboses occurred within the first year after the procedure .", "label": "", "metadata": {}, "score": "66.986336"}
{"text": "The full description of the methods has been published .Randomization was conducted in a 1:1 ratio with the use of a block size of 8 for the 2 study groups and was stratified by the presence of diabetes mellitus .", "label": "", "metadata": {}, "score": "66.9928"}
{"text": "Based on previous data involving a similar patient population profile , 27 a primary end point rate ( NACCE at 12 months ) of 9 % was assumed for both groups .", "label": "", "metadata": {}, "score": "67.01016"}
{"text": "Statistical analysis Statistical analysis and reporting of this trial will be con- ducted in accordance with CONSORT guidelines , with the primary analyses based on the intent - to - treat prin- ciple without imputing missing observations .", "label": "", "metadata": {}, "score": "67.07909"}
{"text": "The interventions for the two groups are conventional treatment , alone , and CBT combined with conventional treatment , for 16 weeks .The primary end - point of SAD severity will be assessed by an independent assessor using the Liebowitz Social Anxiety Scale , and secondary end - points include severity of other social anxieties , depressive severity and functional impairment .", "label": "", "metadata": {}, "score": "67.329994"}
{"text": "Additional customisation of sessions are allowed at any stage of the CBT programme .Overview of the Yoshinaga N , Niitsu T , Hanaoka H , et al .", "label": "", "metadata": {}, "score": "67.348145"}
{"text": "In this study comparing 3 months vs 12 months of dual antiplatelet therapy among patients with coronary artery disease treated with zotarolimus - eluting stents in daily practice , results demonstrated noninferiority for short- vs long - term dual antiplatelet therapy .", "label": "", "metadata": {}, "score": "67.386505"}
{"text": "During these calls , as well as during the supervised training sessions and at follow - up clinic visits , adherence to the exercise training regimen was promoted by study personnel .", "label": "", "metadata": {}, "score": "67.5455"}
{"text": "In clinical practice , sometimes physicians and patients need to decide on the duration of dual antiplatelet therapy prior to the decision to revascularize , because it may be a factor in determining whether to place a drug - eluting stent .", "label": "", "metadata": {}, "score": "67.56341"}
{"text": "All 3 studies had patients engaged in supervised training during the early phases .The differences between studies may be due to adherence during the early stages or differences in baseline characteristics , including \u03b2 - blocker use .", "label": "", "metadata": {}, "score": "67.69495"}
{"text": "The study was conducted in accordance with the principles of the Declaration of Helsinki , International Organization for Standardization guidelines , and Good Clinical Practices guidelines .", "label": "", "metadata": {}, "score": "67.70744"}
{"text": "The average number of patients for these practices was 10 ( range 4 to 22 ) , below the target figure of 15 per practice .", "label": "", "metadata": {}, "score": "67.89067"}
{"text": "The randomization lists will be delivered to the DCC member responsible for quality before the beginning of recruitment .Allocation to treatment arms will be done centrally by web , and the result on the treatment assigned will be reported automatically in the database .", "label": "", "metadata": {}, "score": "67.91011"}
{"text": "The randomization lists will be delivered to the DCC member responsible for quality before the beginning of recruitment .Allocation to treatment arms will be done centrally by web , and the result on the treatment assigned will be reported automatically in the database .", "label": "", "metadata": {}, "score": "67.91011"}
{"text": "The research data will be stored for up to 7 years , in compliance with any integrity issues that may arise from any subsequent publications ( Article 18 , paragraph 1 , of the D.l .", "label": "", "metadata": {}, "score": "67.91905"}
{"text": "Participants in Heart Failure : A Controlled Trial Investigating Outcomes of Exercise Training ( HF - ACTION ) were randomized from April 2003 through February 2007 at 82 centers within the United States , Canada , and France ; median follow - up was 30 months .", "label": "", "metadata": {}, "score": "68.12487"}
{"text": "Data collection .The scheduling of examinations and tests is reported in Table 5 .The treating neurologist will be responsible for the overall medical management of patients , including pharmacological treatment for MS , as well as scheduled ( every 3 months ) and unscheduled follow - up visits .", "label": "", "metadata": {}, "score": "68.23393"}
{"text": "Data collection .The scheduling of examinations and tests is reported in Table 5 .The treating neurologist will be responsible for the overall medical management of patients , including pharmacological treatment for MS , as well as scheduled ( every 3 months ) and unscheduled follow - up visits .", "label": "", "metadata": {}, "score": "68.23393"}
{"text": "Please refer to The JAMA Network 's Privacy Policy for additional information . O'Connor CM , Whellan DJ , Lee KL , et al .Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure : HF - ACTION Randomized Controlled Trial .", "label": "", "metadata": {}, "score": "68.23514"}
{"text": "Feit F , Voeltz MD , Attubato MJ , et al .Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial .", "label": "", "metadata": {}, "score": "68.24887"}
{"text": "Feit F , Voeltz MD , Attubato MJ , et al .Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial .", "label": "", "metadata": {}, "score": "68.24887"}
{"text": "Even in the presence of a higher level of variability , with a standard deviation of nine lesions , our study would have a power of 81 % , to show as statistically significant the same difference .", "label": "", "metadata": {}, "score": "68.42967"}
{"text": "Even in the presence of a higher level of variability , with a standard deviation of nine lesions , our study would have a power of 81 % , to show as statistically significant the same difference .", "label": "", "metadata": {}, "score": "68.42967"}
{"text": "For the eight 3-month windows in the first 2 years , 22 % to 28 % of patients , depending on time point , stated during every telephone call in the 3-month window that they were exercising .", "label": "", "metadata": {}, "score": "68.495964"}
{"text": "Any new revascularization after the procedure occurred in 167 patients ( 5.5 % of the total study population ) and accounted for all cases of prolonged clopidogrel use in the short - term group ( 94 patients [ 6.2 % ] ) .", "label": "", "metadata": {}, "score": "68.60719"}
{"text": "Furthermore , it is not generally made clear in papers how many efficacy end - points were analysed but were not reported .A ranking of end - points pre - unblinding , in the analytic plan , with publication in the pre - specified rank order would be one way to address concerns about multiple comparisons .", "label": "", "metadata": {}, "score": "68.638"}
{"text": "An extensive review of the literature was carried out , and the specific skills and experience in the field of functional testing of the various members of the working group were taken into account .", "label": "", "metadata": {}, "score": "68.75417"}
{"text": "An extensive review of the literature was carried out , and the specific skills and experience in the field of functional testing of the various members of the working group were taken into account .", "label": "", "metadata": {}, "score": "68.75417"}
{"text": "The primary objective will be to investigate whether patients on Nefecon have a larger mean reduction in proteinuria compared to patients on placebo .Pharmalink expects to announce top line results in the first half of 2015 .", "label": "", "metadata": {}, "score": "68.754234"}
{"text": "McKelvie RS .Exercise training in patients with heart failure : clinical outcomes , safety , and indications .Heart Fail Rev .Piepoli MF , Davos C , Francis DP , Coats AJ.ExTraMATCH Collaborative .", "label": "", "metadata": {}, "score": "68.939964"}
{"text": "McKelvie RS .Exercise training in patients with heart failure : clinical outcomes , safety , and indications .Heart Fail Rev .Piepoli MF , Davos C , Francis DP , Coats AJ.ExTraMATCH Collaborative .", "label": "", "metadata": {}, "score": "68.939964"}
{"text": "The primary analysis was based on the principle of intention - to - treat .Analysis of the primary end points was also performed for the per - protocol population .", "label": "", "metadata": {}, "score": "69.10425"}
{"text": "This is often not specified in the reports of trials .In recent malaria vaccine trials in children , efficacy estimates using different parasite density cut - offs , in the same trial , have been presented .", "label": "", "metadata": {}, "score": "69.285255"}
{"text": "Schulz S , Schuster T , Mehilli J , et al .Stent thrombosis after drug - eluting stent implantation : incidence , timing , and relation to discontinuation of clopidogrel therapy over a 4-year period .", "label": "", "metadata": {}, "score": "69.310684"}
{"text": "Schulz S , Schuster T , Mehilli J , et al .Stent thrombosis after drug - eluting stent implantation : incidence , timing , and relation to discontinuation of clopidogrel therapy over a 4-year period .", "label": "", "metadata": {}, "score": "69.310684"}
{"text": "Curiously , this expected effect has not been seen generally in the trials reviewed .Further research into this issue is warranted .Also , it would aid interpretation if the sensitivities and specificities of the various case definitions and parasite density cut - offs used , as derived by the Smith et al method , were presented in publications of intervention trials .", "label": "", "metadata": {}, "score": "69.424805"}
{"text": "The number of patients with a 1-mL /min / kg or greater improvement in peak oxygen consumption was 297 ( 33 % ) in the usual care group and 423 ( 44 % ) in the exercise training group .", "label": "", "metadata": {}, "score": "69.451385"}
{"text": "Each person will then be required to provide written informed consent for their participation in this study .Each patient will also be informed that all of the partici- pants will receive conventional treatment from their general practitioner ; half of the recruited individuals will also receive CBT , in addition to their conventional treat- ment .", "label": "", "metadata": {}, "score": "69.579666"}
{"text": "To provide comparable levels of attention from study personnel in the 2 study groups , all patients were to be called every 2 weeks for the first 9 months , monthly until 24 months of follow - up , and quarterly thereafter .", "label": "", "metadata": {}, "score": "69.58058"}
{"text": "If not explicitly mentioned in the inclusion or exclusion criteria , the concomitant therapies for chronic pathologies not correlated with MS will be continued throughout the study period .", "label": "", "metadata": {}, "score": "69.58555"}
{"text": "If not explicitly mentioned in the inclusion or exclusion criteria , the concomitant therapies for chronic pathologies not correlated with MS will be continued throughout the study period .", "label": "", "metadata": {}, "score": "69.58555"}
{"text": "HR indicates hazard ratio .Definite or probable stent thrombosis up to 90 days occurred in 9 patients in the short - term group ( 0.6 % ) and in 11 patients in the long - term group ( 0.7 % ) ( HR , 0.81 [ 95 % CI , 0.34 to 1.96 ] ) .", "label": "", "metadata": {}, "score": "69.601585"}
{"text": "An electronic query system , managed by the CRO monitor , will be available , and every correction of original data will have to be approved by the member of the DCC responsible for data quality .", "label": "", "metadata": {}, "score": "69.617065"}
{"text": "General practices were randomised to either a collaborative care arm or a usual care arm .The primary outcome is change in depression severity , as measured on the symptoms checklist-90 ( SCL-90 ) .", "label": "", "metadata": {}, "score": "69.66138"}
{"text": "Byrne RA , Schulz S , Mehilli J , et al ; Intracoronary Stenting and Antithrombotic Regimen : Safety And EFficacy of Six Months Dual Antiplatelet Therapy After Drug - Eluting Stenting ( ISAR - SAFE ) Investigators .", "label": "", "metadata": {}, "score": "69.69958"}
{"text": "Byrne RA , Schulz S , Mehilli J , et al ; Intracoronary Stenting and Antithrombotic Regimen : Safety And EFficacy of Six Months Dual Antiplatelet Therapy After Drug - Eluting Stenting ( ISAR - SAFE ) Investigators .", "label": "", "metadata": {}, "score": "69.69958"}
{"text": "HF - ACTION is the largest multicenter , randomized controlled trial of exercise training in heart failure to date .The size and duration of this trial are sufficient to examine for the first time the effect of exercise training on the combined primary end point of all - cause death or all - cause hospitalization in patients with left ventricular systolic dysfunction .", "label": "", "metadata": {}, "score": "69.89663"}
{"text": "Int Clin Psychopharmacol 1999;14:239 - 45 .Blanco C , Heimberg RG , Schneier FR , et al .A placebo - controlled trial of phenelzine , cognitive behavioral group therapy , and their combination for social anxiety disorder .", "label": "", "metadata": {}, "score": "69.91783"}
{"text": "JACC Cardiovasc Interv .Kim JS , Jang IK , Fan C , et al .Evaluation in 3 months duration of neointimal coverage after zotarolimus - eluting stent implantation by optical coherence tomography : the ENDEAVOR OCT trial .", "label": "", "metadata": {}, "score": "69.93179"}
{"text": "JACC Cardiovasc Interv .Kim JS , Jang IK , Fan C , et al .Evaluation in 3 months duration of neointimal coverage after zotarolimus - eluting stent implantation by optical coherence tomography : the ENDEAVOR OCT trial .", "label": "", "metadata": {}, "score": "69.93179"}
{"text": "6 - 8 Most of these previous studies showed positive effects of exercise training on exercise capacity , quality of life , and biomarkers and observed relatively few complications during training .", "label": "", "metadata": {}, "score": "69.93627"}
{"text": "In fact , based on a survey of the patients after randomization , 55 % of patients in the usual care group were not satisfied with the study group to which they were randomly assigned , and many continued some level of physical activity .", "label": "", "metadata": {}, "score": "70.01109"}
{"text": "Safety results that provide a posterior probability of 90 % or more of observing a percentage of serious adverse events in the overall sample higher than an acceptable maximum ( 4 % ) .", "label": "", "metadata": {}, "score": "70.05047"}
{"text": "Safety results that provide a posterior probability of 90 % or more of observing a percentage of serious adverse events in the overall sample higher than an acceptable maximum ( 4 % ) .", "label": "", "metadata": {}, "score": "70.05047"}
{"text": "All the procedures are performed by personnel accredited for the ECD diagnosis of CCSVI , the venous angioplasty intervention and the measurement of the primary and secondary end points .", "label": "", "metadata": {}, "score": "70.10899"}
{"text": "All the procedures are performed by personnel accredited for the ECD diagnosis of CCSVI , the venous angioplasty intervention and the measurement of the primary and secondary end points .", "label": "", "metadata": {}, "score": "70.10899"}
{"text": "Flynn KE , Pi\u00f1a IL , Whellan DJ , et al .Effects of exercise training on health status in patients with chronic heart failure : HF - ACTION randomized controlled trial .", "label": "", "metadata": {}, "score": "70.18986"}
{"text": "Flynn KE , Pi\u00f1a IL , Whellan DJ , et al .Effects of exercise training on health status in patients with chronic heart failure : HF - ACTION randomized controlled trial .", "label": "", "metadata": {}, "score": "70.18986"}
{"text": "Hambrecht R , Niebauer J , Fiehn E , et al .Physical training in patients with stable chronic heart failure : effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles .", "label": "", "metadata": {}, "score": "70.19293"}
{"text": "Hambrecht R , Niebauer J , Fiehn E , et al .Physical training in patients with stable chronic heart failure : effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles .", "label": "", "metadata": {}, "score": "70.19293"}
{"text": "The zotarolimus - eluting stent with a phosphorylcholine durable polymer is a second - generation drug - eluting stent that has demonstrated safety and efficacy in previous reports , despite use of dual antiplatelet therapy of relatively short duration ( 3 to 6 months ) in most trials .", "label": "", "metadata": {}, "score": "70.22955"}
{"text": "Conditions interfering with the measurement of clinical end point .In case of transient impairments hindering measurement of one or more of the five functional tests contributing to the primary outcome ( for example , minor trauma of the leg limiting walking and balance performances ) , the troublesome tests will be postponed until the next follow - up visit .", "label": "", "metadata": {}, "score": "70.5208"}
{"text": "Conditions interfering with the measurement of clinical end point .In case of transient impairments hindering measurement of one or more of the five functional tests contributing to the primary outcome ( for example , minor trauma of the leg limiting walking and balance performances ) , the troublesome tests will be postponed until the next follow - up visit .", "label": "", "metadata": {}, "score": "70.5208"}
{"text": "In fact , an important part of patients ' expectations , sustained and amplified by anecdotal data on improvement of quality of life reported in the Zamboni et al . study [ 34 ] , has to do with precisely these aspects .", "label": "", "metadata": {}, "score": "70.527596"}
{"text": "In fact , an important part of patients ' expectations , sustained and amplified by anecdotal data on improvement of quality of life reported in the Zamboni et al . study [ 34 ] , has to do with precisely these aspects .", "label": "", "metadata": {}, "score": "70.527596"}
{"text": "It is notable that many of the trials identified in this review report the incidence rate of first episodes of clinical malaria as the primary endpoint .", "label": "", "metadata": {}, "score": "70.549675"}
{"text": "Ninety days was selected as the time point for the landmark analysis because it was the prespecified time for discontinuation of clopidogrel in the short - term group .", "label": "", "metadata": {}, "score": "70.56836"}
{"text": "Each participating center is accredited as a MS center by the National Health Service and employs professionals with the following skills : neurology , neuroradiology , noninvasive vascular diagnosis , vascular surgical radiology , physiotherapy and psychometric testing .", "label": "", "metadata": {}, "score": "70.58626"}
{"text": "Each participating center is accredited as a MS center by the National Health Service and employs professionals with the following skills : neurology , neuroradiology , noninvasive vascular diagnosis , vascular surgical radiology , physiotherapy and psychometric testing .", "label": "", "metadata": {}, "score": "70.58626"}
{"text": "In these calculations , missing values of minutes per week were conservatively assumed to be no exercise .Overall , the performance of exercise training was well tolerated and safe .", "label": "", "metadata": {}, "score": "70.604164"}
{"text": "A recent systematic review concluded that SMBG was not cost - effective .However , what was unclear was whether a cheaper method of self - monitoring ( such as urine glucose monitoring ) could produce comparable benefit and patient acceptability for less cost .", "label": "", "metadata": {}, "score": "70.60942"}
{"text": "At 1-year clinical follow - up , the rates of aspirin and clopidogrel use were 98.9 % and 6.2 % , respectively , in the short - term group and 98.8 % and 97.9 % in the long - term group .", "label": "", "metadata": {}, "score": "70.689835"}
{"text": "Considering any bleeding occurring after 90 days , patients in the long - term group had more events than those in the short - term group , but there was no statistically significant association ( HR , 0.43 [ 95 % CI , 0.16 - 1.11 ] ) .", "label": "", "metadata": {}, "score": "70.84531"}
{"text": "Secondary end - points include blood pressure , lipids , body weight and psychosocial measures as well as a qualitative sub - study .Practices were randomised to one of two arms : participants attend a DESMOND programme incorporating a module on self - monitoring of either urine or blood glucose .", "label": "", "metadata": {}, "score": "70.85582"}
{"text": "Med Care 2005;43:1164 - 70 .Wang PS , Lane M , Olfson M , et al .Twelve - month use of mental health services in the United States : results from the National Comorbidity Survey Replication .", "label": "", "metadata": {}, "score": "70.877975"}
{"text": "All authors are members of the Steering Committee and contributed to the design of the Brave Dreams trial .PZ and GF drafted the manuscript .", "label": "", "metadata": {}, "score": "70.92633"}
{"text": "Notably , time - to - event analysis starting at 90 days demonstrated no significant differences between 3 and 12 months .Even when considering the composite outcome of cardiac death , MI , or stent thrombosis , the absolute difference of events occurring between 90 and 360 days was only 0.3 % .", "label": "", "metadata": {}, "score": "70.93281"}
{"text": "Statistical comparisons of the study groups with respect to clinical outcomes were performed according to the intention - to - treat principle .All statistical tests were 2-tailed .", "label": "", "metadata": {}, "score": "70.96178"}
{"text": "Park SJ , Park DW , Kim YH , et al .Duration of dual antiplatelet therapy after implantation of drug - eluting stents .N Engl J Med .", "label": "", "metadata": {}, "score": "71.04158"}
{"text": "Park SJ , Park DW , Kim YH , et al .Duration of dual antiplatelet therapy after implantation of drug - eluting stents .N Engl J Med .", "label": "", "metadata": {}, "score": "71.04158"}
{"text": "Bristow MR , Saxon LA , Boehmer J , et al ; Comparison of Medical Therapy , Pacing , and Defibrillation in Heart Failure ( COMPANION )", "label": "", "metadata": {}, "score": "71.06937"}
{"text": "Bristow MR , Saxon LA , Boehmer J , et al ; Comparison of Medical Therapy , Pacing , and Defibrillation in Heart Failure ( COMPANION )", "label": "", "metadata": {}, "score": "71.06937"}
{"text": "A total of 3119 patients were randomly assigned to 3 months of dual antiplatelet therapy ( 1563 patients ) vs 12 months of dual antiplatelet therapy ( 1556 patients ) .", "label": "", "metadata": {}, "score": "71.38078"}
{"text": "Any deviation from the planned statistical methods will be properly documented in the study report .Stopping Rules .Guidelines have been established to ensure that the study will be stopped as soon as possible in the event of occurrence of an unacceptable proportion of SAEs .", "label": "", "metadata": {}, "score": "71.38506"}
{"text": "Any deviation from the planned statistical methods will be properly documented in the study report .Stopping Rules .Guidelines have been established to ensure that the study will be stopped as soon as possible in the event of occurrence of an unacceptable proportion of SAEs .", "label": "", "metadata": {}, "score": "71.38506"}
{"text": "Time to Event for Individual Components of the Primary Composite End Point ( All - Cause Death , Myocardial Infarction )Among PatientsReceiving Short- and Long - term Dual Antiplatelet Therapy at 0 - 360 Days , 0 - 90 Days , and 91 - 360 Days .", "label": "", "metadata": {}, "score": "71.41934"}
{"text": "As reflected by the interaction P values , there was no significant interaction of exercise training with any of the factors defining these subgroups ; that is , the overall study result was consistent among the various subgroups .", "label": "", "metadata": {}, "score": "71.495346"}
{"text": "This may help bridge the gap between proof - of - concept and evaluation of public health benefit for preventive interventions against clinical malaria .An ambitious , but highly laudable goal , stated as a priority area in the strategic framework of the Malaria Vaccine Technology Roadmap [ 48 ] , is clinical trial standardization .", "label": "", "metadata": {}, "score": "71.610306"}
{"text": "At hospital discharge , all patients received clopidogrel tablets for the first 90 days of treatment after the index procedure .Patients randomized to receive 12 months of dual antiplatelet therapy were given an additional amount of clopidogrel for the remaining 270 days at a mandatory medical visit at 3 months .", "label": "", "metadata": {}, "score": "71.67766"}
{"text": "Although blinding for patients and investigators was not possible due to the nature of the exercise training intervention , deaths and cardiovascular hospitalizations for each patient were adjudicated by a clinical end point committee blinded to treatment assignment .", "label": "", "metadata": {}, "score": "71.6835"}
{"text": "During the study , the IDMC , in collaboration with the SC , will assess new publications on CCSVI and MS that might be relevant to the study protocol .", "label": "", "metadata": {}, "score": "71.80981"}
{"text": "During the study , the IDMC , in collaboration with the SC , will assess new publications on CCSVI and MS that might be relevant to the study protocol .", "label": "", "metadata": {}, "score": "71.80981"}
{"text": "Eisenstein EL , Anstrom KJ , Kong DF , et al .Clopidogrel use and long - term clinical outcomes after drug - eluting stent implantation .", "label": "", "metadata": {}, "score": "71.831055"}
{"text": "Eisenstein EL , Anstrom KJ , Kong DF , et al .Clopidogrel use and long - term clinical outcomes after drug - eluting stent implantation .", "label": "", "metadata": {}, "score": "71.831055"}
{"text": "To avoid introducing bias , the variables selected were required to have little or no missing data .Heart failure etiology ( ischemic vs nonischemic ) , which was a stratification factor in the randomization , was included as a covariate in all time - to - event analyses .", "label": "", "metadata": {}, "score": "71.88561"}
{"text": "( Table 3 ) .Results of the prespecified subgroup analysis for the primary end point are shown in Figure 5 .Between 91 and 360 days postprocedure , major bleeding event rates were 0.2 % in the short - term group vs 0.4 % in the long - term group ( HR , 0.50 [ 95 % CI , 0.12 - 1.99 ] )", "label": "", "metadata": {}, "score": "71.93198"}
{"text": "With time - to - event outcomes , adjustment for strong predictors of the outcome enables the analysis to more specifically compare patients of like risk with like risk and thereby increases the statistical power .", "label": "", "metadata": {}, "score": "72.07283"}
{"text": "Brown S , Thorpe H , Hawkins K , et al .Minimization - reducing predictability for multi - centre trials whilst retaining balance within centre .", "label": "", "metadata": {}, "score": "72.087875"}
{"text": "Strategy for treating selective serotonin reuptake inhibitor- resistant social anxiety disorder in the clinical setting : a randomised controlled trial protocol of cognitive behavioural therapy in combination with conventional treatment .", "label": "", "metadata": {}, "score": "72.12107"}
{"text": "JAMA .Narang R , Swedberg K , Cleland JG .What is the ideal study design for evaluation of treatment for heart failure ? insights from trials assessing the effect of ACE inhibitors on exercise capacity .", "label": "", "metadata": {}, "score": "72.1529"}
{"text": "JAMA .Narang R , Swedberg K , Cleland JG .What is the ideal study design for evaluation of treatment for heart failure ? insights from trials assessing the effect of ACE inhibitors on exercise capacity .", "label": "", "metadata": {}, "score": "72.1529"}
{"text": "The study will provide an answer regarding the efficacy of PTA on patients ' functional disability in balance , motor , sensory , visual and bladder function , cognitive status , and emotional status , which are meaningful clinical outcomes , beyond investigating the effects on inflammation .", "label": "", "metadata": {}, "score": "72.19876"}
{"text": "The study will provide an answer regarding the efficacy of PTA on patients ' functional disability in balance , motor , sensory , visual and bladder function , cognitive status , and emotional status , which are meaningful clinical outcomes , beyond investigating the effects on inflammation .", "label": "", "metadata": {}, "score": "72.19876"}
{"text": "At 12 months , the median time spent walking was 75 minutes per week in the usual care group vs 140 minutes per week in the exercise training group .", "label": "", "metadata": {}, "score": "72.22249"}
{"text": "Such compressions can not always be treated with angioplasty , but they will be reported to differentiate complete from incomplete procedures .The performance of a complete venographic procedure exposes the patient to ionized radiation at an efficacious dose , ranging from a minimum of 25 mSv to a maximum of 50 mSv ( dose comparable to a number ranging between 1250 and 2500 chest X - rays ) .", "label": "", "metadata": {}, "score": "72.25731"}
{"text": "Statistical analyses were performed by the coordinating center ( Duke Clinical Research Institute , Durham , North Carolina ) using SAS software version 8.2 ( SAS Institute Inc , Cary , North Carolina ) .", "label": "", "metadata": {}, "score": "72.32146"}
{"text": "The aim is to provide a resource for those planning clinical trials of preventive malaria interventions .The target audience is clinical trialists , statisticians and other technical personnel .", "label": "", "metadata": {}, "score": "72.39166"}
{"text": "First - line treatments for RRMS patients are interferon \u03b2-1a ( IFN - \u03b2-1a ) and IFN-1b and glatiramer acetate .The effect of these treatments is a moderate reduction in relapse rate and accumulation of disability at 1 to 2 years ' follow - up [ 5 ] .", "label": "", "metadata": {}, "score": "72.404465"}
{"text": "First - line treatments for RRMS patients are interferon \u03b2-1a ( IFN - \u03b2-1a ) and IFN-1b and glatiramer acetate .The effect of these treatments is a moderate reduction in relapse rate and accumulation of disability at 1 to 2 years ' follow - up [ 5 ] .", "label": "", "metadata": {}, "score": "72.404465"}
{"text": "Figure 1 .Meta - analysis of diagnosis of chronic cerebrospinal venous insufficiency ( presence of at least two parameters according to Zamboni criteria in patients with multiple sclerosis ( MS ) ) versus healthy controls .", "label": "", "metadata": {}, "score": "72.40828"}
{"text": "All patients had improvement of physical and mental health as measured by the MS Quality of Life-54 questionnaire at 18-month follow - up .", "label": "", "metadata": {}, "score": "72.410225"}
{"text": "All patients had improvement of physical and mental health as measured by the MS Quality of Life-54 questionnaire at 18-month follow - up .", "label": "", "metadata": {}, "score": "72.410225"}
{"text": "Mariani L , Marubini E : Design and analysis of phase II cancer trials : a review of statistical methods and guidelines for medical researchers .", "label": "", "metadata": {}, "score": "72.46901"}
{"text": "Conclusion .There is a wealth of data available from randomized controlled trials of malaria preventive interventions directed at children , much published in recent years .", "label": "", "metadata": {}, "score": "72.53623"}
{"text": "Thus , this preliminary study suggested that CBT might have potential as a next - step strategy , even for cases of SSRI - resistant SAD .", "label": "", "metadata": {}, "score": "72.61085"}
{"text": "At 12 months ' follow - up , the primary outcome ( cardiac death , MI , stent thrombosis , or ischemia - driven target - vessel revascularization ) was equal in both groups .", "label": "", "metadata": {}, "score": "72.61423"}
{"text": "Lader M , Stender K , B\u00fcrger V , et al .Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder : randomised , double - blind , placebo - controlled , fixed - dose study .", "label": "", "metadata": {}, "score": "72.61607"}
{"text": "Baseline and procedural characteristics were well matched between both groups ( Table 1 and Table 2 ) .A radial approach was used in 40 % of cases , 4120 coronary lesions were treated , 42 % of patients received multiple stents , and mean total stent length was 32.7 ( SD , 20 ) mm per patient .", "label": "", "metadata": {}, "score": "72.6777"}
{"text": "Methods that had been used in these trials were summarized and compared in order to identify issues that were directly relevant to the design of malaria vaccine trials .", "label": "", "metadata": {}, "score": "72.71495"}
{"text": "JAMA .Belardinelli R , Georgiou D , Cianci G , Purcaro A. Randomized , controlled trial of long - term moderate exercise training in chronic heart failure : effects on functional capacity , quality of life , and clinical outcome .", "label": "", "metadata": {}, "score": "72.71506"}
{"text": "JAMA .Belardinelli R , Georgiou D , Cianci G , Purcaro A. Randomized , controlled trial of long - term moderate exercise training in chronic heart failure : effects on functional capacity , quality of life , and clinical outcome .", "label": "", "metadata": {}, "score": "72.71506"}
{"text": "IA contributed to the design of the recruitment strategy and edited the manuscript .KR contributed to writing sections on therapeutic interventions and edited the manuscript .", "label": "", "metadata": {}, "score": "72.7185"}
{"text": "Previous studies have not had adequate statistical power to measure the effects of exercise training on clinical outcomes .Objective To test the efficacy and safety of exercise training among patients with heart failure .", "label": "", "metadata": {}, "score": "72.74553"}
{"text": "Second , an important issue in our study was that the overall event rate for the primary composite end point ( NACCE ) was lower than expected ( 6 % vs 9 % ) , even though the MACE rate was approximately 8 % .", "label": "", "metadata": {}, "score": "72.82535"}
{"text": "CD contributed to study design and outcome selection and edited the manuscript .PB contributed to study design and co - authored the manuscript .CB contributed to the design of the training program and edited the manuscript .", "label": "", "metadata": {}, "score": "72.83717"}
{"text": "The IDMC will evaluate safety , also taking into account early stopping rules .The IDMC will also consider whether the proportion of negative venography in the patients with positive echo Doppler results exceeds the expected 10 % proportion and will discuss with the SC the possible implications for the conduct of the study .", "label": "", "metadata": {}, "score": "72.85219"}
{"text": "The IDMC will evaluate safety , also taking into account early stopping rules .The IDMC will also consider whether the proportion of negative venography in the patients with positive echo Doppler results exceeds the expected 10 % proportion and will discuss with the SC the possible implications for the conduct of the study .", "label": "", "metadata": {}, "score": "72.85219"}
{"text": "The trial will be implemented and reported in accordance with the recommendations of CONSORT . will beconducted atthe Academic DISCUSSION This study is designed to address the lack of research on the use of CBT in combination with the conventional treatment of SSRI - resistant SAD , and is expected to have sufficient power to detect a meaningful difference in outcomes .", "label": "", "metadata": {}, "score": "72.91302"}
{"text": "Simon NM , Hoge EA , Fischmann D , et al .An open - label trial of risperidone augmentation for refractory anxiety disorders .J Clin Psychiatry 2006;67:381 - 5 .", "label": "", "metadata": {}, "score": "72.930664"}
{"text": "Mehta SR , Yusuf S , Peters RJ , et al ; Clopidogrel in Unstable angina to prevent Recurrent Events trial ( CURE ) Investigators .", "label": "", "metadata": {}, "score": "73.08259"}
{"text": "Mehta SR , Yusuf S , Peters RJ , et al ; Clopidogrel in Unstable angina to prevent Recurrent Events trial ( CURE ) Investigators .", "label": "", "metadata": {}, "score": "73.08259"}
{"text": "J Am Coll Cardiol .Lotan C , Meredith IT , Mauri L , Liu M , Rothman MT ; E - Five Investigators .Safety and effectiveness of the Endeavor zotarolimus - eluting stent in real - world clinical practice : 12-month data from the E - Five registry .", "label": "", "metadata": {}, "score": "73.12163"}
{"text": "J Am Coll Cardiol .Lotan C , Meredith IT , Mauri L , Liu M , Rothman MT ; E - Five Investigators .Safety and effectiveness of the Endeavor zotarolimus - eluting stent in real - world clinical practice : 12-month data from the E - Five registry .", "label": "", "metadata": {}, "score": "73.12163"}
{"text": "17 Event ( or censoring ) times for all patients were measured from the time of randomization ( time zero ) .All information available on the primary and secondary end points was collected until the time of final contact with the patient , including patients who withdrew consent or were lost to follow - up , at which point follow - up was censored .", "label": "", "metadata": {}, "score": "73.2861"}
{"text": "Moreover , the treatment history will include the names of the SSRIs to which the participant has exhibited resistance , other prior treatments , current treatment ( medication and others ) at baseline and all changes in conventional treat- ment throughout the study period .", "label": "", "metadata": {}, "score": "73.31145"}
{"text": "FJ contributed to writing the health economic evaluation and edited the manuscript .CR contributed to the statistical analysis of the study .SK contributed to writing the process evaluation section .", "label": "", "metadata": {}, "score": "73.402"}
{"text": "View Article .Metha CR , Caine KC : Charts for the early stopping of pilot studies .J Clin Oncol 1984 , 2 : 676 - 682 .", "label": "", "metadata": {}, "score": "73.42819"}
{"text": "23 , 24 In the CHARM trial and the Valsartan Heart Failure Trial , only 55 % and 35 % of patients , respectively , received \u03b2 - blocker therapy , and an ICD was reported in only 2.4 % to 2.6 % of patients enrolled in CHARM .", "label": "", "metadata": {}, "score": "73.45308"}
{"text": "The point estimate of efficacy is calculated as 1-(incidence rate ratio ) or by using Cox proportional hazards regression models or Poisson regression models , if adjustment for other factors is necessary .", "label": "", "metadata": {}, "score": "73.502625"}
{"text": "Authors ' contributions .PC is the Chief Investigator ; designed the study and wrote the first draft of the protocol ; revised and edited subsequent versions for publication .", "label": "", "metadata": {}, "score": "73.64992"}
{"text": "The lack of change in exercise testing parameters at 12 months may have been due to an insufficient training stimulus in most patients .A potential cause for the blunted training effect was the high use of \u03b2 - blockers , which have been shown to limit peak oxygen consumption changes in healthy patients .", "label": "", "metadata": {}, "score": "73.66936"}
{"text": "[ 30 ] reported the results of an open study of endovascular treatment for CCSVI on 65 MS patients who had undergone percutaneous transluminal angioplasty ( PTA ) to widen the veins .", "label": "", "metadata": {}, "score": "73.67241"}
{"text": "[ 30 ] reported the results of an open study of endovascular treatment for CCSVI on 65 MS patients who had undergone percutaneous transluminal angioplasty ( PTA ) to widen the veins .", "label": "", "metadata": {}, "score": "73.67241"}
{"text": "The other 23 were individually randomized .Choice of the primary end - point .The trials could be classified broadly into two groups .The largest group consisted of trials designed primarily to detect an effect on clinical malaria .", "label": "", "metadata": {}, "score": "73.69191"}
{"text": "PubMed View Article .Rota V , Perucca L , Simone A , Tesio L : Walk ratio ( step length / cadence ) as a summary index of neuromotor control of gait : application to multiple sclerosis .", "label": "", "metadata": {}, "score": "73.765114"}
{"text": "Further trials were identified through the references of retrieved articles .In addition , investigators responsible for the design and analysis of clinical trials of preventive interventions against malaria were interviewed as part of a WHO consultation process on design of phase 3 trials of malaria vaccines .", "label": "", "metadata": {}, "score": "73.831985"}
{"text": "Doppler parameters that detect five anomalous venous hemodynamic criteria affecting cerebrospinal venous return a .Interventions : venography and venous angioplastic procedure , real or sham .", "label": "", "metadata": {}, "score": "73.88063"}
{"text": "Cardiac - resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure .N Engl J Med .Cleland JG , Daubert JC , Erdmann E , et al ; Cardiac Resynchronization - Heart Failure ( CARE - HF ) Study Investigators .", "label": "", "metadata": {}, "score": "73.92899"}
{"text": "Cardiac - resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure .N Engl J Med .Cleland JG , Daubert JC , Erdmann E , et al ; Cardiac Resynchronization - Heart Failure ( CARE - HF ) Study Investigators .", "label": "", "metadata": {}, "score": "73.92899"}
{"text": "Bandelow B , Baldwin DS , Dolberg OT , et al .What is the threshold for symptomatic response and remission for major depressive disorder , panic disorder , social anxiety disorder , and generalized anxiety disorder ?", "label": "", "metadata": {}, "score": "73.99833"}
{"text": "Double reading of all blood smears for efficacy end - points is also undertaken , and is highly desirable , in most intervention trials .Other end - points .", "label": "", "metadata": {}, "score": "74.05336"}
{"text": "Estimates of the treatment effect will be more precise in the largest subgroup of RRMS .For the patients with SPMS , the study will provide preliminary information , possibly requiring an extension of recruitment of SPMS subjects .", "label": "", "metadata": {}, "score": "74.13183"}
{"text": "Estimates of the treatment effect will be more precise in the largest subgroup of RRMS .For the patients with SPMS , the study will provide preliminary information , possibly requiring an extension of recruitment of SPMS subjects .", "label": "", "metadata": {}, "score": "74.13183"}
{"text": "Several observational studies showed a significant association between discontinuation of dual antiplatelet therapy and the occurrence of thrombotic events in the first 6 or 12 months after implantation of a drug - eluting stent , but not afterward . 7 - 10 Most recently , a few randomized trials of modest size tested different durations of dual antiplatelet therapy ( 3 or 6 months vs 12 or 24 months ) with multiple drug - eluting stents , and results did not show benefits favoring prolonged therapy .", "label": "", "metadata": {}, "score": "74.14824"}
{"text": "Although the complication rate for all patients participating in cardiac rehabilitation has been reported to be extremely low , the complication rate for patients with heart failure in clinical trials of exercise training has been substantially higher .", "label": "", "metadata": {}, "score": "74.216835"}
{"text": "Mandato K , Hegener P , Siskin G , Haskal ZJ , Englander MJ , Garla S , Mitchell N , Reutzel L , Doti C : Safety of endovascular treatment of chronic cerebrospinal venous insufficiency : a report of 240 patients with multiple sclerosis .", "label": "", "metadata": {}, "score": "74.24467"}
{"text": "Scores on the Modified Fatigue Impact Scale ( MFIS ) significantly improved from preoperative values , and the positive trend was maintained at 1 year [ 32 ] .", "label": "", "metadata": {}, "score": "74.251785"}
{"text": "Scores on the Modified Fatigue Impact Scale ( MFIS ) significantly improved from preoperative values , and the positive trend was maintained at 1 year [ 32 ] .", "label": "", "metadata": {}, "score": "74.251785"}
{"text": "We prespecified analyses of the primary end point at 1 year according to sex , history of diabetes , clinical presentation , bifurcation , lesion complexity , extent of disease , vessel size , lesion length , lesion type , intervention center , and number of stents implanted .", "label": "", "metadata": {}, "score": "74.387436"}
{"text": "In some trials , both ACD and PCD were used to detect clinical malaria cases and efficacy results were reported for cases detected by each of these methods [ 3 ] .", "label": "", "metadata": {}, "score": "74.617714"}
{"text": "Figure 3 and Figure 4 show the time - to - event curves for the individual components of NACCE .Overall MACE rates at 1 year were 8.3 % with short - term dual antiplatelet therapy vs 7.4 % with long - term therapy ( hazard ratio [ HR ] , 1.12 [ 95 % CI , 0.87 to 1.45 ] ) .", "label": "", "metadata": {}, "score": "74.68535"}
{"text": "In several trials , it was not possible to identify whether a single primary end - point had been specified amongst several end - points that were ostensibly reported as \" co - primaries \" .", "label": "", "metadata": {}, "score": "74.69673"}
{"text": "In some trials an attempt has been made to estimate the extent to which a preventive malaria intervention has reduced the overall burden of illness on the health service , such as the impact on all - cause clinic or hospital attendance .", "label": "", "metadata": {}, "score": "74.81442"}
{"text": "Six - month versus 12-month dual antiplatelet therapy after implantation of drug - eluting stents : the Efficacy of Xience / Promus Versus Cypher to Reduce Late Loss After Stenting ( EXCELLENT ) randomized , multicenter study .", "label": "", "metadata": {}, "score": "74.87178"}
{"text": "Six - month versus 12-month dual antiplatelet therapy after implantation of drug - eluting stents : the Efficacy of Xience / Promus Versus Cypher to Reduce Late Loss After Stenting ( EXCELLENT ) randomized , multicenter study .", "label": "", "metadata": {}, "score": "74.87178"}
{"text": "Results .29 randomized clinical trials of malaria preventive interventions in children published between 1990 and 2007 were identified , which reported estimation of efficacy against clinical malaria , severe malaria or all - cause mortality .", "label": "", "metadata": {}, "score": "74.90433"}
{"text": "Patient flow during Yoshinaga N , Niitsu T , Hanaoka H , et al .BMJ Open 2013;3:e002242 .Page 4 . despite administration at the maximum dose for at least 12 weeks , or intolerance to SSRIs ( eg , because of drowsi- ness , nausea , sleep disturbances , sexual dysfunction and appetite change ) .", "label": "", "metadata": {}, "score": "74.95794"}
{"text": "First , the diagnosis and eligibility for participation will be checked by both a psychiatrist and a study investigator .Second , the validity of the initial diagnosis and eligibility will be discussed at a general meeting , to include psy- chiatrists , nurses , clinical psychologists and psychiatric social workers .", "label": "", "metadata": {}, "score": "75.01135"}
{"text": "Siscovick DS , Weiss NS , Fletcher RH , Lasky T. The incidence of primary cardiac arrest during vigorous exercise .N Engl J Med .", "label": "", "metadata": {}, "score": "75.048584"}
{"text": "Siscovick DS , Weiss NS , Fletcher RH , Lasky T. The incidence of primary cardiac arrest during vigorous exercise .N Engl J Med .", "label": "", "metadata": {}, "score": "75.048584"}
{"text": "Methods / Design The 6S trial will randomise 800 patients with severe sepsis in 30 Scandinavian ICUs to masked fluid resuscitation using either 6 % HES 130/0.4 in Ringer 's acetate or Ringer 's acetate alone .", "label": "", "metadata": {}, "score": "75.07002"}
{"text": "Rodrigues H , Figueira I , Gon\u00e7alves R , et al .CBT for pharmacotherapy non - remitters - a systematic review of a next - step strategy .", "label": "", "metadata": {}, "score": "75.07035"}
{"text": "This information is clearly stated in the informed consent form .Primary end points .We identified two primary end points , one defined by a combination of clinical parameters related to specific functional deficits experienced by patients with MS and the other one based on MRI findings , both measured 12 months after randomization .", "label": "", "metadata": {}, "score": "75.08461"}
{"text": "Arch Gen Psychiatry 1991;48:938 - 45 .Heimberg RG , Liebowitz MR , Hope DA , et al .Cognitive behavioral group therapy vs phenelzine therapy for social phobia : 12-week outcome .", "label": "", "metadata": {}, "score": "75.107635"}
{"text": "The final results of the study demonstrated a significant and clinically meaningful effect in the primary endpoint : reduction in proteinuria .Significant results were also seen in secondary endpoints : reduction of serum creatinine and increase in glomerular filtration rates .", "label": "", "metadata": {}, "score": "75.26712"}
{"text": "Trial registration .Clinicaltrials.gov NCT01371760 .Keywords : .Multiple sclerosis ; Chronic cerebrospinal venous insufficiency ; Percutaneous transluminal angioplasty ; Functional disability .Background .", "label": "", "metadata": {}, "score": "75.293"}
{"text": "Coats AJ , Adamopoulos S , Radaelli A , et al .Controlled trial of physical training in chronic heart failure : exercise performance , hemodynamics , ventilation , and autonomic function .", "label": "", "metadata": {}, "score": "75.29861"}
{"text": "Coats AJ , Adamopoulos S , Radaelli A , et al .Controlled trial of physical training in chronic heart failure : exercise performance , hemodynamics , ventilation , and autonomic function .", "label": "", "metadata": {}, "score": "75.29861"}
{"text": "Blood smear methods .There are three methods for calculating parasite density that have been employed in published intervention trials .Firstly , reading 100 or 200 high power fields , with the assumption that the volume of each high power field is 1/500 \u03bcl .", "label": "", "metadata": {}, "score": "75.310135"}
{"text": "Eligible patients were those with stable coronary artery disease or history of low - risk acute coronary syndrome ( ACS ) undergoing PCI with zotarolimus - eluting stents .", "label": "", "metadata": {}, "score": "75.3104"}
{"text": "The scientific responsibility for monitoring the course of the study will be entrusted to an independent data monitoring committee ( IDMC ) and to the SC that will work in close contact with the DCC and the CRO .", "label": "", "metadata": {}, "score": "75.42078"}
{"text": "The scientific responsibility for monitoring the course of the study will be entrusted to an independent data monitoring committee ( IDMC ) and to the SC that will work in close contact with the DCC and the CRO .", "label": "", "metadata": {}, "score": "75.42078"}
{"text": "The MRI examinations will be carried out at the participating centers in keeping with the technical protocol .Secondary end points .A secondary objective is to estimate the proportion of patients with CCSVI diagnosed by ECD and confirmed by venography .", "label": "", "metadata": {}, "score": "75.45036"}
{"text": "The MRI examinations will be carried out at the participating centers in keeping with the technical protocol .Secondary end points .A secondary objective is to estimate the proportion of patients with CCSVI diagnosed by ECD and confirmed by venography .", "label": "", "metadata": {}, "score": "75.45036"}
{"text": "Based on the results of past studies of exercise training , the American College of Cardiology , American Heart Association , European Society of Cardiology , and Canadian Cardiovascular Society have adopted recommendations that physical activity be considered for medically stable patients with systolic dysfunction . 1 , 13 , 14 However , previous studies have been relatively small single - center trials , have not been adequately powered to evaluate mortality and morbidity , and have often lacked an adequate control group .", "label": "", "metadata": {}, "score": "75.45948"}
{"text": "Patient recruitment began on the 01/05/2012 and is planned to be completed by the 30/04/2013 .Recruitment for general practices was completed on 31/10/2012 , by which time the target of 36 practices had been recruited .", "label": "", "metadata": {}, "score": "75.68408"}
{"text": "Circulation .Kim BK , Hong MK , Shin DH , et al ; RESET Investigators .A new strategy for discontinuation of dual antiplatelet therapy : the RESET Trial ( REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus - eluting stent implantation ) .", "label": "", "metadata": {}, "score": "75.746735"}
{"text": "Circulation .Kim BK , Hong MK , Shin DH , et al ; RESET Investigators .A new strategy for discontinuation of dual antiplatelet therapy : the RESET Trial ( REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus - eluting stent implantation ) .", "label": "", "metadata": {}, "score": "75.746735"}
{"text": "All AEs or SAEs will be reported to the Safety Surveillance Unit / Institutional Review Board ( SSU / IRB ) that approved the protocol , unless otherwise required and documented by the SSU / IRB .", "label": "", "metadata": {}, "score": "75.81799"}
{"text": "All AEs or SAEs will be reported to the Safety Surveillance Unit / Institutional Review Board ( SSU / IRB ) that approved the protocol , unless otherwise required and documented by the SSU / IRB .", "label": "", "metadata": {}, "score": "75.81799"}
{"text": "PubMed View Article .Ludyga T , Kazibudzki M , Simka M , Hartel M , Swierad M , Piegza J , Latacz P , Sedlak L , Tochowicz M : Endovascular treatment for chronic cerebrospinal venous insufficiency : is the procedure safe ?", "label": "", "metadata": {}, "score": "75.845474"}
{"text": "Cutlip DE , Windecker S , Mehran R , et al ; Academic Research Consortium .Clinical end points in coronary stent trials : a case for standardized definitions .", "label": "", "metadata": {}, "score": "75.953"}
{"text": "Cutlip DE , Windecker S , Mehran R , et al ; Academic Research Consortium .Clinical end points in coronary stent trials : a case for standardized definitions .", "label": "", "metadata": {}, "score": "75.953"}
{"text": "General practitioners will be permitted to refer patients for counselling or to secondary care if this is deemed clinically appropriate .However , the initiation of a strictly structured CBT programme is banned in order to properly assess the effectiveness of the CBT intervention .", "label": "", "metadata": {}, "score": "75.953125"}
{"text": "Stangier U , Heidenreich T , Peitz M , et al .Cognitive therapy for social phobia : individual versus group treatment .Behav Res Ther 2003;41:991 - 1007 .", "label": "", "metadata": {}, "score": "76.00095"}
{"text": "A total of 2331 patients were enrolled at 82 participating centers in the United States , Canada , and France .Baseline characteristics of the patients in each randomized group are shown in Table 1 .", "label": "", "metadata": {}, "score": "76.195076"}
{"text": "Banerjee S , Xu H , Fuh E , et al .Endothelial progenitor cell response to antiproliferative drug exposure .Atherosclerosis .Guagliumi G , Musumeci G , Sirbu V , et al ; ODESSA Trial Investigators .", "label": "", "metadata": {}, "score": "76.23421"}
{"text": "Banerjee S , Xu H , Fuh E , et al .Endothelial progenitor cell response to antiproliferative drug exposure .Atherosclerosis .Guagliumi G , Musumeci G , Sirbu V , et al ; ODESSA Trial Investigators .", "label": "", "metadata": {}, "score": "76.23421"}
{"text": "However , changes of 0.5 points are invalid , even if confirmed at 3 or 6 months , and , similarly , 1-point changes are not significantly more likely to occur for worsening than for improvement [ 58 ] .", "label": "", "metadata": {}, "score": "76.24524"}
{"text": "However , changes of 0.5 points are invalid , even if confirmed at 3 or 6 months , and , similarly , 1-point changes are not significantly more likely to occur for worsening than for improvement [ 58 ] .", "label": "", "metadata": {}, "score": "76.24524"}
{"text": "Premature discontinuation of dual antiplatelet therapy has been determined to be one of the most powerful predictors of stent thrombosis following implantation of first - generation drug - eluting stents , mainly within the 6 months after PCI .", "label": "", "metadata": {}, "score": "76.305305"}
{"text": "Background The benefit of self - monitoring of blood glucose ( SMBG ) in people with type 2 diabetes on diet or oral agents other than sulphonylureas remains uncertain .", "label": "", "metadata": {}, "score": "76.31111"}
{"text": "( 9 )Prothrombin time , activated partial thromboplastin time , creatinine values outside laboratory reference ranges .( 10 ) Written informed consent .( 11 ) History of congenital or ischemic cardiopathy , arrhythmias , conditions that can cause changes in motor and/or vision and/or bladder and/or cognitive functions .", "label": "", "metadata": {}, "score": "76.37455"}
{"text": "Severe malaria was a primary outcome measure in only one trial [ 2 ] .Clinical malaria as a primary end - point .For this end - point , following entry into the trial , only the first episode of clinical malaria for each child contributes towards the calculation of the malaria incidence rate .", "label": "", "metadata": {}, "score": "76.418"}
{"text": "At least three functions must remain testable at the last follow - up ; otherwise , the patient will be classified as \" worsened .\" The classification of the clinical end point will be carried out by the CEC , which will evaluate blindly all of the documentation of each patient .", "label": "", "metadata": {}, "score": "76.48477"}
{"text": "At least three functions must remain testable at the last follow - up ; otherwise , the patient will be classified as \" worsened .\" The classification of the clinical end point will be carried out by the CEC , which will evaluate blindly all of the documentation of each patient .", "label": "", "metadata": {}, "score": "76.48477"}
{"text": "In this study , 95 % of patients without a contraindication or intolerance to \u03b2 - blockers or ACE inhibitors received optimal heart failure therapy , defined as a \u03b2 - blocker and either an ACE inhibitor or an angiotensin II receptor blocker .", "label": "", "metadata": {}, "score": "76.50517"}
{"text": "This end - point , though potentially difficult to measure in some circumstances , would be highly informative for those making implementation decisions in malaria control , as it provides a general measure of the potential saving to the health service .", "label": "", "metadata": {}, "score": "76.50738"}
{"text": "N Engl J Med .Valgimigli M , Borghesi M , Tebaldi M , Vranckx P , Parrinello G , Ferrari R ; PROlonging Dual antiplatelet treatment after Grading stent - induced Intimal hyperplasia studY Investigators .", "label": "", "metadata": {}, "score": "76.56443"}
{"text": "N Engl J Med .Valgimigli M , Borghesi M , Tebaldi M , Vranckx P , Parrinello G , Ferrari R ; PROlonging Dual antiplatelet treatment after Grading stent - induced Intimal hyperplasia studY Investigators .", "label": "", "metadata": {}, "score": "76.56443"}
{"text": "A novel functional composite end point was defined to assess the primary clinical end point .The reason for this decision was that the EDSS [ 47 ] , the most widely used disability measure in clinical trials for MS , is an ambulation - centered scale that does not take into account cognitive impairment or upper - arm or bladder dysfunctions that are primary components of disability .", "label": "", "metadata": {}, "score": "76.61125"}
{"text": "A novel functional composite end point was defined to assess the primary clinical end point .The reason for this decision was that the EDSS [ 47 ] , the most widely used disability measure in clinical trials for MS , is an ambulation - centered scale that does not take into account cognitive impairment or upper - arm or bladder dysfunctions that are primary components of disability .", "label": "", "metadata": {}, "score": "76.61125"}
{"text": "Bleeding complications associated with prolonged dual antiplatelet therapy are reported in 0.7 % to 30 % of patients undergoing PCI with stent implantation and have ominous consequences .", "label": "", "metadata": {}, "score": "76.635994"}
{"text": "Blackburn I - M , James IA , Milne DL , et al .The revised cognitive therapy scale ( CTS - R ) : psychometric properties .", "label": "", "metadata": {}, "score": "76.70531"}
{"text": "Meta - analysis of diagnosis of chronic cerebrospinal venous insufficiency ( presence of at least two parameters according to Zamboni criteria in patients with multiple sclerosis ( MS ) ) versus healthy controls .", "label": "", "metadata": {}, "score": "76.74215"}
{"text": "Third , the patient population represented in our trial mostly comprised patients with stable coronary artery disease or history of low - risk ACS .Nevertheless , 84 patients in each group ( 5.4 % ) presented with non - ST - segment elevation MI despite a formal recommendation not to enroll these patients .", "label": "", "metadata": {}, "score": "76.75237"}
{"text": "For the baseline variables , summary statistics are constructed employing frequencies and proportions for categorical data , and mean and SD for continuous variables .The baseline variables are compared using Fisher 's exact test for categorical outcomes and unpaired t test for continu- ous variables , as appropriate .", "label": "", "metadata": {}, "score": "76.83107"}
{"text": "Despite a wide variability among studies , it has been found to be associated with MS .Data from a few small case series suggest possible improvement of the clinical course and quality of life by performing percutaneous balloon angioplasty ( PTA ) of the stenotic veins .", "label": "", "metadata": {}, "score": "76.98509"}
{"text": "Despite a wide variability among studies , it has been found to be associated with MS .Data from a few small case series suggest possible improvement of the clinical course and quality of life by performing percutaneous balloon angioplasty ( PTA ) of the stenotic veins .", "label": "", "metadata": {}, "score": "76.98509"}
{"text": "Nature 2011 , 472 : 410 - 411 .PubMed View Article .Ebers GC , Heigenhauser L , Daumer M , Lederer C , Noseworthy JH : Disability as an outcome in MS clinical trials .", "label": "", "metadata": {}, "score": "77.05055"}
{"text": "Heart failure etiology was ischemic in 51 % , and median left ventricular ejection fraction was 25 % .Exercise adherence decreased from a median of 95 minutes per week during months 4 through 6 of follow - up to 74 minutes per week during months 10 through 12 .", "label": "", "metadata": {}, "score": "77.10449"}
{"text": "Complex models are needed to analyse these sorts of data , on which there is still not a consensus and on which further methodological research is required .", "label": "", "metadata": {}, "score": "77.15587"}
{"text": "Pocock SJ , Assmann SE , Enos LE , Kasten LE .Subgroup analysis , covariate adjustment and baseline comparisons in clinical trial reporting : current practice and problems .", "label": "", "metadata": {}, "score": "77.16546"}
{"text": "Pocock SJ , Assmann SE , Enos LE , Kasten LE .Subgroup analysis , covariate adjustment and baseline comparisons in clinical trial reporting : current practice and problems .", "label": "", "metadata": {}, "score": "77.16546"}
{"text": "All participants will be recruited at the participating Italian MS centers according to the inclusion and exclusion criteria reported in Table 1 .Patients with RRMS or SPMS with a diagnosis of CCSVI will be included .", "label": "", "metadata": {}, "score": "77.303085"}
{"text": "All participants will be recruited at the participating Italian MS centers according to the inclusion and exclusion criteria reported in Table 1 .Patients with RRMS or SPMS with a diagnosis of CCSVI will be included .", "label": "", "metadata": {}, "score": "77.303085"}
{"text": "Fourth , combining efficacy and safety within a single composite outcome may be problematic and may mask important differences .However , analysis of MACE did not show any significant differences between durations of dual antiplatelet therapy .", "label": "", "metadata": {}, "score": "77.3303"}
{"text": "The secondary outcome measures are severe bleeding or allergic reactions , organ failure , acute kidney failure , days alive without renal replacement therapy or ventilator support and 28-day and 1/2- and one - year mortality .", "label": "", "metadata": {}, "score": "77.33075"}
{"text": "Patients were randomized from April 2003 through February 2007 within the United States , Canada , and France .The protocol was reviewed and approved by the appropriate institutional review board or ethics committee for each participating center and by the coordinating center 's institutional review board .", "label": "", "metadata": {}, "score": "77.396385"}
{"text": "Primary End Point and Its Components .Kaplan - Meier curves depicting the primary end point of death or hospitalization from any cause for each randomized group are shown in Figure 2 .", "label": "", "metadata": {}, "score": "77.408646"}
{"text": "J Clin Psychiatry 2005;66:238 - 47 .Stein MB , Pollack MH , Bystritsky A , et al .Efficacy of low and higher dose extended - release venlafaxine in generalized social anxiety disorder : a 6-month randomized controlled trial .", "label": "", "metadata": {}, "score": "77.48588"}
{"text": "ISBN : .Description : .\u00a9 2011 Perner et al ; licensee BioMed Central Ltd.Strategy for treating selective serotonin reuptake inhibitor - resistant social anxiety disorder in the clinical setting : A randomised controlled trial protocol of cognitive behavioural therapy in combination with conventional treatment .", "label": "", "metadata": {}, "score": "77.581375"}
{"text": "Study concept and design : O'Connor , Whellan , Lee , Keteyian , Cooper , Kraus , Kitzman , Blumenthal , Zannad , Pi\u00f1a .Acquisition of data : O'Connor , Whellan , Lee , Keteyian , Kraus , Kitzman , Rendall , McKelvie , Zannad , Pi\u00f1a .", "label": "", "metadata": {}, "score": "77.591736"}
{"text": "Access to the PDF is only available via article purchase .Publisher main menu .Follow BioMed Central .Trials main menu .Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis .", "label": "", "metadata": {}, "score": "77.718216"}
{"text": "Participants randomized to venous angioplasty will receive the intervention during the diagnostic venography session .The anomalies of the main extracranial cerebrospinal veins that interfere with normal blood outflow of brain parenchyma are reported in Table 3 [ 12 , 13 , 30 ] .", "label": "", "metadata": {}, "score": "77.734344"}
{"text": "Roy P , Bonello L , Torguson R , et al .Temporal relation between clopidogrel cessation and stent thrombosis after drug - eluting stent implantation .", "label": "", "metadata": {}, "score": "77.77314"}
{"text": "Roy P , Bonello L , Torguson R , et al .Temporal relation between clopidogrel cessation and stent thrombosis after drug - eluting stent implantation .", "label": "", "metadata": {}, "score": "77.77314"}
{"text": "A relatively large number of possible efficacy end - points are potentially available to malaria investigators and malaria preventive intervention trials may be particularly vulnerable to the multiple comparisons problems in trial design .", "label": "", "metadata": {}, "score": "77.779854"}
{"text": "6 Two meta - analyses suggested improved survival and decreased hospitalizations for patients with heart failure undergoing exercise training compared with a non - exercising control group .", "label": "", "metadata": {}, "score": "77.81344"}
{"text": "To compare the treatment groups , the LSMeans and the associated 95 % CI are expressed as a proportion of the reference treatment LSMean .As a sensitivity analysis , the outcomes at weeks 0 , 8 and 16 are modelledasa function treatment - by - time interaction using linear mixed - effects models .", "label": "", "metadata": {}, "score": "77.84375"}
{"text": "29 controlled trials of preventive malaria interventions were identified , of which eight were vaccine trials .Vaccine trials that were designed to detect an effect on clinical malaria all reported the incidence rate of first episodes of clinical malaria as their primary endpoint .", "label": "", "metadata": {}, "score": "77.850266"}
{"text": "In trials of malaria vaccines , an assessment has commonly been made of the effect of the vaccine on the incidence of parasitaemia as well as on clinical malaria .", "label": "", "metadata": {}, "score": "77.870834"}
{"text": "Also , baseline angiographic characteristics demonstrated relatively high lesion complexity , including 15 % bifurcations , one - third type C lesions , mean lesion length of 18 mm , and mean vessel size of 2.76 mm .", "label": "", "metadata": {}, "score": "77.96055"}
{"text": "Doppler parameters that detect five anomalous venous hemodynamic criteria affecting cerebrospinal venous return a .Reflux - bidirectional flow constantly present in the IJV and/or vertebral vein with the patient in both examination positions ( sitting and supine posture ) in at least one of the three landmarks ( J1 , J2 , J3 ) .", "label": "", "metadata": {}, "score": "77.989624"}
{"text": "Mauri L , Massaro JM , Jiang S , et al .Long - term clinical outcomes with zotarolimus - eluting versus bare - metal coronary stents .", "label": "", "metadata": {}, "score": "78.10956"}
{"text": "Mauri L , Massaro JM , Jiang S , et al .Long - term clinical outcomes with zotarolimus - eluting versus bare - metal coronary stents .", "label": "", "metadata": {}, "score": "78.10956"}
{"text": "After age 15 to 18 years , about 50 % of patients need assistance to walk , are confined to a wheelchair or have died , but there is substantial variation [ 3 ] .", "label": "", "metadata": {}, "score": "78.174675"}
{"text": "After age 15 to 18 years , about 50 % of patients need assistance to walk , are confined to a wheelchair or have died , but there is substantial variation [ 3 ] .", "label": "", "metadata": {}, "score": "78.174675"}
{"text": "View Article PubMed .Binka FN , Kubaje A , Adjuik M , Williams LA , Lengeler C , Maude GH , Armah GE , Kajihara B , Adiamah JH , Smith PG : Impact of permethrin impregnated bednets on child mortality in Kassena - Nankana district , Ghana : a randomized controlled trial .", "label": "", "metadata": {}, "score": "78.20524"}
{"text": "PubMed View Article .Honarmand K , Feinstein A : Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients .Mult Scler 2009 , 15 : 1518 - 1524 .", "label": "", "metadata": {}, "score": "78.28595"}
{"text": "The pharmacological treatments currently available for MS can modify , to a limited degree and over the long term , the natural history of the disease .", "label": "", "metadata": {}, "score": "78.357086"}
{"text": "The pharmacological treatments currently available for MS can modify , to a limited degree and over the long term , the natural history of the disease .", "label": "", "metadata": {}, "score": "78.357086"}
{"text": "It is a multi - site cluster randomised controlled trial , conducted across 8 sites ( 7 primary care trusts ) in England , UK involving individuals with newly diagnosed Type 2 diabetes .", "label": "", "metadata": {}, "score": "78.35841"}
{"text": "At 1 year , there was a restenosis rate of 27 % [ 34 ] .A case series of 495 PTA procedures in 461 patients reported restenosis requiring reintervention in 11 cases [ 35 ] .", "label": "", "metadata": {}, "score": "78.40994"}
{"text": "At 1 year , there was a restenosis rate of 27 % [ 34 ] .A case series of 495 PTA procedures in 461 patients reported restenosis requiring reintervention in 11 cases [ 35 ] .", "label": "", "metadata": {}, "score": "78.40994"}
{"text": "Following that time period , the data will be under the control of the treating neurologist .Adverse events .All subjects will be monitored throughout the study for adverse events ( AEs ) .", "label": "", "metadata": {}, "score": "78.45281"}
{"text": "Following that time period , the data will be under the control of the treating neurologist .Adverse events .All subjects will be monitored throughout the study for adverse events ( AEs ) .", "label": "", "metadata": {}, "score": "78.45281"}
{"text": "Zaider TI , Heimberg RG , Fresco DM , et al .Evaluation of the clinical global impression scale among individuals with social anxiety disorder .", "label": "", "metadata": {}, "score": "78.54794"}
{"text": "Bloomgren G , Richman S , Hotermans C , Subramanyam M , Goelz S , Natarajan A , Lee S , Plavina T , Scanlon JV , Sandrock A , Bozic C : Risk of natalizumab - associated progressive multifocal leukoencephalopathy .", "label": "", "metadata": {}, "score": "78.567726"}
{"text": "Both the ITT and PP analyses will also be conducted across the whole study sample ( RRMS and SPMS ) .Patients with RRMS .This comparison will also be evaluated using a regression model , adjusting for some important factors , that is , time from diagnosis of MS disease , concomitant treatments and EDSS at baseline .", "label": "", "metadata": {}, "score": "78.64111"}
{"text": "Both the ITT and PP analyses will also be conducted across the whole study sample ( RRMS and SPMS ) .Patients with RRMS .This comparison will also be evaluated using a regression model , adjusting for some important factors , that is , time from diagnosis of MS disease , concomitant treatments and EDSS at baseline .", "label": "", "metadata": {}, "score": "78.64111"}
{"text": "Am Heart J .Mauri L , Kereiakes DJ , Normand SL , et al .Am Heart J .Time to Event for the Primary Composite End Point ( NACCE )", "label": "", "metadata": {}, "score": "78.65864"}
{"text": "T2-weighted brain MRI will be used to determine the number of new brain lesions over the entire 1-year period .The number of brain lesions will be defined as new or enlarging lesions or lesions reappearing at the site of previously healed lesions on T2-weighted MRI scans .", "label": "", "metadata": {}, "score": "78.819496"}
{"text": "T2-weighted brain MRI will be used to determine the number of new brain lesions over the entire 1-year period .The number of brain lesions will be defined as new or enlarging lesions or lesions reappearing at the site of previously healed lesions on T2-weighted MRI scans .", "label": "", "metadata": {}, "score": "78.819496"}
{"text": "PubMed View Article .Singh AV , Zamboni P : Anomalous venous blood flow and iron deposition in multiple sclerosis .J Cereb Blood Flow Metab 2009 , 29 : 1867 - 1878 .", "label": "", "metadata": {}, "score": "79.25187"}
{"text": "The angiography room operators will simulate the procedure of balloon angioplasty , describing to the participants what they are doing at each step and letting them know what they might feel , not forgetting to assure them that lack of sensation is also normal .", "label": "", "metadata": {}, "score": "79.26218"}
{"text": "The angiography room operators will simulate the procedure of balloon angioplasty , describing to the participants what they are doing at each step and letting them know what they might feel , not forgetting to assure them that lack of sensation is also normal .", "label": "", "metadata": {}, "score": "79.26218"}
{"text": "Bhatt DL , Fox KA , Hacke W , et al ; CHARISMA Investigators .Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events .", "label": "", "metadata": {}, "score": "79.3798"}
{"text": "Bhatt DL , Fox KA , Hacke W , et al ; CHARISMA Investigators .Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events .", "label": "", "metadata": {}, "score": "79.3798"}
{"text": "Physicians should claim only the credit commensurate with the extent of their participation in the activity .Physicians who complete the CME course and score at least 80 % correct on the quiz are eligible for AMA PRA Category 1 Credit TM .", "label": "", "metadata": {}, "score": "79.40475"}
{"text": "Thirdly , a calculation of white cell count individually and then reading to 200 WBC , with adjustment using the calculated count .It is difficult to compare the results of studies in which different counting methods have been used .", "label": "", "metadata": {}, "score": "79.45173"}
{"text": "Bangalore S , Kumar S , Fusaro M , et al . Short- and long - term outcomes with drug - eluting and bare - metal coronary stents : a mixed - treatment comparison analysis of 117 762 patient - years of follow - up from randomized trials .", "label": "", "metadata": {}, "score": "79.514"}
{"text": "Bangalore S , Kumar S , Fusaro M , et al . Short- and long - term outcomes with drug - eluting and bare - metal coronary stents : a mixed - treatment comparison analysis of 117 762 patient - years of follow - up from randomized trials .", "label": "", "metadata": {}, "score": "79.514"}
{"text": "All data will be securely stored in an electronic case report form ( e - CRF ) .Data access will be protected by user name and password according to different profiles , depending on the user .", "label": "", "metadata": {}, "score": "79.56235"}
{"text": "( 6 )EDSS from 2 to 5.5 . 7 ) Contraindications to MRI and/or its contrast medium .( 8) Stable neurological condition without relapse for at least 30 days .", "label": "", "metadata": {}, "score": "79.56695"}
{"text": "Where pre - treatment is used , it may be a major complicating factor for interpretation of morbidity end - points .Surveillance methods .All malaria vaccine trials in children published to date have included some form of active case detection ( ACD ) for at least some trial participants .", "label": "", "metadata": {}, "score": "79.59812"}
{"text": "Blinding of the patients and the research personnel was not possible .More than 50 % of the patients randomized to the usual care group were either somewhat or very dissatisfied with their treatment assignment ; a number of these patients likely crossed over and initiated exercise training .", "label": "", "metadata": {}, "score": "79.629"}
{"text": "PubMed View Article .Zamboni P , Galeotti R , Weinstock - Guttman B , Kennedy C , Salvi F , Zivadinov R : Venous angioplasty in patients with multiple sclerosis : results of a pilot study .", "label": "", "metadata": {}, "score": "79.65997"}
{"text": "Curtis LH , Whellan DJ , Hammill BG , et al .Incidence and prevalence of heart failure in elderly persons , 1994 - 2003 .", "label": "", "metadata": {}, "score": "79.73529"}
{"text": "Curtis LH , Whellan DJ , Hammill BG , et al .Incidence and prevalence of heart failure in elderly persons , 1994 - 2003 .", "label": "", "metadata": {}, "score": "79.73529"}
{"text": "PubMed View Article .La Mantia L , Vacchi L , Di Pietrantonj C , Ebers G , Rovaris M , Fredrikson S , Filippini G : Interferon \u03b2 for secondary progressive multiple sclerosis .", "label": "", "metadata": {}, "score": "79.7765"}
{"text": "Curr Psychiatry Rep 2010;12:471 - 7 .M\u00f6rtberg E , Clark DM , Sundin O , et al .Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia : a randomized controlled trial .", "label": "", "metadata": {}, "score": "79.77715"}
{"text": "The lack of blinding also may have caused differential attention to patients by the study personnel .However , the investigators attempted to control for the inherent differences in the amount of contact with caregivers by regular telephone contact and follow - up of the patients in both study groups of the trial .", "label": "", "metadata": {}, "score": "79.81036"}
{"text": "Italia : Roma ; 2011 .Ann Neurol 2005 , 58 : 840 - 846 .PubMed View Article .Sekiya N , Nagasaki H : Reproducibility of the walking patterns of normal young adults : test - retest reliability of the walk ratio ( step - length / step - rate ) .", "label": "", "metadata": {}, "score": "79.95516"}
{"text": "The implantation of a baclofen pump will lead to the classification of the patient as \" worsened . \" Monitoring of the study .The monitoring procedures will be entrusted to a CRO .", "label": "", "metadata": {}, "score": "79.97052"}
{"text": "The implantation of a baclofen pump will lead to the classification of the patient as \" worsened . \" Monitoring of the study .The monitoring procedures will be entrusted to a CRO .", "label": "", "metadata": {}, "score": "79.97052"}
{"text": "In some settings , an effect on severe malaria may also be ascertainable in a study in which all - cause mortality is the primary end - point [ 2 ] .", "label": "", "metadata": {}, "score": "80.08893"}
{"text": "Senior supervisors will also assess the general quality of each CBT programme on the basis of the revised CognitiveTherapy reviewing randomly selected , videotaped sessions .", "label": "", "metadata": {}, "score": "80.12167"}
{"text": "Data access will be protected by user name and password according to different profiles , depending on the user .In particular , centers will have access only to data relative to their own center , whereas the center responsible for informatics infrastructure of the CRO and the member of the DCC responsible for quality will have online access to the entire database to perform periodic quality checks .", "label": "", "metadata": {}, "score": "80.14843"}
{"text": "Based on data elicited from the physical activity questionnaire , the median time spent walking at baseline was 40 minutes per week in the usual care group vs 45 minutes per week in the exercise training group .", "label": "", "metadata": {}, "score": "80.20294"}
{"text": "The proponent group took into account that the end points currently used in clinical pharmacological studies have been criticized on both clinical and methodological grounds [ 58 , 59 ] .", "label": "", "metadata": {}, "score": "80.205635"}
{"text": "The proponent group took into account that the end points currently used in clinical pharmacological studies have been criticized on both clinical and methodological grounds [ 58 , 59 ] .", "label": "", "metadata": {}, "score": "80.205635"}
{"text": "References .Moorthy V , Reed Z , Smith PG : Measurement of malaria vaccine efficacy in phase III trials : report of a WHO consultation .", "label": "", "metadata": {}, "score": "80.211136"}
{"text": "Randomised controlled general practice trial of sertraline , exposure therapy and combined treatment in generalised social phobia .Br J Psychiatry 2001;179:23 - 30 .Davidson JRT , Foa EB , Huppert JD , et al .", "label": "", "metadata": {}, "score": "80.23923"}
{"text": "Pharmalink hopes to bring a new medicine to patients for early treatment , halting disease progression and further loss of renal function .We look forward to confirming the highly promising results we have seen so far with Nefecon and to advancing the product in this pivotal phase IIb trial .", "label": "", "metadata": {}, "score": "80.32144"}
{"text": "We will use a combined end point obtained through the integration of five functional indicators clinically meaningful and measured with validated instrumental methods .These are related to walking [ 41 , 42 ] , balance [ 43 ] , manual dexterity [ 44 ] , bladder control [ 45 ] and low - contrast visual acuity [ 46 ] .", "label": "", "metadata": {}, "score": "80.382256"}
{"text": "We will use a combined end point obtained through the integration of five functional indicators clinically meaningful and measured with validated instrumental methods .These are related to walking [ 41 , 42 ] , balance [ 43 ] , manual dexterity [ 44 ] , bladder control [ 45 ] and low - contrast visual acuity [ 46 ] .", "label": "", "metadata": {}, "score": "80.382256"}
{"text": "Mehran R , Rao SV , Bhatt DL , et al .Standardized bleeding definitions for cardiovascular clinical trials : a consensus report from the Bleeding Academic Research Consortium .", "label": "", "metadata": {}, "score": "80.41464"}
{"text": "Mehran R , Rao SV , Bhatt DL , et al .Standardized bleeding definitions for cardiovascular clinical trials : a consensus report from the Bleeding Academic Research Consortium .", "label": "", "metadata": {}, "score": "80.41464"}
{"text": "PubMed View Article .Kos D , Nagels G , D'Hooghe MB , Duportail M , Kerckhofs E : A rapid screening tool for fatigue impact in multiple sclerosis .", "label": "", "metadata": {}, "score": "80.46698"}
{"text": "Ben - Dor I , Torguson R , Scheinowitz M , et al .Incidence , correlates , and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug - eluting stents .", "label": "", "metadata": {}, "score": "80.50314"}
{"text": "Ben - Dor I , Torguson R , Scheinowitz M , et al .Incidence , correlates , and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug - eluting stents .", "label": "", "metadata": {}, "score": "80.50314"}
{"text": "Surgical removal of the balloon was required in one patient , and difficulty in removing the balloon or delivery system occurred in four patients .No deaths , cerebral strokes , severe bleeding or injury to the nerves were reported .", "label": "", "metadata": {}, "score": "80.69716"}
{"text": "Surgical removal of the balloon was required in one patient , and difficulty in removing the balloon or delivery system occurred in four patients .No deaths , cerebral strokes , severe bleeding or injury to the nerves were reported .", "label": "", "metadata": {}, "score": "80.69716"}
{"text": "PubMed View Article .Zamboni P , Menegatti E , Galeotti R , Malagoni AM , Tacconi G , Dall'Ara S , Bartolomei I , Salvi F : The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis .", "label": "", "metadata": {}, "score": "80.77518"}
{"text": "No other authors reported disclosures .Funding / Support : The OPTIMIZE trial was a physician - initiated trial cosponsored by an independent clinical research organization - Cardiovascular Research Center , SA , S\u00e3o Paulo , S\u00e3o Paulo , Brazil , and Medtronic Comercial Ltda , S\u00e3o Paulo , S\u00e3o Paulo , Brazil .", "label": "", "metadata": {}, "score": "80.78636"}
{"text": "37 In our study , no significant differences were observed in the occurrence of major bleeding according to the primary outcome definition .Moreover , noncardiac surgery may occur in a relatively high number of patients following implantation of drug - eluting stents in daily practice .", "label": "", "metadata": {}, "score": "80.789795"}
{"text": "The criteria used to trigger the taking of a blood smear to assess for a possible clinical malaria episode varied from trial to trial .This also affects interpretation of efficacy results .", "label": "", "metadata": {}, "score": "80.804924"}
{"text": "LM designed the MRI measures .PZ designed the ECD protocol , RG the PTA protocol and they are in charge of training the staff of the participating centers in ECD diagnosis of CCSVI and in the PTA procedure .", "label": "", "metadata": {}, "score": "80.829575"}
{"text": "PubMed View Article .Petrov I , Grozdinski L , Kaninski G , Iliev N , Iloska M , Radev A : Safety profile of endovascular treatment for chronic cerebrospinal venous insufficiency in patients with multiple sclerosis .", "label": "", "metadata": {}, "score": "80.84119"}
{"text": "PubMed View Article .Zamboni P , Galeotti R , Menegatti E , Malagoni AM , Gianesini S , Bartolomei I , Mascoli F , Salvi F : A prospective open - label study of endovascular treatment of chronic cerebrospinal venous insufficiency .", "label": "", "metadata": {}, "score": "80.94924"}
{"text": "Sande MA , Waight P , Mendy M , Rayco - Solon P , Hutt P , Fulford T , Doherty C , McConkey SJ , Jeffries D , Hall AJ , Whittle HC : Long - term protection against carriage of hepatitis B virus after infant vaccination .", "label": "", "metadata": {}, "score": "80.95675"}
{"text": "Serotonin - noradrenaline reuptake inhibitors are also recommended for first - line pharmacotherapy .SSRI administration should last for at least 12 weeks before its efficacy is assessed.36Of course , SSRI treatment usually includes some type of non - specific psychotherapy ( eg , supportive counselling ) from the general practitioner .", "label": "", "metadata": {}, "score": "80.98853"}
{"text": "Levine GN , Bates ER , Blankenship JC , et al .2011 ACCF / AHA / SCAI Guideline for Percutaneous Coronary Intervention : a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [ published correction appears in Circulation .", "label": "", "metadata": {}, "score": "80.99591"}
{"text": "Levine GN , Bates ER , Blankenship JC , et al .2011 ACCF / AHA / SCAI Guideline for Percutaneous Coronary Intervention : a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [ published correction appears in Circulation .", "label": "", "metadata": {}, "score": "80.99591"}
{"text": "Pfeffer MA , Swedberg K , Granger CB , et al ; CHARM Investigators and Committees .Effects of candesartan on mortality and morbidity in patients with chronic heart failure : the CHARM - Overall Programme .", "label": "", "metadata": {}, "score": "81.10999"}
{"text": "Pfeffer MA , Swedberg K , Granger CB , et al ; CHARM Investigators and Committees .Effects of candesartan on mortality and morbidity in patients with chronic heart failure : the CHARM - Overall Programme .", "label": "", "metadata": {}, "score": "81.10999"}
{"text": "PubMed View Article .Mandato K , Hegener P , Siskin G , Haskal ZJ , Englander MJ , Garla S , Mitchell N , Reutzel L , Doti C : Safety of endovascular treatment of chronic cerebrospinal venous insufficiency : a report of 240 patients with multiple sclerosis .", "label": "", "metadata": {}, "score": "81.11514"}
{"text": "Receiving Short- and Long - term Dual Antiplatelet Therapy-0 - 360 Days , 0 - 90 Days , and 91 - 360 Days .Numbers of events listed under the x - axes are not cumulative but rather incremental numbers of events ; numbers of events listed under the x - axes on day 0 represent periprocedural events .", "label": "", "metadata": {}, "score": "81.14535"}
{"text": "View Article PubMed .Terlouw DJ , Desai MR , Wannemuehler KA , Kariuki SK , Pfeiffer CM , Kager PA , Shi YP , Ter Kuile FO : Relation between the response to iron supplementation and sickle cell hemoglobin phenotype in preschool children in western Kenya .", "label": "", "metadata": {}, "score": "81.188515"}
{"text": "An adverse event can be any unfavourable and unintended sign , symptom or disease temporally asso- ciated with this interventional study , whether or not con- sidered related to this CBT , and all adverse events will be reported .", "label": "", "metadata": {}, "score": "81.194214"}
{"text": "Conclusions In the protocol - specified primary analysis , exercise training resulted in nonsignificant reductions in the primary end point of all - cause mortality or hospitalization and in key secondary clinical end points .", "label": "", "metadata": {}, "score": "81.200554"}
{"text": "Mitoxantrone is moderately effective in reducing disability progression and relapse rate in patients with RRMS , PRMS and SPMS at short - term follow - up ( 2 years ) , but there is a long - term risk of therapy - related leukemias and cardiotoxicity [ 8 ] .", "label": "", "metadata": {}, "score": "81.2348"}
{"text": "Mitoxantrone is moderately effective in reducing disability progression and relapse rate in patients with RRMS , PRMS and SPMS at short - term follow - up ( 2 years ) , but there is a long - term risk of therapy - related leukemias and cardiotoxicity [ 8 ] .", "label": "", "metadata": {}, "score": "81.2348"}
{"text": "Strengths include a setting in primary care , a cluster design , a health economic analysis , a comparison of different methods of monitoring while controlling for other components of training within the context of a quality assured structured education programme and a qualitative sub - study .", "label": "", "metadata": {}, "score": "81.326004"}
{"text": "Berger PB , Kleiman NS , Pencina MJ , et al ; EVENT Investigators .Frequency of major noncardiac surgery and subsequent adverse events in the year after drug - eluting stent placement results from the EVENT ( Evaluation of Drug - Eluting Stents and Ischemic Events ) Registry .", "label": "", "metadata": {}, "score": "81.32771"}
{"text": "Berger PB , Kleiman NS , Pencina MJ , et al ; EVENT Investigators .Frequency of major noncardiac surgery and subsequent adverse events in the year after drug - eluting stent placement results from the EVENT ( Evaluation of Drug - Eluting Stents and Ischemic Events ) Registry .", "label": "", "metadata": {}, "score": "81.32771"}
{"text": "These findings are consistent with the 33 previous trials and the meta - analyses showing improved outcomes .Corresponding Author : Christopher M. O'Connor , MD , Duke Clinical Research Institute , PO Box 17969 , Durham , NC 27715 ( oconn002@mc.duke.edu ) .", "label": "", "metadata": {}, "score": "81.34543"}
{"text": "Postprocedure use of aspirin ( 100 - 200 mg daily ) was prescribed indefinitely .Postprocedural clopidogrel use ( 75 mg daily ) was maintained according to the randomization scheme ( 3 vs 12 months ) .", "label": "", "metadata": {}, "score": "81.65981"}
{"text": "PubMed View Article .Williams NP , Roland PS , Yellin W : Vestibular evaluation in patients with early multiple sclerosis .Am J Otol 1997 , 18 : 93 - 100 .", "label": "", "metadata": {}, "score": "81.6771"}
{"text": "These included atrial fibrillation in four patients ( two resolved spontaneously and two resolved following treatment with amiodarone ) and ventricular fibrillation ( successfully treated ) and ventricular tachycardia ( timing not reported ) in one patient each .", "label": "", "metadata": {}, "score": "81.683235"}
{"text": "These included atrial fibrillation in four patients ( two resolved spontaneously and two resolved following treatment with amiodarone ) and ventricular fibrillation ( successfully treated ) and ventricular tachycardia ( timing not reported ) in one patient each .", "label": "", "metadata": {}, "score": "81.683235"}
{"text": "Clark DM , Ehlers A , McManus F , et al .Cognitive therapy versus fluoxetine in generalized social phobia : a randomized placebo - controlled trial .", "label": "", "metadata": {}, "score": "81.72981"}
{"text": "Eighty - three patients ( 4 % ) withdrew consent at a median time of 6.8 months following randomization .A total of 736 patients completed 36 supervised training sessions with the median time to completion ( for 36 sessions ) of 3.9 months ( interquartile range , 3.4 - 4.8 months ) .", "label": "", "metadata": {}, "score": "81.93944"}
{"text": "Moorthy VS , Reed Z , Smith PG : MALVAC 2008 : Measures of efficacy of malaria vaccines in phase 2b and phase 3 trials - Scientific , regulatory and public health perspectives .", "label": "", "metadata": {}, "score": "81.94971"}
{"text": "Hofmann SG , Smits JAJ .Cognitive - behavioral therapy for adult anxiety disorders : a meta - analysis of randomized placebo - controlled trials .", "label": "", "metadata": {}, "score": "81.994545"}
{"text": "Study objective .In this study , we aim to evaluate the efficacy and safety of angioplasty of extracranial veins for patients with RRMS or SPMS and CCSVI .", "label": "", "metadata": {}, "score": "81.99748"}
{"text": "Study objective .In this study , we aim to evaluate the efficacy and safety of angioplasty of extracranial veins for patients with RRMS or SPMS and CCSVI .", "label": "", "metadata": {}, "score": "81.99748"}
{"text": "Although rest was traditionally recommended for patients with heart failure , over the past 2 decades it has been recognized that physical deconditioning may play a key role in the progression of symptoms and poor outcomes .", "label": "", "metadata": {}, "score": "82.02533"}
{"text": "Stein DJ , Stein MB , Pitts CD , et al .Predictors of response to pharmacotherapy in social anxiety disorder : an analysis of 3 13 .", "label": "", "metadata": {}, "score": "82.06722"}
{"text": "Kirtane AJ , Leon MB , Ball MW , et al ; ENDEAVOR IV Investigators .The \" final \" 5-year follow - up from the ENDEAVOR IV trial comparing a zotarolimus - eluting stent with a paclitaxel - eluting stent .", "label": "", "metadata": {}, "score": "82.10075"}
{"text": "Kirtane AJ , Leon MB , Ball MW , et al ; ENDEAVOR IV Investigators .The \" final \" 5-year follow - up from the ENDEAVOR IV trial comparing a zotarolimus - eluting stent with a paclitaxel - eluting stent .", "label": "", "metadata": {}, "score": "82.10075"}
{"text": "Data provided are for informational purposes only .Although carefully collected , accuracy can not be guaranteed .The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .", "label": "", "metadata": {}, "score": "82.110756"}
{"text": "Eur Heart J .Kirtane AJ , Gupta A , Iyengar S , et al .Safety and efficacy of drug - eluting and bare metal stents : comprehensive meta - analysis of randomized trials and observational studies .", "label": "", "metadata": {}, "score": "82.118935"}
{"text": "Eur Heart J .Kirtane AJ , Gupta A , Iyengar S , et al .Safety and efficacy of drug - eluting and bare metal stents : comprehensive meta - analysis of randomized trials and observational studies .", "label": "", "metadata": {}, "score": "82.118935"}
{"text": "PubMed View Article .Mayer CA , Pfeilschifter W , Lorenz MW , Nedelmann M , Bechmann I , Steinmetz H , Ziemann U : The perfect crime ?", "label": "", "metadata": {}, "score": "82.15968"}
{"text": "Kaplan - Meier estimates demonstrated MACE rates at 1 year of 8.3 % ( 128 ) in the short - term group and 7.4 % ( 114 ) in the long - term group ( HR , 1.12 [ 95 % CI , 0.87 - 1.45 ] ) .", "label": "", "metadata": {}, "score": "82.16539"}
{"text": "Nasreddine ZS , Phillips NA , Bedirian V , Charbonneau S , Whitehead V , Collin I , Cummings JL , Chertkow H : The Montreal Cognitive Assessment , MoCA : a brief screening tool for mild cognitive impairment .", "label": "", "metadata": {}, "score": "82.171135"}
{"text": "Sabate M , Cequier A , I\u00f1iguez A , et al .Everolimus - eluting stent versus bare - metal stent in ST - segment elevation myocardial infarction ( EXAMINATION ) : 1-year results of a randomised controlled trial .", "label": "", "metadata": {}, "score": "82.33391"}
{"text": "Sabate M , Cequier A , I\u00f1iguez A , et al .Everolimus - eluting stent versus bare - metal stent in ST - segment elevation myocardial infarction ( EXAMINATION ) : 1-year results of a randomised controlled trial .", "label": "", "metadata": {}, "score": "82.33391"}
{"text": "Categorical variables were reported as counts and percentages , and differences were assessed using the \u03c7 2 test or the Fisher exact test in the case of low counts .", "label": "", "metadata": {}, "score": "82.33751"}
{"text": "Differing provisions from the publisher 's actual policy or licence agreement may be applicable .", "label": "", "metadata": {}, "score": "82.479904"}
{"text": "21 In fact , early vessel healing was the basis for the hypothesis tested in our study for short - term duration of dual antiplatelet therapy with zotarolimus - eluting stents .", "label": "", "metadata": {}, "score": "82.4812"}
{"text": "Laupacis A , Lillie E , Dueck A , Straus S , Perrier L , Burton JM , Aviv R , Thorpe K , Feasby T , Spears J : Association between chronic cerebrospinal venous insufficiency and multiple sclerosis : a meta - analysis .", "label": "", "metadata": {}, "score": "82.58235"}
{"text": "Laupacis A , Lillie E , Dueck A , Straus S , Perrier L , Burton JM , Aviv R , Thorpe K , Feasby T , Spears J : Association between chronic cerebrospinal venous insufficiency and multiple sclerosis : a meta - analysis .", "label": "", "metadata": {}, "score": "82.58235"}
{"text": "Recruiting .The present trial is registered ( Clinical Trials Registration No . NCT01371760 ) and is supported by a grant of \u20ac2,922,404 from Regione Emilia Romagna , Italy .", "label": "", "metadata": {}, "score": "82.63696"}
{"text": "Recruiting .The present trial is registered ( Clinical Trials Registration No . NCT01371760 ) and is supported by a grant of \u20ac2,922,404 from Regione Emilia Romagna , Italy .", "label": "", "metadata": {}, "score": "82.63696"}
{"text": "SG is responsible for data quality monitoring and for the statistical design .MGV is in charge of the statistical analysis and statistical design .AB , GF , PC and PZ are responsible for accreditation of the participating centers .", "label": "", "metadata": {}, "score": "82.817856"}
{"text": "SG is responsible for data quality monitoring and for the statistical design .MGV is in charge of the statistical analysis and statistical design .AB , GF , PC and PZ are responsible for accreditation of the participating centers .", "label": "", "metadata": {}, "score": "82.817856"}
{"text": "Treatment preferences among depressed primary care patients .J Gen Intern Med 2000;15:527 - 34 .Insel TR .Translating scientific opportunity into public health impact : a strategic plan for research on mental illness .", "label": "", "metadata": {}, "score": "82.91972"}
{"text": "In a case - control study , eight patients had PTA in addition to medical therapy ( immediate treatment group ( ITG ) ) , whereas seven had treatment with PTA after 6 months of medical therapy alone ( delayed treatment group ( DTG ) ) .", "label": "", "metadata": {}, "score": "82.92959"}
{"text": "In a case - control study , eight patients had PTA in addition to medical therapy ( immediate treatment group ( ITG ) ) , whereas seven had treatment with PTA after 6 months of medical therapy alone ( delayed treatment group ( DTG ) ) .", "label": "", "metadata": {}, "score": "82.92959"}
{"text": "PubMed View Article .Zaniewski M , Kostecki J , Kuczmik W , Ziaja D , Opala G , Swiat M , Korzeniowski T , Majewski E , Urbanek T , Pawlicki K : Neck duplex Doppler ultrasound evaluation for assessing chronic cerebrospinal venous insufficiency in multiple sclerosis patients .", "label": "", "metadata": {}, "score": "82.95842"}
{"text": "TN , FO , SM , OK , MN , AN and MI contributed to the conceptualisation and design of the study , and all revised this manuscript critically for important intellectual content .", "label": "", "metadata": {}, "score": "83.00173"}
{"text": "Methods .To prepare for a WHO consultation on design issues in malaria vaccine trials , controlled trials of preventive interventions against malaria in children in endemic countries were identified in which clinical malaria , or death , had been one of the main end - points .", "label": "", "metadata": {}, "score": "83.10962"}
{"text": "BMJ Open 2013;3:e002242 .Page 8 . placebo - controlled paroxetine trials .J Clin Psychiatry 2002;63:152 - 5 .Stein MB , Stein DJ .", "label": "", "metadata": {}, "score": "83.13945"}
{"text": "BMJ Open 2013;3:e002242 .Page 9 . doi : 10.1136/bmjopen-2012 - 002242 2013 3 : BMJ Open .Naoki Yoshinaga , Tomihisa Niitsu , Hideki Hanaoka , et al . combination with conventional treatment cognitive behavioural therapy in randomised controlled trial protocol of disorder in the clinical setting : a reuptake inhibitor - resistant social anxiety Strategy for treating selective serotonin .", "label": "", "metadata": {}, "score": "83.15147"}
{"text": "The median left ventricular ejection fraction was 25 % , and 51 % of the patients had heart failure with an ischemic etiology .Of patients without an intolerance or contraindication to angiotensin - converting enzyme ( ACE ) inhibitors or \u03b2 - blockers , 95 % were taking a \u03b2 - blocker and either an ACE inhibitor or an angiotensin II receptor blocker .", "label": "", "metadata": {}, "score": "83.20528"}
{"text": "PubMed View Article .N Engl J Med 2006 , 354 : 899 - 910 .PubMed View Article .Westfall PH , Tobias RD , Rom D , Wolfinger RD , Hochberg Y : Multiple Comparisons and Multiple Tests Using the SAS System .", "label": "", "metadata": {}, "score": "83.21721"}
{"text": "J Affect Disord 1996;39:115 - 21 .Seedat S , Stein MB .Double - blind , placebo - controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder .", "label": "", "metadata": {}, "score": "83.23563"}
{"text": "LT designed the clinical outcome measures and is in charge of training the outcome assessors .LM designed the MRI measures .PZ designed the ECD protocol , RG the PTA protocol and they are in charge of training the staff of the participating centers in ECD diagnosis of CCSVI and in the PTA procedure .", "label": "", "metadata": {}, "score": "83.35502"}
{"text": "Figures in this Article .Original recommendations for patients receiving first - generation drug - eluting stents ( sirolimus- and paclitaxel - eluting stents ) specified that these patients also receive 3 to 6 months of dual antiplatelet therapy with aspirin and a thienopyridine .", "label": "", "metadata": {}, "score": "83.60097"}
{"text": "Only one trial was identified reporting multiple episodes of malaria as its primary end - point [ 20 ] .In some trials molecular markers have also been used to distinguish recurrences from new infections .", "label": "", "metadata": {}, "score": "83.720276"}
{"text": "Valgimigli M , Campo G , Monti M , et al ; Prolonging Dual Antiplatelet Treatment After Grading Stent - Induced Intimal Hyperplasia Study ( PRODIGY )", "label": "", "metadata": {}, "score": "83.77453"}
{"text": "Valgimigli M , Campo G , Monti M , et al ; Prolonging Dual Antiplatelet Treatment After Grading Stent - Induced Intimal Hyperplasia Study ( PRODIGY )", "label": "", "metadata": {}, "score": "83.77453"}
{"text": "Physicians who complete the CME course and score at least 80 % correct on the quiz are eligible for AMA PRA Category 1 Credit TM .", "label": "", "metadata": {}, "score": "83.81721"}
{"text": "PubMed View Article .Pisco JM , Rio Tinto H , Bilhim T , Duarte M : Percutaneous transluminal angioplasty and stenting in patients with multiple sclerosis and venous insufficiency : preliminary results [ Abstract 33].", "label": "", "metadata": {}, "score": "83.922516"}
{"text": "However , the analysis of data including multiple episodes in the same child is not straightforward as multiple episodes are not independent events .That is , once a child has had one episode , the child is more likely to have another episode , for a variety of reasons , than a child who has never had an episode .", "label": "", "metadata": {}, "score": "84.0892"}
{"text": "Internet - based cognitive behavior therapy vs. cognitive behavioral group therapy for social anxiety disorder : a randomized controlled non - inferiority trial .PLoS ONE 2011;6:e18001 .", "label": "", "metadata": {}, "score": "84.23961"}
{"text": "Baldwin DS , Anderson IM , Nutt DJ , et al .Evidence - based guidelines for the pharmacological treatment of anxiety disorders : recommendations from the British Association for Psychopharmacology .", "label": "", "metadata": {}, "score": "84.30925"}
{"text": "Clinical malaria episodes , identified only by children presenting at a clinic , are therefore likely to have been more severe , on average , than those experienced in other vaccine trials in which active case detection was employed .", "label": "", "metadata": {}, "score": "84.37672"}
{"text": "Aust N Z J Psychiatry 2004;38:125 - 34 .Liebowitz MR , Schneier F , Campeas R , et al .Phenelzine vs atenolol in social phobia .", "label": "", "metadata": {}, "score": "84.41934"}
{"text": "HR indicates hazard ratio ; NACCE , net adverse clinical and cerebral events ( a composite of all - cause death , myocardial infarction , stroke , or major bleeding ) .", "label": "", "metadata": {}, "score": "84.426575"}
{"text": "Skevington SM , Lotfy M , O'Connell KA .The World Health Organization 's WHOQOL - BREF quality of life assessment : psychometric properties and results of the international field trial .", "label": "", "metadata": {}, "score": "84.47422"}
{"text": "Martinelli Boneschi F , Rovaris M , Capra R , Comi G : Mitoxantrone for multiple sclerosis .Cochrane Database Syst Rev 2005 , 4 : CD002127 .", "label": "", "metadata": {}, "score": "84.53598"}
{"text": "Am J Trop Med Hyg 2003 , 68 : 68 - 77 .PubMed .Muller O , Traore C , Kouyate B , Ye Y , Frey C , Coulibaly B , Becher H : Effects of insecticide - treated bednets during early infancy in an African area of intense malaria transmission : a randomized controlled trial .", "label": "", "metadata": {}, "score": "84.56938"}
{"text": "Hunt SA , Abraham WT , Chin MH , et al ; American College of Cardiology ; American Heart Association Task Force on Practice Guidelines ; American College of Chest Physicians ; International Society for Heart and Lung Transplantation ; Heart Rhythm Society .", "label": "", "metadata": {}, "score": "84.58114"}
{"text": "This update details changes to the cluster and patient recruitment strategy for the COINCIDE study .Modifications were made to the recruitment targets in response to lower - than - expected patient recruitment at the first ten general practices recruited into the study .", "label": "", "metadata": {}, "score": "84.7503"}
{"text": "Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis ( 6S - Scandinavian Starch for Severe Sepsis / Septic Shock trial ) : Study protocol , design and rationale for a double - blinded , randomised clinical trial .", "label": "", "metadata": {}, "score": "84.78039"}
{"text": "View Article PubMed . D'Alessandro U , Olaleye BO , McGuire W , Langerock P , Bennett S , Aikins MK , Thomson MC , Cham MK , Cham BA , Greenwood BM : Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme .", "label": "", "metadata": {}, "score": "84.79286"}
{"text": "Blanco C , Bragdon LB , Schneier FR , et al .The evidence - based pharmacotherapy of social anxiety disorder .Int J Neuropsychopharmacol 2003;6:427 - 42 .", "label": "", "metadata": {}, "score": "84.85306"}
{"text": "Previous Presentation : Presented as a late - breaking clinical trial at the American Heart Association Scientific Sessions ; November 11 , 2008 ; New Orleans , Louisiana .", "label": "", "metadata": {}, "score": "84.88045"}
{"text": "Correspondence to Dr Naoki Yoshinaga ; nao@chiba-u.jp ABSTRACT Introduction : Pharmacotherapy and cognitive behavioural therapy ( CBT ) are consistently effective as first - line treatments for social anxiety disorders ( SADs ) .", "label": "", "metadata": {}, "score": "84.90869"}
{"text": "At each visit , the treating neurologist will record any new symptoms , any adverse events and their management and treatment decisions , including discontinuation of pharmacological treatments .", "label": "", "metadata": {}, "score": "84.940796"}
{"text": "At each visit , the treating neurologist will record any new symptoms , any adverse events and their management and treatment decisions , including discontinuation of pharmacological treatments .", "label": "", "metadata": {}, "score": "84.940796"}
{"text": "Statistical analyses are planned for the study design stage so that field materials can be appropriately designed .Ethics and dissemination : This study will be conducted at the academic outpatient clinic of Chiba University Hospital .", "label": "", "metadata": {}, "score": "84.95028"}
{"text": "Statistical analyses are planned for the study design stage so that field materials can be appropriately designed .Ethics and dissemination : This study will be conducted at the academic outpatient clinic of Chiba University Hospital .", "label": "", "metadata": {}, "score": "84.95028"}
{"text": "Camenzind E , Wijns W , Mauri L , et al ; PROTECT Steering Committee and Investigators .Stent thrombosis and major clinical events at 3 years after zotarolimus - eluting or sirolimus - eluting coronary stent implantation : a randomised , multicentre , open - label , controlled trial .", "label": "", "metadata": {}, "score": "85.0491"}
{"text": "Camenzind E , Wijns W , Mauri L , et al ; PROTECT Steering Committee and Investigators .Stent thrombosis and major clinical events at 3 years after zotarolimus - eluting or sirolimus - eluting coronary stent implantation : a randomised , multicentre , open - label , controlled trial .", "label": "", "metadata": {}, "score": "85.0491"}
{"text": "N Engl J Med .Konstam MA , Gheorghiade M , Burnett JC Jr , et al ; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan ( EVEREST ) Investigators .", "label": "", "metadata": {}, "score": "85.07396"}
{"text": "N Engl J Med .Konstam MA , Gheorghiade M , Burnett JC Jr , et al ; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan ( EVEREST ) Investigators .", "label": "", "metadata": {}, "score": "85.07396"}
{"text": "Patients with RRMS .The sample size was estimated on the basis of the primary end point on MRI .We assume that the average total number of MRI active lesions in the control group is equal to 6 with a standard deviation of 7.6 [ 53 ] .", "label": "", "metadata": {}, "score": "85.10227"}
{"text": "Patients with RRMS .The sample size was estimated on the basis of the primary end point on MRI .We assume that the average total number of MRI active lesions in the control group is equal to 6 with a standard deviation of 7.6 [ 53 ] .", "label": "", "metadata": {}, "score": "85.10227"}
{"text": "Electronic supplementary material .1475 - 2875 - 8 - 23-S1.doc Additional file 1 : Tables 1 - 4 .Tables summarising methods and reporting for identified randomized controlled trials of preventive malaria interventions .", "label": "", "metadata": {}, "score": "85.13382"}
{"text": "Sareen J , Jacobi F , Cox BJ , et al .Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions .", "label": "", "metadata": {}, "score": "85.13822"}
{"text": "Obtained funding : Feres , Abizaid , Negoita .Administrative , technical , or material support : Feres , Negoita , Castro .Study supervision : Feres , Costa , Negoita , Castro , Andrea Abizaid .", "label": "", "metadata": {}, "score": "85.17215"}
{"text": "Echo Core Lab : Julius M. Gardin , MD ( director ) ; Renee L. Bess , BS , RDCS , RVT , Gerald I. Cohen , MD ( St John Hospital and Medical Center , Detroit , Michigan ) .", "label": "", "metadata": {}, "score": "85.35631"}
{"text": "Nevertheless , pharmacotherapy is often the first choice in clinical practice .In many countries , the first line of pharmacotherapy involves the administration of a selective serotonin reuptake inhibitor ( SSRI ) .", "label": "", "metadata": {}, "score": "85.37141"}
{"text": "20 The overall interpretation of the results , then , is that this structured exercise training intervention had at best a modest effect on clinical end points in a large cohort of patients .", "label": "", "metadata": {}, "score": "85.43733"}
{"text": "This article reports an investigation into the ways in which trial design and reporting could be improved and standardized to enable comparative evaluation of the relative merits of malaria control measures , and specifically with respect to the design of malaria vaccine trials .", "label": "", "metadata": {}, "score": "85.45602"}
{"text": "Competing interests .PC , CG , CJG , CK , IA , KR , AC , FJ , CD , CCG declare they have no competing interests .", "label": "", "metadata": {}, "score": "85.47173"}
{"text": "Patients with SPMS .A multivariate analysis based on a logistic regression model will be carried out , taking into account relevant factors , such as gender , time from MS diagnosis , concomitant treatments and EDSS at baseline .", "label": "", "metadata": {}, "score": "85.581795"}
{"text": "Patients with SPMS .A multivariate analysis based on a logistic regression model will be carried out , taking into account relevant factors , such as gender , time from MS diagnosis , concomitant treatments and EDSS at baseline .", "label": "", "metadata": {}, "score": "85.581795"}
{"text": "Any arising complications ( hematoma , venous thrombosis or vessel rupture ) will require reexamination in the vascular diagnostic center .Table 3 .Anomalies at catheter venography of the main extracranial cerebrospinal veins that interfere with normal blood outflow of brain parenchyma described in patients with MS a .", "label": "", "metadata": {}, "score": "85.64143"}
{"text": "Any arising complications ( hematoma , venous thrombosis or vessel rupture ) will require reexamination in the vascular diagnostic center .Table 3 .Anomalies at catheter venography of the main extracranial cerebrospinal veins that interfere with normal blood outflow of brain parenchyma described in patients with MS a .", "label": "", "metadata": {}, "score": "85.64143"}
{"text": "Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life .Arch Gen Psychiatry 2007;64:903 - 12 .", "label": "", "metadata": {}, "score": "85.71495"}
{"text": "In western countries , it represents the second most common cause of disability in young adults , with onset usually occurring in the third or fourth decade of life .", "label": "", "metadata": {}, "score": "85.72313"}
{"text": "PubMed View Article .Baracchini C , Perini P , Calabrese M , Causin F , Rinaldi F , Gallo P : No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset .", "label": "", "metadata": {}, "score": "85.91098"}
{"text": "Tsivgoulis G , Mantatzis M , Bogiatzi C , Vadikolias K , Voumvourakis K , Prassopoulos P , Piperidou C , Heliopoulos I : Extracranial venous hemodynamics in multiple sclerosis : a case - control study .", "label": "", "metadata": {}, "score": "85.98092"}
{"text": "View Article PubMed .Lancet 2004 , 364 : 1757 - 1765 .View Article PubMed .Eskola J , Kilpi T , Palmu A , Jokinen J , Haapakoski J , Herva E , Takala A , Kayhty H , Karma P , Kohberger R , Siber G , Makela PH : Efficacy of a pneumococcal conjugate vaccine against acute otitis media .", "label": "", "metadata": {}, "score": "86.10162"}
{"text": "2nd edn .San Antonio : Psychological Corporation , 1997 .Leon AC , Olfson M , Portera L , et al .Assessing psychiatric impairment in primary care with the Sheehan Disability Scale .", "label": "", "metadata": {}, "score": "86.14377"}
{"text": "Dr Keteyian reported receiving honoraria for lectures to scientific , educational , and community groups and receiving royalties from books published by Human Kinetics and McGraw - Hill .", "label": "", "metadata": {}, "score": "86.29116"}
{"text": "Biomarker and DNA Core Lab : Kirkwood Adams , MD ( University of North Carolina , Chapel Hill ) ; Mark Donahue , MD , Mike Felker , MD ( Duke University , Durham , North Carolina ) .", "label": "", "metadata": {}, "score": "86.31044"}
{"text": "Yoshinaga N , Niitsu T , Hanaoka H , et al .BMJ Open 2013;3:e002242 .Page 2 .If left untreated , SAD is associated with the subsequent devel- opment of major depression , substance abuse and other mental health problems .", "label": "", "metadata": {}, "score": "86.31579"}
{"text": "Clearly , it is of increasing importance to consider therapeutic alternatives for patients with SAD who demonstrate resistance to SSRIs .BMJ Open 2013;3:e002242 .", "label": "", "metadata": {}, "score": "86.416794"}
{"text": "AB , LT , MGV , RDA , SG and SS revised the manuscript critically .All authors read and approved the final manuscript .Author information .", "label": "", "metadata": {}, "score": "86.45694"}
{"text": "Heimberg RG , Horner KJ , Juster HR , et al .Psychometric properties of the Liebowitz Social Anxiety Scale .Psychol Med 1999;29:199 - 212 .", "label": "", "metadata": {}, "score": "86.49646"}
{"text": "Swinson RP , Antony MM , Bleau PB , et al .Clinical practice guidelines : management of anxiety disorders .Can J Psychiatry 2006;51:9S-91S. Stein DJ , Baldwin DS , Bandelow B , et al .", "label": "", "metadata": {}, "score": "86.66888"}
{"text": "Cross - sectional area of the IJV at J2 point greater in sitting that in supine posture .a As described by Zamboni [ 12 ] .", "label": "", "metadata": {}, "score": "86.76004"}
{"text": "Lancet 2008;371:1115 - 25 .Fava GA , Tomba E. Increasing psychological well - being and resilience by psychotherapeutic methods .J Pers 2009;77:1903 - 34 .", "label": "", "metadata": {}, "score": "86.77023"}
{"text": "Brain 1989 , 112 : 133 - 146 .PubMed View Article .Filippini G , Munari L , Incorvaia B , Ebers GC , Polman C , D'Amico R , Rice GPA : Interferons in relapsing remitting multiple sclerosis : a systematic review .", "label": "", "metadata": {}, "score": "86.84676"}
{"text": "Published Online : October 31 , 2013 .doi:10.1001/jama.2013.282183 .Author Contributions : Drs Feres and Costa had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis .", "label": "", "metadata": {}, "score": "86.85859"}
{"text": "In recent years , there have been a considerable number of randomized controlled trials of new malaria interventions directed at children , including trials evaluating candidate malaria vaccines , insecticide - treated bed nets ( ITN ) and intermittent presumptive or preventive therapy in infants ( IPTi ) .", "label": "", "metadata": {}, "score": "86.927025"}
{"text": "HR indicates hazard ratio .References .Stone GW , Moses JW , Ellis SG , et al .Safety and efficacy of sirolimus- and paclitaxel - eluting coronary stents .", "label": "", "metadata": {}, "score": "86.9408"}
{"text": "Abbreviations .Competing interests .All the other authors declare that they have no competing interests .Authors ' contributions .All authors are members of the Steering Committee and contributed to the design of the Brave Dreams trial .", "label": "", "metadata": {}, "score": "86.954735"}
{"text": "Rush AJ , Zimmerman M , Wisniewski SR , et al .Comorbid psychiatric disorders in depressed outpatients : demographic and clinical features .J Affect Disord 2005;87:43 - 55 .", "label": "", "metadata": {}, "score": "86.99637"}
{"text": "Promoter .Acknowledgements .The authors thank the Governor , Assessorato alla Sanit\u00e0 , and the Regional Agency for Health and Social Care of the Regione Emilia Romagna for supporting and funding the Brave Dreams Trial .", "label": "", "metadata": {}, "score": "87.06598"}
{"text": "Expert Rev Pharmacoecon Outcomes Res 2012;12:745 - 64 .Lepola U , Bergtholdt B , St Lambert J , et al .Controlled - release paroxetine in the treatment of patients with social anxiety disorder .", "label": "", "metadata": {}, "score": "87.07417"}
{"text": "View Article PubMed .Massaga JJ , Kitua AY , Lemnge MM , Akida JA , Malle LN , Ronn AM , Theander TG , Bygbjerg IC : Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania : a randomised placebo - controlled trial .", "label": "", "metadata": {}, "score": "87.10144"}
{"text": "Pharmacotherapy augmentation strategies in treatment - resistant anxiety disorders .Cochrane Database Syst Rev 2006 Oct 18;(4);CD005473 .Liebowitz MR , Mangano RM , Bradwejn J , et al .", "label": "", "metadata": {}, "score": "87.1063"}
{"text": "N Engl J Med 1995 , 332 : 1399 - 1404 .View Article PubMed .Waller D , Krishna S , Crawley J , Miller K , Nosten F , Chapman D , ter Kuile FO , Craddock C , Berry C , Holloway PA , et al .", "label": "", "metadata": {}, "score": "87.15625"}
{"text": "Vounatsou P , Smith T , Kitua AY , Alonso PL , Tanner M : Apparent tolerance of Plasmodium falciparum in infants in a highly endemic area .", "label": "", "metadata": {}, "score": "87.16649"}
{"text": "Ms Houston Miller reported receiving personal income for consulting from Triage Wireless and receiving honoraria from Pfizer , CV Therapeutics , and AstraZeneca .Dr Pi\u00f1a reported receiving grants or funding from the National Institutes of Health , receiving personal income for consulting from the Food and Drug Administration , and receiving honoraria from AstraZeneca , Innovia , Merck , Novartis , Sanofi - Aventis , and Solvay .", "label": "", "metadata": {}, "score": "87.23125"}
{"text": "References .Trials 2012 , 13 : 139 .PubMed View Article .BMJ 2012 , 344 : e2758 .PubMed View Article .Medical Research Council : Guidelines for Good Clinical Practice .", "label": "", "metadata": {}, "score": "87.27327"}
{"text": "PubMed View Article .Cadavid D , Tang Y , O'Neill G : Responsiveness of the Expanded Disability Status Scale ( EDSS ) to disease progression and therapeutic intervention in progressive forms of multiple sclerosis .", "label": "", "metadata": {}, "score": "87.275536"}
{"text": "Vranckx P , Cutlip DE , Mehran R , et al .Myocardial infarction adjudication in contemporary all - comer stent trials : balancing sensitivity and specificity : addendum to the historical MI definitions used in stent studies .", "label": "", "metadata": {}, "score": "87.29342"}
{"text": "Vranckx P , Cutlip DE , Mehran R , et al .Myocardial infarction adjudication in contemporary all - comer stent trials : balancing sensitivity and specificity : addendum to the historical MI definitions used in stent studies .", "label": "", "metadata": {}, "score": "87.29342"}
{"text": "Does self monitoring of blood blucose as opposed to urinalysis provide additional benefit in patients newly diagnosed with type 2 diabetes receiving structured education ?The DESMOND SMBG randomised controlled trial protocol .", "label": "", "metadata": {}, "score": "87.3141"}
{"text": "A placebo - controlled trial of captopril in refractory chronic congestive heart failure .J Am Coll Cardiol .Captopril - Digoxin Multicenter Research Group .", "label": "", "metadata": {}, "score": "87.38429"}
{"text": "A placebo - controlled trial of captopril in refractory chronic congestive heart failure .J Am Coll Cardiol .Captopril - Digoxin Multicenter Research Group .", "label": "", "metadata": {}, "score": "87.38429"}
{"text": "View Article PubMed .Smith T , Schellenberg JA , Hayes R : Attributable fraction estimates and case definitions for malaria in endemic areas .Stat Med 1994 , 13 : 2345 - 2358 .", "label": "", "metadata": {}, "score": "87.447586"}
{"text": "Acquisition of data : Feres , Costa , Abizaid , Marin - Neto , Botelho , de Paula , Mangione , Meireles , Castello Jr , Nicolela Jr , Perin , Devito , Labrunie , Salvadori Jr , Gusm\u00e3o , Staico , Costa Jr. , Castro , Abizaid .", "label": "", "metadata": {}, "score": "87.71348"}
{"text": "View Article PubMed .Lancet 2004 , 364 : 1411 - 1420 .View Article PubMed .PLoS Clin Trials 2006 , 1 : e29 .", "label": "", "metadata": {}, "score": "87.74666"}
{"text": "Methods .Identification of studies .Reports of trials published between 1990 and 2007 evaluating the impact of preventive malaria interventions were identified ( specifically vaccines , impregnated bed nets and IPTi ) .", "label": "", "metadata": {}, "score": "87.82393"}
{"text": "WW contributed to the design of the recruitment strategy for South Asian patients and translation of outcome measures .MH performed the sample size calculation and edited the manuscript .", "label": "", "metadata": {}, "score": "87.83922"}
{"text": "Henry MC , Assi SB , Rogier C , Dossou - Yovo J , Chandre F , Guillet P , Carnevale P : Protective efficacy of lambda - cyhalothrin treated nets in Anopheles gambiae pyrethroid resistance areas of Cote d'Ivoire .", "label": "", "metadata": {}, "score": "87.91838"}
{"text": "View Article PubMed .Copyright .\u00a9Moorthy et al .2009 .This article is published under license to BioMed Central Ltd.Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure : HF - ACTION Randomized Controlled Trial FREE .", "label": "", "metadata": {}, "score": "87.951385"}
{"text": "Access to the PDF is only available via article purchase .Affiliated with .Abstract .Background .Recent years have seen publication of a considerable number of clinical trials of preventive interventions against clinical malaria in children .", "label": "", "metadata": {}, "score": "88.073204"}
{"text": "In an analysis to examine the effect of exercise training by subgroup , we used the reported race categories \" black or African American \" and \" white \" and combined all others as \" other .", "label": "", "metadata": {}, "score": "88.08098"}
{"text": "Main Outcome Measures Composite primary end point of all - cause mortality or hospitalization and prespecified secondary end points of all - cause mortality , cardiovascular mortality or cardiovascular hospitalization , and cardiovascular mortality or heart failure hospitalization .", "label": "", "metadata": {}, "score": "88.083275"}
{"text": "The analysis was based on the risk rather than the rate of malaria .Thus , the number of cases of malaria was divided by the number of children at risk rather than by the person - time at risk .", "label": "", "metadata": {}, "score": "88.093956"}
{"text": "Topol EJ , Armstrong P , Van de Werf F , et al ; Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries ( GUSTO ) Steering Committee .", "label": "", "metadata": {}, "score": "88.284805"}
{"text": "Topol EJ , Armstrong P , Van de Werf F , et al ; Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries ( GUSTO ) Steering Committee .", "label": "", "metadata": {}, "score": "88.284805"}
{"text": "The observation of a statistically significant advantage in only one of the two end points ( clinical or MRI ) will be sufficient to declare the study results in favor of the superiority of angioplasty over sham procedure .", "label": "", "metadata": {}, "score": "88.55345"}
{"text": "The observation of a statistically significant advantage in only one of the two end points ( clinical or MRI ) will be sufficient to declare the study results in favor of the superiority of angioplasty over sham procedure .", "label": "", "metadata": {}, "score": "88.55345"}
{"text": "Auriel E , Karni A , Bornstein NM , Nissel T , Gadoth A , Hallevi H : Extra - cranial venous flow in patients with multiple sclerosis .", "label": "", "metadata": {}, "score": "88.59213"}
{"text": "Snow RW , Bastos de Azevedo I , Lowe BS , Kabiru EW , Nevill CG , Mwankusye S , Kassiga G , Marsh K , Teuscher T : Severe childhood malaria in two areas of markedly different falciparum transmission in east Africa .", "label": "", "metadata": {}, "score": "88.59651"}
{"text": "The clinical phenotypes include relapsing - remitting MS ( RRMS ) , secondary progressive MS ( SPMS ) , primary progressive MS ( PPMS ) and progressive relapsing MS ( PRMS ) [ 2 ] .", "label": "", "metadata": {}, "score": "88.77111"}
{"text": "Istituto Neurologico Besta Milano .References .Pugliatti M , Rosati G , Cartone H , Riise T , Drulovic J , V\u00e9csei L , Milanov I : The epidemiology of multiple sclerosis in Europe .", "label": "", "metadata": {}, "score": "89.02883"}
{"text": "AB , LT , MGV , RDA , SG and SS revised the manuscript critically .All authors read and approved the final manuscript .Authors ' Affiliations .", "label": "", "metadata": {}, "score": "89.050964"}
{"text": "Daemen J , Wenaweser P , Tsuchida K , et al .Early and late coronary stent thrombosis of sirolimus - eluting and paclitaxel - eluting stents in routine clinical practice : data from a large two - institutional cohort study .", "label": "", "metadata": {}, "score": "89.16751"}
{"text": "Although the cause of MS is unknown , it is regarded as a complex disease that results from the combined effect of unidentified environmental factors and susceptibility genes .", "label": "", "metadata": {}, "score": "89.29973"}
{"text": "MS has a chronic course that evolves over 30 to 40 years .The clinical phenotypes include relapsing - remitting MS ( RRMS ) , secondary progressive MS ( SPMS ) , primary progressive MS ( PPMS ) and progressive relapsing MS ( PRMS ) [ 2 ] .", "label": "", "metadata": {}, "score": "89.38397"}
{"text": "View Article .Malagoni AM , Galeotti R , Menegatti E , Manfredini F , Basaglia N , Salvi F , Zamboni P : Is chronic fatigue the symptom of venous insufficiency associated with multiple sclerosis ?", "label": "", "metadata": {}, "score": "89.42592"}
{"text": "PubMed View Article .Blinkenberg M , Akeson P , Sillesen H , L\u00f6vgaard S , Sellebjerg F , Paulson OB , Siebner HR , S\u00f8rensen PS : Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis .", "label": "", "metadata": {}, "score": "89.60448"}
{"text": "References .Hunt SA , Abraham WT , Chin MH , et al ; American College of Cardiology ; American Heart Association Task Force on Practice Guidelines ; American College of Chest Physicians ; International Society for Heart and Lung Transplantation ; Heart Rhythm Society .", "label": "", "metadata": {}, "score": "89.62349"}
{"text": "If you believe that your rights have been infringed by this repository , please contact drosupport@deakin.edu.au .Publisher main menu .Follow BioMed Central .Trials main menu .", "label": "", "metadata": {}, "score": "89.671425"}
{"text": "Figures in this Article .Heart failure is a major and increasingly common cardiovascular syndrome , and is the end result of many cardiovascular disorders .", "label": "", "metadata": {}, "score": "89.76127"}
{"text": "Int Angiol 2010 , 29 : 176 - 182 .PubMed .Lugli M , Morelli M , Guerzoni S , Maleti O : The hypothesis of pathophysiological correlation between chronic cerebrospinal venous insufficiency and multiple sclerosis : rationale of treatment .", "label": "", "metadata": {}, "score": "89.776566"}
{"text": "PubMed .Lyke KE , Dicko A , Kone A , Coulibaly D , Guindo A , Cissoko Y , Traore K , Plowe CV , Doumbo OK : Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara , Mali .", "label": "", "metadata": {}, "score": "89.83242"}
{"text": "Stone GW , Moses JW , Ellis SG , et al .Safety and efficacy of sirolimus- and paclitaxel - eluting coronary stents .N Engl J Med .", "label": "", "metadata": {}, "score": "89.932465"}
{"text": "A case series of 247 procedures ( 229 primary procedures and 18 secondary procedures due to restenosis ) in 231 patients reported that 2 % of patients had symptomatic stenosis that required retreatment within 30 days [ 37 ] .", "label": "", "metadata": {}, "score": "90.079025"}
{"text": "A case series of 247 procedures ( 229 primary procedures and 18 secondary procedures due to restenosis ) in 231 patients reported that 2 % of patients had symptomatic stenosis that required retreatment within 30 days [ 37 ] .", "label": "", "metadata": {}, "score": "90.079025"}
{"text": "Lancet 1997 , 350 : 844 - 850 .View Article PubMed .Schellenberg D , Menendez C , Kahigwa E , Aponte J , Vidal J , Tanner M , Mshinda H , Alonso P : Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants : a randomised , placebo - controlled trial .", "label": "", "metadata": {}, "score": "90.12448"}
{"text": "The included studies were conducted in Italy , the United States , Germany , Poland , Jordan and Iran [ 12 , 16 - 29 ] .", "label": "", "metadata": {}, "score": "90.22389"}
{"text": "The included studies were conducted in Italy , the United States , Germany , Poland , Jordan and Iran [ 12 , 16 - 29 ] .", "label": "", "metadata": {}, "score": "90.22389"}
{"text": "Washington DC : American Psychiatric Pub , 1997 .First MB , Gibbon M. User 's guide for the structured clinical interview for Dsm - IV Axis II personality disorders : Scid - II .", "label": "", "metadata": {}, "score": "90.25419"}
{"text": "13 , no .18 , pp . 1 - 9 .Does self monitoring of blood blucose as opposed to urinalysis provide additional benefit in patients newly diagnosed with type 2 diabetes receiving structured education ?", "label": "", "metadata": {}, "score": "90.2983"}
{"text": "Hofmann SG , Barlow DH , Papp LA , et al .Pretreatment attrition in a comparative treatment outcome study on panic disorder .Am J Psychiatry 1998;155:43 - 7 .", "label": "", "metadata": {}, "score": "90.32277"}
{"text": "Liebowitz MR , Gelenberg AJ , Munjack D. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder .Arch Gen Psychiatry 2005;62:190 - 8 .", "label": "", "metadata": {}, "score": "90.37163"}
{"text": "In many countries , the first line of pharmacotherapy involves the administration of a selective serotonin reuptake inhibitor ( SSRI ) .Although a significant proportion of patients with SAD fail to respond to the initial SSRI administration , there is no standard approach to the management of SSRI - resistant SAD .", "label": "", "metadata": {}, "score": "90.37511"}
{"text": "View Article PubMed .Jama 2005 , 293 : 1461 - 1470 .View Article PubMed .Newton CR , Valim C , Krishna S , Wypij D , Olola C , Agbenyega T , Taylor TE : The prognostic value of measures of acid / base balance in pediatric falciparum malaria , compared with other clinical and laboratory parameters .", "label": "", "metadata": {}, "score": "90.37926"}
{"text": "Unger EF : Interferon \u03b2-1b ( Betaseron ) treatment of secondary progressive forms of multiple sclerosis .Medical Officer Clinical Review of the June 28 , 2000 Amendment to Supplemental BLA 98 - 0737 ( STN103471 file ) .", "label": "", "metadata": {}, "score": "90.40097"}
{"text": "Circulation .2011;124(23):e574-e651 .Airoldi F , Colombo A , Morici N , et al .Incidence and predictors of drug - eluting stent thrombosis during and after discontinuation of thienopyridine treatment .", "label": "", "metadata": {}, "score": "90.41414"}
{"text": "Circulation .2011;124(23):e574-e651 .Airoldi F , Colombo A , Morici N , et al .Incidence and predictors of drug - eluting stent thrombosis during and after discontinuation of thienopyridine treatment .", "label": "", "metadata": {}, "score": "90.41414"}
{"text": "It is assumed that the number of events follows a binomial distribution , and the a priori distribution of the probability of event is a \u03b2 ( 1,1 ) , which corresponds to an uninformative uniform distribution .", "label": "", "metadata": {}, "score": "90.4306"}
{"text": "It is assumed that the number of events follows a binomial distribution , and the a priori distribution of the probability of event is a \u03b2 ( 1,1 ) , which corresponds to an uninformative uniform distribution .", "label": "", "metadata": {}, "score": "90.4306"}
{"text": "View Article PubMed .Jha P , Jacob B , Gajalakshmi V , Gupta PC , Dhingra N , Kumar R , Sinha DN , Dikshit RP , Parida DK , Kamadod R , Boreham J , Peto R : A nationally representative case - control study of smoking and death in India .", "label": "", "metadata": {}, "score": "90.455826"}
{"text": "The Multiple Sclerosis Collaborative Research Group ( MSCRG ) .Pharmalink commences Nefecon Phase IIb study in primary IgA nephropathy .Pharmalink AB , a Swedish specialty pharma company , today announces it has initiated a Phase IIb study with Nefecon \u00ae ( Nefigan ) in patients with primary IgA nephropathy at risk of developing end - stage renal disease .", "label": "", "metadata": {}, "score": "90.474075"}
{"text": "Arch Gen Psychiatry 2011;68:692 - 700 .Clark DM , Ehlers A , Hackmann A , et al .Cognitive therapy versus exposure and applied relaxation in social phobia : a randomized controlled trial .", "label": "", "metadata": {}, "score": "90.62224"}
{"text": "View Article PubMed .Alonso PL , Smith T , Schellenberg JR , Masanja H , Mwankusye S , Urassa H , Bastos de Azevedo I , Chongela J , Kobero S , Menendez C , et al .", "label": "", "metadata": {}, "score": "90.73592"}
{"text": "Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients .Int Clin Psychopharmacol 2005;20:9 - 11 .Pallanti S , Quercioli L. Resistant social anxiety disorder response to Escitalopram .", "label": "", "metadata": {}, "score": "90.9768"}
{"text": "PubMed .Rojas JI , Romano M , Ciapponi A , Patrucco L , Cristiano E : Interferon \u03b2 for primary progressive multiple sclerosis .Cochrane Database Syst Rev 2010 , 1 : CD006643 .", "label": "", "metadata": {}, "score": "90.98201"}
{"text": "Sign up in Collections Topic ( 99 articles ) Mental health ?( 75 articles)Evidence based practice ?Articles on similar topics can be found in the following collections .", "label": "", "metadata": {}, "score": "91.0099"}
{"text": "PubMed View Article .Mult Scler 2009 , 15 : 984 - 997 .PubMed View Article .Coyne KS , Matza LS , Thompson CL , Kopp ZS , Khullar V : Determining the importance of change in the overactive bladder questionnaire .", "label": "", "metadata": {}, "score": "91.060684"}
{"text": "The primary end point was a composite of all - cause mortality or all - cause hospitalization .Secondary end points included all - cause mortality , the composite of cardiovascular mortality or cardiovascular hospitalization , and the composite of cardiovascular mortality or heart failure hospitalization .", "label": "", "metadata": {}, "score": "91.06331"}
{"text": "Zamboni P , Galeotti R , Menegatti E , Malagoni AM , Tacconi G , Dall'Ara S , Bartolomei I , Salvi F : Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis .", "label": "", "metadata": {}, "score": "91.09235"}
{"text": "By using it you agree that that you are requesting the material solely for personal , non - commercial use , and that it is subject to the AMA 's Terms of Use .", "label": "", "metadata": {}, "score": "91.098175"}
{"text": "By using it you agree that that you are requesting the material solely for personal , non - commercial use , and that it is subject to the AMA 's Terms of Use .", "label": "", "metadata": {}, "score": "91.098175"}
{"text": "Subtyping social anxiety disorder in developed and developing countries .Depress Anxiety 2010;27:390 - 403 .Stein MB , Roy - Byrne PP , Craske MG , et al .", "label": "", "metadata": {}, "score": "91.23344"}
{"text": "van der Linden GJ , Stein DJ , van Balkom AJ .The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder ( social phobia ) : a meta - analysis of randomized controlled trials .", "label": "", "metadata": {}, "score": "91.26608"}
{"text": "Alogliptin after acute coronary syndrome in patients with type 2 diabetes .N Engl J Med .Scirica BM , Bhatt DL , Braunwald E , et al ; SAVOR - TIMI 53 Steering Committee and Investigators .", "label": "", "metadata": {}, "score": "91.28494"}
{"text": "Alogliptin after acute coronary syndrome in patients with type 2 diabetes .N Engl J Med .Scirica BM , Bhatt DL , Braunwald E , et al ; SAVOR - TIMI 53 Steering Committee and Investigators .", "label": "", "metadata": {}, "score": "91.28494"}
{"text": "Heimberg RG .Social phobia : diagnosis , assessment , and treatment .New York : Guilford Press , 1995 .Stangier U , Schramm E , Heidenreich T , et al .", "label": "", "metadata": {}, "score": "91.33275"}
{"text": "Mehrpour M , Najimi N , Fereshtehnejad SM , Safa FN , Mirzaeizadeh S , Motamed MR , Nabavi M , Sahraeian MA : Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis : a case - control study from Iran .", "label": "", "metadata": {}, "score": "91.36607"}
{"text": "Abstract .Background .The COINCIDE trial aims to evaluate the effectiveness and cost - effectiveness of a collaborative care intervention for depression in people with diabetes and/or coronary heart disease attending English general practices .", "label": "", "metadata": {}, "score": "91.56525"}
{"text": "The primary end- point of SAD severity will be assessed by an independent assessor using the Liebowitz Social Anxiety Scale , and secondary end - points include severity of other social anxieties , depressive severity and functional impairment .", "label": "", "metadata": {}, "score": "91.61324"}
{"text": "Qual Life Res 2004;13:299 - 310 .EuroQol group .A new facility for the measurement of health - related quality of life .The EuroQol Group .", "label": "", "metadata": {}, "score": "91.77742"}
{"text": "Hawn MT , Graham LA , Richman JS , Itani KM , Henderson WG , Maddox TM .Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents .", "label": "", "metadata": {}, "score": "91.950874"}
{"text": "Hawn MT , Graham LA , Richman JS , Itani KM , Henderson WG , Maddox TM .Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents .", "label": "", "metadata": {}, "score": "91.950874"}
{"text": "All authors edited the manuscript and read and approved the final manuscript .Authors ' Affiliations .Greater Manchester Collaboration for Leadership in Applied Health Research and Care , Institute of Population Health and Manchester Academic Health Science Centre , University of Manchester .", "label": "", "metadata": {}, "score": "92.02843"}
{"text": "PubMed View Article .Lublin FD , Reingold SC : Defining the clinical course of multiple sclerosis : results of an international survey .National Multiple Sclerosis Society ( USA ) .", "label": "", "metadata": {}, "score": "92.1407"}
{"text": "Fedoroff IC , Taylor S. Psychological and pharmacological treatments of social phobia : a meta - analysis .J Clin Psychopharmacol 2001;21:311 - 24 .Stein DJ , Ipser JC , Balkom AJ .", "label": "", "metadata": {}, "score": "92.44345"}
{"text": "MS has an incidence of about 4 to 4.5 per 100.000 every year , an average prevalence of 83 per 100,000 in Europe and a female - to - male ratio of about 3:1 [ 1 ] .", "label": "", "metadata": {}, "score": "92.44376"}
{"text": "The funding sponsor ( Medtronic ) had the right to review the manuscript but no authority to change any aspect of it .Additional Contributions : The primary statistical analysis was performed by statistician Alexandre Shinzato , MSc ( Cardiovascular Research Center , S\u00e3o Paulo , S\u00e3o Paulo , Brazil ) .", "label": "", "metadata": {}, "score": "92.56134"}
{"text": "Arch Gen Psychiatry 1992;49:290 - 300 .Davidson JR , Potts N , Richichi E , et al .Treatment of social phobia with clonazepam and placebo .", "label": "", "metadata": {}, "score": "92.57913"}
{"text": "A recent WHO consultation highlighted the need for an explanatory document , outlining the merits and disadvantages of the different approaches to measurement of efficacy against clinical malaria in preventive intervention trials [ 21 ] .", "label": "", "metadata": {}, "score": "92.604294"}
{"text": "Vertebral vein .Declarations .Acknowledgements .The authors thank the Governor , Assessorato alla Sanit\u00e0 , and the Regional Agency for Health and Social Care of the Regione Emilia Romagna for supporting and funding the Brave Dreams Trial .", "label": "", "metadata": {}, "score": "92.60774"}
{"text": "Antimicrob Agents Chemother 2007 , 51 : 3273 - 3281 .View Article PubMed .Clin Infect Dis 2007 , 45 : 16 - 25 .", "label": "", "metadata": {}, "score": "92.61014"}
{"text": "Liebowitz MR .Social phobia .Mod Probl Pharmacopsychiatry 1987;22:141 - 73 .Simon NM , Otto MW , Wisniewski SR , et al .Anxiety disorder comorbidity in bipolar disorder patients : data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder ( STEP - BD ) .", "label": "", "metadata": {}, "score": "92.682816"}
{"text": "Malagoni AM , Galeotti R , Menegatti E , Manfredini F , Basaglia N , Salvi F , Zamboni P : Is chronic fatigue the symptom of venous insufficiency associated with multiple sclerosis ?", "label": "", "metadata": {}, "score": "92.69713"}
{"text": "Obtained funding : O'Connor , Whellan , Lee , Keteyian , Kitzman .Administrative , technical , or material support : O'Connor , Whellan , Lee , Keteyian , Cooper , Kitzman , Blumenthal , Rendall , Fleg , Schulman , Zannad , Pi\u00f1a .", "label": "", "metadata": {}, "score": "92.781906"}
{"text": "PubMed .Rogers WO , Atuguba F , Oduro AR , Hodgson A , Koram KA : Clinical case definitions and malaria vaccine efficacy .J Infect Dis 2006 , 193 : 467 - 473 .", "label": "", "metadata": {}, "score": "92.87042"}
{"text": "PubMed View Article .Marder E , Gupta P , Greenberg BM , Frohman EM , Awad AM , Bagert B , St\u00fcve O : No cerebral or cervical venous insufficiency in US veterans with multiple sclerosis .", "label": "", "metadata": {}, "score": "92.903435"}
{"text": "Drafting of the manuscript : O'Connor , Whellan , Lee , Keteyian , Kraus , Kitzman .Critical revision of the manuscript for important intellectual content : O'Connor , Whellan , Lee , Keteyian , Cooper , Ellis , Leifer , Kraus , Kitzman , Blumenthal , Rendall , Houston Miller , Fleg , Schulman , McKelvie , Zannad , Pi\u00f1a .", "label": "", "metadata": {}, "score": "93.06764"}
{"text": "In addition to mortality and hospitalization , other cardiovascular adverse events were captured , including worsening heart failure , myocardial infarction , unstable angina , serious adverse arrhythmia , stroke , and transient ischemic attack .", "label": "", "metadata": {}, "score": "93.07542"}
{"text": "The sum of the probabilities across individuals was taken as the total \" episodes \" of malaria in the group .For analysis purposes , only one episode was included within any six - week period .", "label": "", "metadata": {}, "score": "93.148964"}
{"text": "Competing interests .The authors declare that they have no competing interests .Authors ' contributions .VSM performed the literature search , extracted the data on methods and reporting and wrote the first draft of the manuscript .", "label": "", "metadata": {}, "score": "93.17391"}
{"text": "The development and deployment of new and improved intervention methods for malaria control shows promising signs of reducing significantly the global burden of malaria .However , the search for more effective control methods still has very high priority .", "label": "", "metadata": {}, "score": "93.28797"}
{"text": "Ann Neurol 2011 , 70 : 51 - 58 .PubMed View Article .Doepp F , Paul F , Valdueza JM , Schmierer K , Schreiber SJ : No cerebrocervical venous congestion in patients with multiple sclerosis .", "label": "", "metadata": {}, "score": "93.31192"}
{"text": "However , the utility of \" time - to - first - event analyses \" for public health policymakers has been questioned as it is argued that it does not measure the overall burden of malaria , which includes second and subsequent episodes in the same individual .", "label": "", "metadata": {}, "score": "93.33122"}
{"text": "Local bleeding from the groin requiring readmission to the hospital occurred in four patients ( including two patients with pseudoaneurysms successfully treated with thrombin injection ) .", "label": "", "metadata": {}, "score": "93.472664"}
{"text": "Local bleeding from the groin requiring readmission to the hospital occurred in four patients ( including two patients with pseudoaneurysms successfully treated with thrombin injection ) .", "label": "", "metadata": {}, "score": "93.472664"}
{"text": "View Article PubMed .Bmj 2004 , 329 : 1212 .View Article PubMed .Mockenhaupt FP , Ehrhardt S , Burkhardt J , Bosomtwe SY , Laryea S , Anemana SD , Otchwemah RN , Cramer JP , Dietz E , Gellert S , Bienzle U : Manifestation and outcome of severe malaria in children in northern Ghana .", "label": "", "metadata": {}, "score": "93.547775"}
{"text": "Cochrane Database Syst Rev 2004 Oct 18;(4):CD001206 .Bandelow B , Zohar J , Hollander E , et al .World Federation of Societies of Biological Psychiatry ( WFSBP ) guidelines for the pharmacological treatment of anxiety , obsessive - compulsive and post - traumatic stress disorders - first revision .", "label": "", "metadata": {}, "score": "93.6557"}
{"text": "A brilliant innovator , a pioneer in directing and organizing health research at an international level , he continued to work with passion and thoroughness until a few days before his death , a unique example of intelligence and ethics .", "label": "", "metadata": {}, "score": "93.77006"}
{"text": "Talking therapies : a four year plan of action , London , 2011 .Pirkis J , Livingston J , Herrman H , et al .", "label": "", "metadata": {}, "score": "93.78326"}
{"text": "6 Yoshinaga N , Niitsu T , Hanaoka H , et al .BMJ Open 2013;3:e002242 .Page 7 .Further , we would like to thank Editage for providing editorial assistance .", "label": "", "metadata": {}, "score": "93.89726"}
{"text": "As all partici- pants will continue to be treated by their general practi- tioners , the patients will be required to obtain permission from their general practitioner prior to study enrolment .", "label": "", "metadata": {}, "score": "93.95323"}
{"text": "Interventions : venography and venous angioplastic procedure , real or sham .Participants will undergo selective venography of the lumbar vein , left renal vein , azygos vein , and IJV by catheterization of the left iliac femoral venous axis to evaluate for the presence and location of venous malformations .", "label": "", "metadata": {}, "score": "93.993744"}
{"text": "Side effects of these treatments are common , including influenza - like symptoms , injection site reactions , headache , depression and fatigue .Hematological toxic effects include hemoglobin reduction , leukopenia , lymphocytopenia , thrombocytopenia and increased liver enzymes [ 5 - 7 ] .", "label": "", "metadata": {}, "score": "94.16029"}
{"text": "Side effects of these treatments are common , including influenza - like symptoms , injection site reactions , headache , depression and fatigue .Hematological toxic effects include hemoglobin reduction , leukopenia , lymphocytopenia , thrombocytopenia and increased liver enzymes [ 5 - 7 ] .", "label": "", "metadata": {}, "score": "94.16029"}
{"text": "PubMed .Radiol Med in press .Krogias C , Schr\u00f6der A , Wiendl H , Hohlfeld R , Gold R : [ \" Chronic cerebrospinal venous insufficiency \" and multiple sclerosis : critical analysis and first observation in an unselected cohort of MS patients ] [ in German].", "label": "", "metadata": {}, "score": "94.22716"}
{"text": "A recent hypothesis suggests that the presence of stenosis of the internal jugular vein ( IJV ) and/or azygos veins that restricts normal blood flow from the brain and spinal cord may be an important factor in the pathogenesis of MS [ 12 , 13 ] .", "label": "", "metadata": {}, "score": "94.25454"}
{"text": "A recent hypothesis suggests that the presence of stenosis of the internal jugular vein ( IJV ) and/or azygos veins that restricts normal blood flow from the brain and spinal cord may be an important factor in the pathogenesis of MS [ 12 , 13 ] .", "label": "", "metadata": {}, "score": "94.25454"}
{"text": "All information relative to patient identity must be kept confidential according to Italian law ( D. Lvo 96/2003 ) .Participants will be identified on the e - CRF only by a conventional code to keep their personal and sensitive information anonymous .", "label": "", "metadata": {}, "score": "94.437"}
{"text": "All information relative to patient identity must be kept confidential according to Italian law ( D. Lvo 96/2003 ) .Participants will be identified on the e - CRF only by a conventional code to keep their personal and sensitive information anonymous .", "label": "", "metadata": {}, "score": "94.437"}
{"text": "The social phobia and anxiety inventory : construct validity .J Psychopathol Behav Assess 1989;11:221 - 34 .Beck AT , Steer RA , Brown GK .", "label": "", "metadata": {}, "score": "94.49054"}
{"text": "Net provides this medical information service in accordance with these terms and conditions .Please note that medical information found on this website is designed to support , not to replace the relationship between patient and physician / doctor and the medical advice they may provide .", "label": "", "metadata": {}, "score": "94.57286"}
{"text": "Lublin FD , Reingold SC : Defining the clinical course of multiple sclerosis : results of an international survey .National Multiple Sclerosis Society ( USA ) .", "label": "", "metadata": {}, "score": "94.83817"}
{"text": "View Article PubMed .Nevill CG , Some ES , Mung'ala VO , Mutemi W , New L , Marsh K , Lengeler C , Snow RW : Insecticide - treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast .", "label": "", "metadata": {}, "score": "94.90682"}
{"text": "View Article PubMed .Am J Trop Med Hyg 2003 , 68 : 23 - 29 .PubMed .Am J Trop Med Hyg 2003 , 68 : 38 - 43 .", "label": "", "metadata": {}, "score": "94.96804"}
{"text": "This condition has been named \" chronic cerebrospinal venous insufficiency \" ( CCSVI ) and is postulated to be congenital and genetically determined .CCSVI , as defined by Zamboni et al . , is diagnosed with combined extracranial and transcranial echo color Doppler ( ECD ) radiography when two or more of five established parameters are present [ 12 ] .", "label": "", "metadata": {}, "score": "95.31142"}
{"text": "This condition has been named \" chronic cerebrospinal venous insufficiency \" ( CCSVI ) and is postulated to be congenital and genetically determined .CCSVI , as defined by Zamboni et al . , is diagnosed with combined extracranial and transcranial echo color Doppler ( ECD ) radiography when two or more of five established parameters are present [ 12 ] .", "label": "", "metadata": {}, "score": "95.31142"}
{"text": "Cohn JN , Tognoni G.Valsartan Heart Failure Trial Investigators .A randomized trial of the angiotensin - receptor blocker valsartan in chronic heart failure .N Engl J Med .", "label": "", "metadata": {}, "score": "95.34369"}
{"text": "Cohn JN , Tognoni G.Valsartan Heart Failure Trial Investigators .A randomized trial of the angiotensin - receptor blocker valsartan in chronic heart failure .N Engl J Med .", "label": "", "metadata": {}, "score": "95.34369"}
{"text": "Lancet .Steinhubl SR , Berger PB , Mann JT III , et al ; CREDO Investigators .Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention : a randomized controlled trial .", "label": "", "metadata": {}, "score": "95.43009"}
{"text": "Lancet .Steinhubl SR , Berger PB , Mann JT III , et al ; CREDO Investigators .Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention : a randomized controlled trial .", "label": "", "metadata": {}, "score": "95.43009"}
{"text": "Abbreviations .COINCIDE : .Collaborative Interventions for Circulation and Depression .ICC : . intraclass correlation .PHQ : .Patient Health Questionnaire .SCL : . symptom checklist .", "label": "", "metadata": {}, "score": "95.65101"}
{"text": "Thus , in preventive trials , it is common practice to define clinical malaria as being present in those who have symptoms and signs consistent with malaria and who also have a density of parasites in their blood greater than some specified level .", "label": "", "metadata": {}, "score": "95.68538"}
{"text": "Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management .Can J Cardiol .Dickstein K , Cohen - Solal A , Filippatos G , et al ; Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology ; ESC Committee for Practice Guidelines ; Document Reviewers .", "label": "", "metadata": {}, "score": "96.00615"}
{"text": "Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management .Can J Cardiol .Dickstein K , Cohen - Solal A , Filippatos G , et al ; Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology ; ESC Committee for Practice Guidelines ; Document Reviewers .", "label": "", "metadata": {}, "score": "96.00615"}
{"text": "18 Relative risks were expressed as hazard ratios ( HRs ) with 95 % confidence intervals ( CIs ) and were calculated using the Cox proportional hazards model .", "label": "", "metadata": {}, "score": "96.06521"}
{"text": "View Article PubMed .Marsh K , Forster D , Waruiru C , Mwangi I , Winstanley M , Marsh V , Newton C , Winstanley P , Warn P , Peshu N , et al .", "label": "", "metadata": {}, "score": "96.12234"}
{"text": "View Article PubMed .Trans R Soc Trop Med Hyg 2006 , 100 : 615 - 622 .View Article PubMed .Korenromp EL , Williams BG , Gouws E , Dye C , Snow RW : Measurement of trends in childhood malaria mortality in Africa : an assessment of progress toward targets based on verbal autopsy .", "label": "", "metadata": {}, "score": "96.13913"}
{"text": "Am Heart J .Mauri L , Kereiakes DJ , Normand SL , et al .Am Heart J .Letters .The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians .", "label": "", "metadata": {}, "score": "96.246925"}
{"text": "ES supervised the overall conduct of the study .All authors read , critically revised and approved the final manuscript .Funding The primary sources for funding for this project are grants from Grant - in - Aid for Scientific Research from the Japanese Ministry of Health , Labour and Welfare ( MHLW ) ( 22SE1P0051 ) .", "label": "", "metadata": {}, "score": "96.48863"}
{"text": "PubMed .J Infect Dis 2002 , 185 : 820 - 827 .View Article PubMed .Am J Trop Med Hyg 2002 , 67 : 604 - 610 .", "label": "", "metadata": {}, "score": "96.67436"}
{"text": "21 , 22 Although the overall significance level was .05 , a significance level of .044 was required at the final analysis due to adjustment for the interim analyses .", "label": "", "metadata": {}, "score": "96.80966"}
{"text": "Absent flow in internal jugular veins and/or vertebral veins after repeated deep inhalations with the patient in both examination positions ( sitting and supine ) in at least one of the three landmarks ( J1 , J2 , J3 ) .", "label": "", "metadata": {}, "score": "96.87996"}
{"text": "Am J Trop Med Hyg 1998 , 59 : 539 - 542 .PubMed .Imbert P , Gerardin P , Rogier C , Ka AS , Jouvencel P , Brousse V , Guyon P : Severe falciparum malaria in children : a comparative study of 1990 and 2000 WHO criteria for clinical presentation , prognosis and intensive care in Dakar , Senegal .", "label": "", "metadata": {}, "score": "97.10063"}
{"text": "p Values of less than 0.05 are considered to indicate stat- istical significance .ETHICS AND DISSEMINATION This study Outpatient Clinic of Chiba University .The study proto- col has been approved by the Institutional Review Board of the Chiba University Hospital ( Reference number : G23075 ) .", "label": "", "metadata": {}, "score": "97.13757"}
{"text": "Al - Omari MH , Rousan LA : Internal jugular vein morphology and hemodynamics in patients with multiple sclerosis .Int Angiol 2010 , 29 : 115 - 120 .", "label": "", "metadata": {}, "score": "97.17291"}
{"text": "Kelsey JE .Venlafaxine in social phobia .Psychopharmacol Bull 1995;31:767 - 71 .Altamura AC , Pioli R , Vitto M , et al .", "label": "", "metadata": {}, "score": "97.25185"}
{"text": "Competing interests None .Patient consent Obtained .Ethics approval Institutional Review Board ( IRB ) of Chiba University Hospital ( Reference number : G23075 ) .", "label": "", "metadata": {}, "score": "97.691696"}
{"text": "For example , in areas where malaria is relatively uncommon , the finding of any malaria parasites in the blood of someone presenting to a health facility with fever provides a sensitive and specific diagnosis of the disease .", "label": "", "metadata": {}, "score": "97.78533"}
{"text": "Drafting of the manuscript : Feres , Costa , Bhatt .Critical revision of the manuscript for important intellectual content : Feres , Costa , Abizaid , Leon , Marin - Neto , Botelho , King , Negoita , Castro , Andrea Abizaid , Bhatt .", "label": "", "metadata": {}, "score": "97.9715"}
{"text": "PubMed View Article .Ministero della Salute Consiglio Superiore di Sanit\u00e0 : Trasmissione parere \" Insufficienza venosa cerebro - spinale cronica ( CCSVI )e sclerosi multipta ( SM ) .", "label": "", "metadata": {}, "score": "98.077995"}
{"text": "In the PROTECT ( Patient - Related Outcomes With Endeavor Versus Cypher Stenting Trial ) , significant differences were seen only in the occurrence of very late stent thrombosis , with lower rates found with zotarolimus - eluting stents compared with sirolimus - eluting stents .", "label": "", "metadata": {}, "score": "98.142944"}
{"text": "Department of Health .No health without mental health : a cross - government mental health outcomes strategy for people of all ages , London , 2011 .", "label": "", "metadata": {}, "score": "98.24568"}
{"text": "Electronic supplementary material .The online version of this article ( doi : 10 .1186/\u200b1475 - 2875 - 8 - 23 ) contains supplementary material , which is available to authorized users .", "label": "", "metadata": {}, "score": "98.26121"}
{"text": "Financial Disclosures : Dr O'Connor reported receiving grants or funding , personal income for consulting , and honoraria from GE Medical , Roche , and the National Institutes of Health .", "label": "", "metadata": {}, "score": "98.34844"}
{"text": "The anomalies of the main extracranial cerebrospinal veins that interfere with normal blood outflow of brain parenchyma are reported in Table 3 [ 12 , 13 , 30 ] .", "label": "", "metadata": {}, "score": "98.38234"}
{"text": "Arch Gen Psychiatry 2004;61:1005 - 13 .Gelernter CS , Uhde TW , Cimbolic P , et al .Cognitive - behavioral and pharmacological treatments of social phobia .", "label": "", "metadata": {}, "score": "98.39557"}
{"text": "Dr Costa reported receiving speakers honoraria from Medtronic Vascular and Biosensors International and research grant support from Abbott Vascular .Dr King reported receiving Data and Safety Monitoring Board honoraria from Merck & Company , Wyeth Pharmaceuticals , and nContact Surgical ; receiving consulting fees from Celonova Biosciences Inc ; and serving on the speakers bureau of the Network for Continuing Medical Education .", "label": "", "metadata": {}, "score": "98.441956"}
{"text": "Early and late coronary stent thrombosis of sirolimus - eluting and paclitaxel - eluting stents in routine clinical practice : data from a large two - institutional cohort study .", "label": "", "metadata": {}, "score": "98.587425"}
{"text": "Severe malaria , malaria - related mortality and all - cause mortality .Identifying deaths due to malaria is problematic in situations where post - mortem is uncommon and many children may die out of a hospital setting .", "label": "", "metadata": {}, "score": "98.946594"}
{"text": "Dr Kraus reported receiving grants or funding from the National Institutes of Health .Dr Blumenthal reported receiving grants or funding from the National Institutes of Health .", "label": "", "metadata": {}, "score": "99.21923"}
{"text": "Serruys PW , Silber S , Garg S , et al .Comparison of zotarolimus - eluting and everolimus - eluting coronary stents .N Engl J Med .", "label": "", "metadata": {}, "score": "99.34288"}
{"text": "Serruys PW , Silber S , Garg S , et al .Comparison of zotarolimus - eluting and everolimus - eluting coronary stents .N Engl J Med .", "label": "", "metadata": {}, "score": "99.34288"}
{"text": "What is clinical malaria ?Defining what constitutes an episode of clinical malaria is not straightforward in areas in which the disease is highly endemic .", "label": "", "metadata": {}, "score": "99.64708"}
{"text": "Shoklo SPf66 Malaria Vaccine Trial Group .Lancet 1996 , 348 : 701 - 707 .View Article PubMed .Bojang KA , Obaro SK , D'Alessandro U , Bennett S , Langerock P , Targett GA , Greenwood BM : An efficacy trial of the malaria vaccine SPf66 in Gambian infants - second year of follow - up .", "label": "", "metadata": {}, "score": "99.73543"}
{"text": "A different approach to defining clinical malaria was used in an ITN trial performed in C\u00f4te d'Ivoire [ 23 ] .In this trial , each participant was regularly tested for the level of malaria parasites in their blood .", "label": "", "metadata": {}, "score": "99.890076"}
{"text": "Trial registration number : ISRCTN80309252 .Keywords .Depression Diabetes Coronary heart disease Primary care Collaborative care .Update .Introduction .The Collaborative Interventions for Circulation and Depression ( COINCIDE ) trial aims to investigate the effectiveness and cost - effectiveness of a collaborative care intervention for depression for people with diabetes and/or coronary heart disease [ 1 ] .", "label": "", "metadata": {}, "score": "100.16611"}
{"text": "J Neurol Neurosurg Psychiatry 2011 , 82 : 436 - 440 .PubMed View Article .Mehrpour M , Najimi N , Fereshtehnejad SM , Safa FN , Mirzaeizadeh S , Motamed MR , Nabavi M , Sahraeian MA : Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis : a case - control study from Iran .", "label": "", "metadata": {}, "score": "100.23967"}
{"text": "Exclusion criteria The exclusion criteria for this study include psychosis , pervasive developmental disorders / mental retardation , autism spectrum disorders , suicide , substance abuse or dependence within the 6 months prior to enrolment , antisocial personality dis- order , unstable medical condition , pregnancy or lacta- tion . current highrisk of Eligibility procedure for participation and diagnosis All patients will be evaluated by a psychiatrist and a study investigator using the Structured Clinical Interview for Axis I Disorders ( SCID - I)54and SCID - II.55Treatment history will be confirmed by the prescribing clinician and by chart review .", "label": "", "metadata": {}, "score": "100.24576"}
{"text": "Inversion of valve direction , twisting of a venous segment with consequent stenosis , hypoplasia of a venous segment or agenesis of a venous segment .", "label": "", "metadata": {}, "score": "101.146835"}
{"text": "Filter Type .Tue , 28 Aug 2012 , 15:37:53 EST Tue , 28 Aug 2012 , 16:08:51 EST Tue , 28 Aug 2012 , 16:11:34 EST .", "label": "", "metadata": {}, "score": "101.80019"}
{"text": "Stone GW , Rizvi A , Newman W , et al ; SPIRIT IV Investigators .Everolimus - eluting versus paclitaxel - eluting stents in coronary artery disease .", "label": "", "metadata": {}, "score": "101.86772"}
{"text": "Stone GW , Rizvi A , Newman W , et al ; SPIRIT IV Investigators .Everolimus - eluting versus paclitaxel - eluting stents in coronary artery disease .", "label": "", "metadata": {}, "score": "101.86772"}
{"text": "IgA nephropathy is an orphan condition and Nefecon is aimed at providing patients with IgA nephropathy a disease modifying medication .Alex Mercer , Clinical Development Director at Pharmalink , said : \" IgA nephropathy is a disease with a high unmet medical need and no approved treatments available on the market today .", "label": "", "metadata": {}, "score": "102.30094"}
{"text": "Neurology 1996 , 46 : 907 - 911 .PubMed View Article .Weinshenker BG , Bass B , Rice GP , Noseworthy J , Carriere W , Baskerville J , Ebers GC : The natural history of multiple sclerosis : a geographically based study .", "label": "", "metadata": {}, "score": "102.34277"}
{"text": "PubMed View Article .J Neurol Neurosurg Psychiatry 2009 , 80 : 767 - 772 .PubMed View Article .Kurtzke JF : Rating neurological impairment in multiple sclerosis : an expanded disability status scale ( EDSS ) .", "label": "", "metadata": {}, "score": "103.19585"}
{"text": "View Article PubMed .Habluetzel A , Diallo DA , Esposito F , Lamizana L , Pagnoni F , Lengeler C , Traore C , Cousens SN : Do insecticide - treated curtains reduce all - cause child mortality in Burkina Faso ?", "label": "", "metadata": {}, "score": "103.414444"}
{"text": "View Article PubMed .Lancet 1997 , 349 : 1191 - 1197 .View Article PubMed .Bmj 2005 , 331 : 727 - 733 .", "label": "", "metadata": {}, "score": "103.75691"}
{"text": "Role of the Sponsors : The sponsors had no role in the design of the study .The independent academic clinical research organization ( Cardiovascular Research Center ) , was responsible for the conduct of the study and the collection , management , analysis , and interpretation of the data .", "label": "", "metadata": {}, "score": "104.33095"}
{"text": "Myocardial infarction was defined according to the historical extended World Health Organization definition as previously reported .23 Based on evolving definitions for MI since the design of the OPTIMIZE protocol , the previously considered definition 22 , 24 was changed to the World Health Organization definition 23 by the steering committee while still blinded to group allocation and results .", "label": "", "metadata": {}, "score": "104.43715"}
{"text": "doi:10.1001/jama.2013.282183 .Athens and Shibboleth are access management services that provide single sign - on to protected resources .They replace the multiple user names and passwords necessary to access subscription - based content with a single user name and password that can be entered once per session .", "label": "", "metadata": {}, "score": "104.921265"}
{"text": "If your institution uses Athens or Shibboleth authentication , please contact your site administrator to receive your user name and password .What is this ?", "label": "", "metadata": {}, "score": "105.03747"}
{"text": "If your institution uses Athens or Shibboleth authentication , please contact your site administrator to receive your user name and password .What is this ?", "label": "", "metadata": {}, "score": "105.03747"}
{"text": "Author information .AL died on 1 January 2012 .A brilliant innovator , a pioneer in directing and organizing health research at an international level , he continued to work with passion and thoroughness until a few days before his death , a unique example of intelligence and ethics .", "label": "", "metadata": {}, "score": "105.29277"}
{"text": "Now lower molecular weight HES 130/0.4 is the preferred colloid in Scandinavian intensive care units ( ICUs ) and 1st choice fluid for patients with severe sepsis .", "label": "", "metadata": {}, "score": "106.09493"}
{"text": "Letters .The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians .The AMA designates this journal - based CME activity for a maximum of 1 AMA PRA Category 1 Credit TM per course .", "label": "", "metadata": {}, "score": "106.19162"}
{"text": "doi:10.1001/jama.2009.454 .Athens and Shibboleth are access management services that provide single sign - on to protected resources .They replace the multiple user names and passwords necessary to access subscription - based content with a single user name and password that can be entered once per session .", "label": "", "metadata": {}, "score": "106.247086"}
{"text": "The Multiple Sclerosis Collaborative Research Group ( MSCRG ) .Mult Scler 1998 , 4 : 480 - 486 .PubMed .Kalsi V , Fowler CJ : Therapy insight : bladder dysfunction associated with multiple sclerosis .", "label": "", "metadata": {}, "score": "107.74223"}
{"text": "REFERENCES 1 .American Psychiatric Association .Diagnostic and statistical manual of mental disorders .4th edn .DSM - IV - TR .Washington DC : American Psychiatric Pub , 2000 .", "label": "", "metadata": {}, "score": "107.76661"}
{"text": "Lancet 1994 , 344 : 1175 - 1181 .View Article PubMed .Trop Med Int Health 1999 , 4 : 368 - 376 .View Article PubMed .", "label": "", "metadata": {}, "score": "108.08807"}
{"text": "Clin Infect Dis 1995 , 21 : 577 - 587 .PubMed .Lancet 1997 , 349 : 1650 - 1654 .View Article PubMed .", "label": "", "metadata": {}, "score": "108.25041"}
{"text": "Declarations .Acknowledgements .This work was performed as preparation for a WHO consultation .The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions or the stated policy of the World Health Organization .", "label": "", "metadata": {}, "score": "108.6083"}
{"text": "Trans R Soc Trop Med Hyg 1997 , 91 : 68 - 73 .View Article PubMed .Lancet 1999 , 354 : 203 - 209 .", "label": "", "metadata": {}, "score": "108.87341"}
{"text": "Lancet 2007 , 370 : 1543 - 1551 .View Article PubMed .J Infect Dis 2007 , 196 : 1595 - 1602 .View Article PubMed .", "label": "", "metadata": {}, "score": "108.88271"}
{"text": "PubMed View Article .N Engl J Med 2010 , 362 : 402 - 415 .PubMed View Article .Neurology 2012 , 78 : 1069 - 1078 .", "label": "", "metadata": {}, "score": "109.11439"}
{"text": "Anomalous presence of inverted flow with respect to the physiological direction ( for example , in supine position , azygos vein that empties into the left renal vein instead of into the superior vena cava ; azygos vein that refluxes into the perivertebral plexus with stasis ) .", "label": "", "metadata": {}, "score": "109.89932"}
{"text": "Brave dreams study ( brain venous drainage exploited against multiple sclerosis ) : study protocol for a randomized controlled trial .Abstract .Background .Multiple sclerosis ( MS ) is a chronic inflammatory demyelinating disease of the central nervous system with a disabling progressive course .", "label": "", "metadata": {}, "score": "110.04593"}
{"text": "Trial registration .Clinicaltrials.gov NCT01371760 .Keywords .Multiple sclerosis Chronic cerebrospinal venous insufficiency Percutaneous transluminal angioplasty Functional disability .Background .Multiple sclerosis ( MS ) is a chronic inflammatory demyelinating disease of the central nervous system ( CNS ) with a progressive course .", "label": "", "metadata": {}, "score": "110.705154"}
{"text": "Affiliated with .Abstract .Background .Multiple sclerosis ( MS ) is a chronic inflammatory demyelinating disease of the central nervous system with a disabling progressive course .", "label": "", "metadata": {}, "score": "110.88265"}
{"text": "View Article PubMed .Lancet 2006 , 367 : 659 - 667 .View Article PubMed .J Infect Dis 2006 , 194 : 276 - 285 .", "label": "", "metadata": {}, "score": "110.91272"}
{"text": "PubMed .Copyright .\u00a9 Zamboni et al . ; licensee BioMed Central Ltd. 2012 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "111.25415"}
{"text": "MRI : .Magnetic resonance imaging .MS : .Multiple sclerosis .RRMS : .Relapsing remitting multiple sclerosis .SPMS : .Secondary progressive multiple sclerosis .", "label": "", "metadata": {}, "score": "111.556"}
{"text": "Many will be asymptomatic and others will have symptoms consistent with malaria .In some of this latter group the symptoms may be directly attributable to malaria but , because malaria symptoms are not specific to the illness , in others the symptoms may be due to another condition and the malaria parasites in their blood are merely coincidental .", "label": "", "metadata": {}, "score": "112.23129"}
{"text": "San Carlo Borromeo Hospital , Milano ; 2 .San Donato University Hospital - University of Milano ; 3 .Foundation Neurological Institute C Besta , IRCCS , Milan ; 4 .", "label": "", "metadata": {}, "score": "112.54727"}
{"text": "San Carlo Borromeo Hospital , Milano ; 2 .San Donato University Hospital - University of Milano ; 3 .Foundation Neurological Institute C Besta , IRCCS , Milan ; 4 .", "label": "", "metadata": {}, "score": "112.54727"}
{"text": "Careggi University Hospital - University of Florence ; 11 .Hospital Civitanova , Marche ; 12 .Cannizzaro Hospital , Catania ; 13 .Policlinico G. Rodolico - University Vittorio Emanuele , Catania ; 14 .", "label": "", "metadata": {}, "score": "114.19299"}
{"text": "Careggi University Hospital - University of Florence ; 11 .Hospital Civitanova , Marche ; 12 .Cannizzaro Hospital , Catania ; 13 .Policlinico G. Rodolico - University Vittorio Emanuele , Catania ; 14 .", "label": "", "metadata": {}, "score": "114.19299"}
{"text": "Hospital Maggiore della Carit\u00e0 , Novara ; 6 .Sant'Antonio Hospital , Padova ; 7 .University Hospital of Ferrara ; 8 .Bellaria Hospital , Bologna ; 9 .", "label": "", "metadata": {}, "score": "114.96966"}
{"text": "Hospital Maggiore della Carit\u00e0 , Novara ; 6 .Sant'Antonio Hospital , Padova ; 7 .University Hospital of Ferrara ; 8 .Bellaria Hospital , Bologna ; 9 .", "label": "", "metadata": {}, "score": "114.96966"}
{"text": "Copyright .\u00a9 Coventry et al . ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd. Email updates .", "label": "", "metadata": {}, "score": "115.68573"}
{"text": "Peninsula College of Medicine and Dentistry , University of Exeter and Peninsula Collaboration for Leadership in Applied Health Research and Care ( PenCLAHRC ) .IAPT North West Programme Field Lead , NHS North West .", "label": "", "metadata": {}, "score": "117.322426"}
{"text": "Psychopharmacology research branch .Division of extramural research programs .ECDEU assessment manual for 37 . psychopharmacology .Rockville , MD . : U.S. Dept . of Health , Education , and Welfare , Public Health Service , Alcohol , Drug Abuse , and Mental Health Administration , National Institute of Mental Health , Psychopharmacology Research Branch , Division of Extramural Research Programs 1976 .", "label": "", "metadata": {}, "score": "119.00886"}
{"text": "Neurology , University of Firenze .Neurology , Bellaria Hospital .International MS Cochrane Group .Vascular Surgery , University of Bologna .Universit\u00e0 degli Studi and the Istituto Auxologico Italiano , IRCCS .", "label": "", "metadata": {}, "score": "121.25634"}
{"text": "Funding .Governor of the Regione Emilia Romagna , Italy .Competing interests .All the other authors declare that they have no competing interests .", "label": "", "metadata": {}, "score": "122.16968"}
{"text": "Neurology , University of Bologna .Statistics Institute , University of Modena and Reggio Emilia .Neurology , La Spezia Hospital .Interventional Radiology , University of Ferrara .", "label": "", "metadata": {}, "score": "125.52313"}
{"text": "PS provided input and review into the final manuscript .Authors ' Affiliations .Nuffield Department of Clinical Medicine , John Radcliffe Hospital .World Health Organization , Initiative for Vaccine Research .", "label": "", "metadata": {}, "score": "130.33588"}
{"text": "Unless expressly stated otherwise , the copyright for items in DRO is owned by the author , with all rights reserved .Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO .", "label": "", "metadata": {}, "score": "134.20485"}
